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General introduction 
The caesarean section (CS) was originally designed as an emergency life-saving procedure 
for the pregnant woman. However, the nowadays worldwide rising CS rates implicate 
unnecessary use of this procedure which might even lead to higher morbidity and costs. The 
increasing CS rates also result in an expanding group of women who are pregnant with a CS 
scar, which demands a different approach to the management of pregnancy and labour. 
Clear evidence-based peer-reviewed guidelines exist on when to perform a CS, however to 
what extent these guidelines are implemented is currently unknown.  This thesis will focus 
on the analysis of guideline-adherence around the performance of CSs in The Netherlands 
(part one). Subsequently a tailored strategy to improve care will be developed (part two) 
which is focused on management of birth after CS. In this chapter, an introduction is 
provided to current practice of CSs. Also, in respect to part two of this thesis, management 
of pregnancy after CS will be discussed in particular. The chapter concludes with a 
description of the aims an outline of this thesis. 
Part I Current practice of caesarean sections 
In 1985, the WHO advised a CS rate of 10 to 15%.1 Yet, internationally, the rate of CSs has 
risen in many countries far beyond this recommended range. The highest reported rates are 
41.9% in Iran and the Dominican Republic to 45.9% in Brazil.2 In The Netherlands, the CS 
rate has risen from 7.4% to 16.4% between 1990 and 2013.3,4 A study amongst 
22 industrialized countries showed that between 1987 and 2007, 20 of the 22 countries had 
a statistical significant rise of their CS rate, with a mean relative increase of 49%.5 This rise 
in CSs implies not only a higher risk of feto-maternal complications6,7 but also enormous 
economic implications. A study performed by the WHO showed that in 2008, the costs of 
all CSs exceeding the level of 15% are 2.32 billion US dollars based on data of 
137 countries, representing 95% of global births per year.8 
Implementation of contemporary guidelines 
Compared to a planned vaginal delivery, women with a planned CS have a higher risk of 
prolonged hospital stay, hysterectomy and cardiac arrest.9 For the child there is an increased 
risk of admission to the neonatal intensive care unit.9 Yet a planned CS reduces the risk of 
perineal and abdominal pain during birth and three days postpartum, early postpartum 
haemorrhage and obstetric shock.9 Hence, clear evidence-based recommendations on when 
to perform a CS are provided in several national and international guidelines such as the 
NICE guideline of the Royal College of Obstetricians and Gynaecologists (RCOG)9 and 
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similar guidelines provided by the American College of Obstetricians and Gynaecologists 
(ACOG)10 and the Dutch society of Obstetrics and Gynaecology (NVOG).11 Leading 
indications for CSs include failure to progress during labour (35%), non-reassuring fetal 
heart rate pattern (24%) and fetal malpresentation (19%).12 To what extent contemporary 
guideline recommendations are implemented is currently unknown. We hypothesize that 
one of the causes of the rising CS rates might be inadequate adherence to these guidelines. 
This is supported by the finding of a meta-analysis of  guideline implementation strategies 
of practice of CSs which showed that CS rates can be reduced without impeding safety for 
mother and child using interventions on guideline adherence.13 Interventions which are 
thoroughly designed and correctly targeted might lead to a change of approximately 
5-10%.14,15 Chaillet et al.16 have shown in a meta-analysis of guideline implementations 
studies within obstetrics, that in this field educational strategies are generally ineffective. Yet 
a multifaceted strategy, incorporating feedback from audits and supported by the 
organisation, were much more effective. The authors recommended to tailor the 
implementation strategy to the target-group by carrying out a prospective study which sets 
out to identify possible barriers to change. This approach is reflected in an evidence-based 
stepwise approach for implementing evidence-based guidelines which was developed by 
Grol et al.17 This stepwise approach consists of the following actions: 1) analysis of the 
setting in order to identify targets for change; 2) identification of barriers and facilitators to 
change; 3) the development of an implementation strategy based on the in step two found 
barriers and facilitators; and 4) evaluation of progress. In this thesis, the stepwise approach 
of Grol et al.17 will be applied in order to evaluate and improve current practice of CS in 
The Netherlands and care for pregnant women with a prior CS in particular. 
Part II Improving current practice on pregnancy following 
caesarean section 
In The Netherlands, approximately 10% of all pregnant women have had a prior CS.18 
Medical guidance of these pregnancies requires thoughtful medical attention, especially with 
regard to antenatal counselling on mode of delivery. Based on the results of the in part one 
of this thesis described analysis of current care, the second part of this thesis will elaborate 
on the systematically development of a care improvement strategy on counselling on mode 
of birth after prior CS, directed at physicians and pregnant women. The second part of the 
current chapter will provide an introduction to current care on birth after CS and to 
guideline-recommendations on counselling on pregnancy following CS in particular. 
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Definitions 
Several terms are used in international literature to describe mode of delivery after 
caesarean. In general, the term ‘trial of labour after caesarean’ (TOL or TOLAC) is used to 
describe women who try to have a vaginal birth after a prior CS. A successful TOL results 
in a vaginal birth after caesarean (VBAC), an unsuccessful TOL results in an (emergency) 
CS. In this project we use the term ‘intended VBAC’ instead of TOL, as this merely 
highlights the high probability of success instead of possible failure. When women opt for a 
scheduled or planned CS, this is described as an elective repeat CS (ERCS). 
Current care on mode of birth after CS 
According to contemporary guidelines on pregnancy after CS, pregnant women with a prior 
CS should be provided with a choice between an intended VBAC and an ERCS.19-22 Yet, 
worldwide, the amount of ERCSs rises23 and several hospitals in the USA even abandoned 
the option of intended VBAC.24 For the USA, the most recent literature shows a VBAC rate 
of only 8.3%25 while earlier studies reported a rate of 50% in 1996.26 Most European 
countries report higher VBAC rates. For instance, current known VBAC rates in England 
and Wales are approximately 30-37%.27,28 In comparison to other countries, The 
Netherlands have a relatively high VBAC rate: in 2002-2003 the total VBAC rate was 
54.4%18, current numbers are unknown. Supposed causes for the decreasing VBAC rates 
centre around the safety issue regarding the possible occurrence of uterine rupture during 
labour. Hence, fear for claims and litigation, insurance policies play a role24 but also the 
attitudes of providers and patients towards intended VBAC are changing.23  
Contents of antenatal counselling 
Absolute contraindications for an intended VBAC are prior uterine rupture, a vertical CS 
scar, three or more prior CSs, placenta previa or other factors which preclude a vaginal 
birth, and the inability to perform an emergency CS.19,29 The majority of women has none 
of these contraindications for an intended VBAC and in those cases both birth options 
should be offered and discussed.19,30 Within the decision making process, many factors 
count and therefore optimal counselling is of key importance. The following text elaborates 
on main factors that are regarded to be key-elements within decision-making. 
Probability of successful intended VBAC in relation to morbidity  
The probability that an intended VBAC results in a VBAC is generally 60-80%.23 Most 
studies which discuss risks of feto-maternal morbidity and mortality focus on the 
comparison of intended VBAC with ERCS. However, the probability of morbidity within 
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intended VBAC also coincides with the probability that an intended VBAC results in a 
VBAC.31-33 This is illustrated by observations which show that the incidence of maternal 
morbidity is lowest in women who have a VBAC (0.2%) in comparison to emergency CS 
(3.8%) and ERCS (0.8%).31 Since the incidence of morbidity within a planned CS is 
significantly lower than within an emergency CS, an ERCS might be the better choice for 
women with a low probability of successful intended VBAC. From a statistical point of 
view this would be the ideal approach, assuming that women could be accurately classified 
as ‘low risk’ and ‘high risk’ for failed intended VBAC. Several prediction models which aim 
to provide this calculation have been published and many provide reasonable 
predictability.34 However none of these models are prospectively evaluated or implemented 
within current care. Therefore, it is currently unknown to what extend such a prediction 
model would be valid and useful in clinical practice. Furthermore, current published models 
have been developed in diverse types of populations and settings. Before a model would be 
applied in Dutch practice, it should be adapted to the Dutch population. 
Uterine rupture 
Along general risks and benefits of a CS and vaginal delivery as described in ‘part I’ of this 
chapter, there is the probability of the occurrence of a uterine rupture during labour. A 
uterine rupture is the most feared complication during labour after CS, though the 
probability that it occurs is relatively small. However, when a uterine rupture occurs, the 
consequences can be severe. The probability of fetal death in case of uterine rupture is 6.2-
12.4%.23,35 No studies report on maternal mortality as a result of uterine rupture, however 
the probability of hysterectomy amongst this group is 14-33%.26 Many cohorts with several 
types of settings, sample sizes and case-mix have described the incidence of uterine rupture. 
A recently published large case-control study revealed an incidence of 0.2% in women who 
had an intended VBAC.35 The earlier published meta-analysis of Guise et al.23 showed a 
pooled incidence of 0.47%.23 The incidence increases when labour has been induced. There 
exists a large heterogeneity amongst published studies in this context, hence the quality of 
pooled-data is limited. A rough estimation provided by the previously named meta-analysis 
of Guise et al.23 shows an incidence of uterine rupture of 1.1% in women who are induced 
with oxytocin, 2.0% when induction occurs with prostaglandin E2 and 6.0% when 
induction occurs with misoprostol.23 Induction of labour using a Foley catheter seems not 
to effect the probability of rupture though data are limited.23 Other factors that are 
associated with to an increased risk of uterine rupture are two or more prior CSs, a 
pregnancy within twelve months of the prior CS, a prior vertical incision, macrosomia and 
high body mass index (BMI).23 Prior vaginal delivery seems to be protective.23, 36 Within the 
group of women who chooses ERCS, the mean incidence of uterine rupture is 0.03%.23,35 
To date, for the prediction of uterine rupture, there is no valid model available. Several 
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reports show that sonographic measurements of the thickness of the CS-scar might be an 
powerful predictor, though there is currently no consensus on cut-off values that 
significantly show increase of the risk of uterine rupture37, also the methods of 
measurement has yet to be standardized . 
Fetal complications 
The total chance of fetal morbidity and mortality plays a significant role within the decision-
making process. Apart from general risks and benefits of a CS and vaginal delivery, the total 
chance of fetal mortality is higher in intended VBAC, which is mainly attributable to the 
occurrence of uterine rupture. For intended VBAC, the weighted incidence of perinatal 
mortality is about 0.13%, which is higher than the reported 0.05% for ERCS.26 However, to 
put these numbers into context, for all pregnant women the combined chance of perinatal 
mortality at term is approximately 0.23%.38 Furthermore, the probability of hypoxic-
ischaemic encephalopathy might be higher in an intended VBAC although lack of high-
quality studies impair clearness about this topic.39,40  
Future pregnancies 
Mode of delivery in the current pregnancy has consequences for subsequent pregnancies. 
Studies show that with each extra CS, there is an increase of the incidence of placenta 
accreta, hysterectomy, IC admission, massive blood loss, operative injury and increase of 
duration of operation time.23,41 In absolute risks, the study of Silver et al.41 showed for 
placenta abnormalities an incidence of 0.31% in women having their second CS and of 
0.57% for the third CS. For hysterectomy, these numbers were 0.42% and 0.90%, 
respectively.1 Furthermore, an increasing number of studies reports on an increased risk of 
unexplained antepartum stillbirth in women with a uterine scar. A recent meta-analysis on 
this topic performed by O’Neill et al.42 suggests an increased relative risk of 23% on 
stillbirth for women with a prior CS compared to women without a prior CS. The aetiology 
however remains unravelled and confounding by indication might explain the larger part of 
the found association.  
Shared decision making 
Qualitative studies show that women experience the decision on mode of birth after CS to 
be a difficult decision yet they wish to be involved in decision making.50,51 Key items in the 
decision making process were the opinions of the providers, women’s own prior 
experiences and expectations, experienced safety and whether information was tailored to 
their personal situation.50,52 Because of the complex nature of this decision-making process, 
 14 
C
ha
pt
er
 1
C
ha
pt
er
 1
mode of birth after CS might be discussed within a shared decision making setting. Shared 
decision making (SDM) is defined as a process in which the provider and patient come to a 
shared decision regarding a health issue. SDM is mainly practiced within preference-
sensitive decisions of major importance53 and results in higher patient satisfaction, higher 
quality of decisions and better patient-provider communication.53,54 A patient decision aid 
(PtDA) is an example of a tool that can be used to effectively enhance SDM.55 In this thesis 
we will develop a PtDA for decision-making on mode of birth after CS in order to enhance 
guideline-adherence and to improve care.  
Aim and outline of this thesis 
In order to gain more insight into current quality of care on the practice of CSs in The 
Netherlands, the caesarean Section IMPLEmentation (SIMPLE) study is designed. The aim 
of this study is to evaluate both current physicians’ adherence to guideline-based quality 
indicators as cognitions of medical professionals and patients on decision-making about 
CSs. Based on the results of the evaluation of current care, a tailored guideline 
implementation strategy will be developed in order to improve care. 
Part I Current practice of caesarean sections  
Chapter 2 defines the study protocol of the SIMPLE study. Chapter 3 describes both the 
development process of the guideline-based quality indicators for measurement of current 
Dutch practice of CSs and the results of the actual adherence to these indicators. Finally this 
chapter uncovers counselling of women on mode of birth after prior CS to be one of the 
main target points for intervention. Chapter 4 elaborates on practice variation in mode of 
birth after CS between Dutch hospitals. 
Part II Improving current practice on pregnancy following caesarean section 
Clinical prediction models and patient decision aids may help physicians in the management 
of patients. This concept is discussed in part II of this thesis and elaborated into the 
development and applicability of a guideline-implementation strategy with regard to the 
counselling-process of mode of birth after prior CS. Chapter 5 describes the external 
validation of two existing prediction models for the Dutch population, chapter 6 presents a 
new prediction model and chapter 7 elaborates on whether a prediction model is useful in 
terms of comparison to current care. Chapter 8 describes the development and pilot-testing 
of the developed guideline-implementation strategy.  
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Chapter 9, the general discussion, highlights the implications of this thesis for current 
practice and future research.  
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Abstract 
Background 
Caesarean section (CS) rates are rising worldwide. In the Netherlands, the most significant 
rise is observed in healthy women with a singleton in vertex position between 37 and 
42 weeks gestation, whereas it is doubtful whether an improved outcome for the mother or 
her child was obtained. It can be hypothesized that evidence-based guidelines on CS are not 
implemented sufficiently.  
 
Therefore, the present study has the following objectives: to develop quality indicators on 
the decision to perform a CS based on key recommendations from national and 
international guidelines; to use the quality indicators in order to gain insight into actual 
adherence of Dutch gynaecologists to guideline recommendations on the performance of a 
CS; to explore barriers and facilitators that have a direct effect on guideline application 
regarding CS; and to develop, execute, and evaluate a strategy in order to reduce the CS 
incidence for a similar neonatal outcome (based on the information gathered in the second 
and third objectives).  
 
Methods 
An independent expert panel of Dutch gynaecologists and midwives will develop a set of 
quality indicators on the decision to perform a CS. These indicators will be used to measure 
current care in 20 hospitals with a population of 1,000 women who delivered by CS, and a 
random selection of 1,000 women who delivered vaginally in the same period. Furthermore, 
by interviewing healthcare professionals and patients, the barriers and facilitators that may 
influence the decision to perform a CS will be measured. Based on the results, a tailor-made 
implementation strategy will be developed and tested in a controlled before-and-after study 
in 12 hospitals (six intervention, six control hospitals) with regard to effectiveness, 
experiences, and costs.  
 
Discussion 
This study will offer insight into the current CS care and into the hindering and facilitating 
factors influencing obstetrical policy on CS. Furthermore, it will allow definition of patient 
categories or situations in which a tailor-made implementation strategy will most likely be 
meaningful and cost effective, without negatively affecting the outcome for mother and 
child. 
 SIMPLE study design 
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Background 
The worldwide rise in caesarean section (CS) rate is a major healthcare issue, with rates 
reported as high as 32% in the United States (US) and 37% in Brazil.1,2 In the Netherlands, 
the overall CS rate has increased from 8.1% to 13.6% over the recent decade. Although this 
rise is relatively low compared to other countries, a striking detail is that the most 
impressive rise, in absolute numbers, was among healthy women with a singleton in vertex 
position between 37 and 42 weeks gestation.3 However, an increasing CS rate does not 
imply an improved outcome for mother and infant.4 CS are associated with an increased risk 
of maternal mortality as well as serious morbidity, such as admission to the intensive care 
unit (Odds Ratios (ORs) between 30.8 and 63.4), hysterectomy (ORs between 3.2 and 13.5), 
and puerperal infection (OR 3.0).5-7 
Besides the short-term risks, CS have an impact on the mother’s future reproductive health, 
for example uterine rupture, placenta praevia, or placenta accrete.8,9 
There is no evidence suggesting a better neonatal outcome from the increased CS rate in 
terms of mortality, intracranial haemorrhage, or impaired neurological development in the 
general population.10,11 In fact, an elective CS performed before 39 completed weeks is 
associated with respiratory distress and admission to the neonatal intensive care unit.11,12  
The question arises what causes the worldwide increase in CS rate considering the fact that 
in most situations there are no apparent benefits of a CS for mother and child; the costs are 
higher compared to vaginal birth5; and the incidence of both maternal and neonatal 
complications are increased. There are concerns about the increasing rate of planned CS as 
well as a declining rate of vaginal birth after a previous CS (VBAC) in the US and 
Australia.13,14 
To optimize CS practice, the Royal College of Obstetricians and Gynaecologists (RCOG) 
developed an evidence-based guideline (NICE: National Institute of Clinical Evidence) with 
clear recommendations for obstetric care. Similar recommendations, which have a direct 
effect on the decision to perform a CS, are also mentioned in the different guidelines of the 
Dutch Society of Obstetrics and Gynaecology (NVOG), Society of Obstetricians and 
Gynaecologists of Canada (SOGC), American College of Obstetrics and Gynaecology 
(ACOG), and National Guideline Clearinghouse from the US department of health and 
human services (NGC).  
 
Despite the introduction of evidence-based guidelines, the CS rate continues to increase. 
We hypothesize that poor adherence to the guidelines plays a key role in the rising CS rate. 
In order to optimize adherence to the CS guidelines, the stepwise model by Grol can be 
used to select the proper strategies.15,16 The first step in this model is to analyze the current 
care (measured by valid quality indicators) compared to the optimal care as described in 
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evidence-based guidelines, and to determine which barriers and facilitators might influence 
the implementation of optimal care. Subsequently, a tailor-made implementation strategy 
can be developed with activities applied to the determined barriers. In the last step, the 
strategy is executed and evaluated in terms of effectiveness, feasibility, and costs. 
 
In view of the rising CS rate, this study aims are: 
1. To develop a set of quality indicators on the decision to perform a CS based on key 
recommendations of both Dutch and international guidelines.  
2. To gain insight into actual adherence of Dutch gynaecologists to guideline 
recommendations on the performance of CS. 
3. To explore barriers and facilitators that have a direct effect on application of guideline 
recommendations regarding CS.  
4. To develop, execute and evaluate a strategy in order to improve care and possibly 
decrease the CS incidence for a similar neonatal outcome, based on the information 
gathered in steps two and three. 
Methods 
The four aims were approached in four parts: the development of quality indicators, the 
assessment of current care, the identification of barriers and facilitators, and the 
development of a tailored implementation strategy and executing and evaluating this 
strategy in a clustered controlled before-and-after study (CBA). 
The development of quality indicators 
Design and methods 
In order to measure current Dutch practice on CS, quality indicators regarding the process, 
structure, and outcome of care need to be developed. This will be achieved according to the 
RAND-modified Delphi method.17, 18 The indicators will be based on key recommendations 
extracted from the guidelines of several international obstetric organisations (RCOG, 
NVOG, SOGC, ACOG and NGC). These key recommendations will be evaluated in two 
rounds by an independent expert panel consisting of Dutch obstetricians and midwives. In 
the first round, a questionnaire will be developed on three subjects (planned CS, emergency 
CS, and methods to reduce the CS rate). The questionnaire will be sent to the experts who 
will be asked to individually rate the key recommendations on a 9-point Likert scale ranging 
from 1 to 9 (‘not relevant’ to ‘extremely relevant’ for measuring the quality of CS care). 
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Furthermore, a ranking of the key recommendations will be asked per subject to ultimately 
extract those indicators considered to be most important for quality-of-care measurement. 
The experts also have the opportunity to add comments or suggest additional 
recommendations they consider suitable as a quality indicator. The returned questionnaires 
will be analysed based on the ratings of the recommendations on the 9-point Likert scale, 
and the median score of these items will be calculated and rated as described previously by 
Campbell.19 Furthermore, scoring variables reflecting the ranking of the items in each of the 
three subjects will be developed (e.g., in a top 3 ranking, a first ranking creates 3 points, a 
second ranking 2 points, and a third ranking 1 point).  
The second round consists of a consensus meeting where the experts will receive their 
individual as well as the overall results of the first round to promote discussion. The aim of 
this meeting is to reach consensus on those recommendations that are most suitable for 
assessing the quality of care on performing CS. After consensus is reached, the 
recommendations will be operationalized into a set of measurable quality indicators.  
Study population and setting 
A representative, national expert panel consisting of obstetricians and midwives (about 12 
to 15 experts) will be invited. The obstetricians and midwives will have worked at various 
types of hospitals, ranging from small regional hospitals to university hospitals. 
Outcome measures 
The outcome of the first step of the study is a set of valid quality indicators regarding the 
decision to perform a CS the can then be used to measure the current practice.  
The assessment of current care 
Design and methods 
A retrospective medical record search based on the set of quality indicators will be 
performed in order to assess the Dutch gynaecologists’ adherence to the CS guideline 
recommendations. Adherence to these indicators will be quantified, as well as the variation 
in care and adherence between the participating hospitals. To gain insight into the current 
Dutch care compared to international care, the CS percentages of the different risk groups 
will be calculated according to the Robson classification (Table 2.1).20 
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Table 2.1 Ten-group classification according to Robson. 
Groups 
1. Nulliparous, single cephalic, >37 weeks, in spontaneous labour 
2. Nulliparous, single cephalic, >37 weeks, induced or CS before labour 
3. Multiparous (excluding previous CS), single cephalic, >37 weeks, in spontaneous labour 
4. Multiparous (excluding previous CS), single cephalic, >37 weeks, induced or CS before labour 
5. Previous CS, single cephalic, >37 weeks 
6. All nulliparous breeches 
7. All multiparous breeches (including previous CS) 
8. All multiple pregnancies (including previous CS) 
9. All abnormal lies (including previous CS) 
10. All single cephalic, <36 weeks, (including previous CS) 
 
 
Furthermore, the maternal mortality or severe acute morbidity (Table 2.2)21, and perinatal 
mortality or serious morbidity (pH <7.00, Apgar 5 min <7, and NICU admission) will be 
noted. This study will provide us with information about current practice on CS in the 
Netherlands and insight into the effects on outcome of mother and child. 
 
Table 2.2 Inclusion criteria for severe acute maternal morbidity. 
Group 1: ICU admission 
- Admission to ICU or coronary care unit, other than for standard postoperative recovery 
Group 2: Uterine rupture 
- 
 
Clinical symptoms (pain, fetal distress, acute loss of contractions and haemorrhage) that led to an 
emergency CS, at which the presumed diagnosis of uterine rupture was confirmed 
- Peripartum hysterectomy or laparotomy for uterine rupture 
Group 3: Eclampsia/ HELLP syndrome 
- Eclampsia 
- HELLP syndrome only when accompanied by liver haematoma or rupture 
Group 4: Major obstetric haemorrhage 
- Transfusion need of > 4 units of packed cells 
- Embolisation or hysterectomy for major obstetric haemorrhage 
Group 5: Miscellaneous 
- Other cases of severe maternal morbidity to the opinion of the treating obstetrician, not to be included in 
group 1-4 
 
Study population and setting 
In order to create a representative view of the current obstetrical care in the Netherlands, a 
multi-centre study will be carried out. Twenty hospitals of different Dutch regions will 
participate in this study, including university teaching hospitals, non-university teaching 
hospitals and non-university, non-teaching hospitals. The present study will take place in the 
setting of a Dutch Obstetric Research Consortium in which all the participating hospitals 
collaborate. 
In the participating hospitals, data on basic obstetrical care and adherence to the quality 
indicators will be collected. Per hospital 100 women will be selected from the local database: 
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50 women who delivered by CS and a random set of 50 women who delivered vaginally in 
the same time period. Exclusion criteria will be a major fetal congenital malformality and 
fetal death prior to onset of delivery. 
Outcome measures  
The main outcome is adherence to the guideline recommendations, based on the adherence 
to the quality indicators. Therefore, basic obstetrical data and indicator specific data will be 
gathered. For example, consider the indicator ‘every woman with a child in breech 
presentation at 34 to 36 weeks gestation should be offered external cephalic version unless a 
contraindication for external cephalic version is present.’ This implies that we need to assess 
the incidence of breech presentation at 34 to 36 weeks gestation, as well as data that show 
whether an external cephalic version is being offered. Furthermore, we will note in which 
cases this procedure was not offered for a valid reason. This will allow us to determine the 
frequencies of adherence for this indicator.  
 
The secondary outcomes are the number of preventable CS, and Dutch practice as 
compared to international data using the Robson criteria. 
Sample size considerations  
Assuming an adherence to the guidelines of 75%, an alpha of 0.05, and a precision of the 
estimation of 5%, 300 patients must be included. However, this number has to be adapted 
to take clustering of data across clinicians and within obstetrical departments into account. 
Assuming an intra-cluster correlation (ICC) of 0.2 and 80 professionals in 20 hospitals, 960 
medical records need to be analysed. In order to compensate for loss to follow-up or 
incomplete data, 1,000 women with a CS will be included in 20 hospitals within a timescale 
of three to four months. In order to enable the calculation of specific events, as described in 
‘outcome measures,’ a random selection of 1,000 women with a vaginal birth will be 
included. Thus, there will be 2,000 participants, i.e., 1,000 women after a caesarean delivery 
and 1,000 women after a vaginal birth. Sampling fraction will be adjusted to the fraction of 
women with CS in each individual hospital. 
Data analysis  
The frequencies of adherence per quality indicator will be calculated. This will be calculated 
by dividing the total number of women who apply for an indicator and for whom care was 
appropriate by the total number of women who apply for an indicator. For example, 
women with a child in breech presentation between 34 to 36 weeks of gestation, without 
contraindication for external cephalic version, should have been offered an external cephalic 
version. Adherence is the total number of women with a child in breech presentation 
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between 34 to 36 weeks of gestation without contraindication for external cephalic version, 
in whom an external version was offered, divided by the total number of women with a 
child in breech presentation between 34 to 36 weeks of gestation without contraindication 
for external cephalic version.  
Barrier and facilitator study  
Design and methods 
To determine the barriers and facilitators that influence the decision to perform a CS for 
healthcare professionals and patients, a qualitative study will be performed. The setting for 
guideline implementation will be analysed. Focus group interviews will be held among 
healthcare professionals (obstetricians, residents, and midwives) to discover factors that 
determine the decision to perform a CS or not. The interviewer will explore the following 
categories of influencing factors: features of the guidelines itself; features of the target group 
of professionals who should use the guidelines; features of patients who have to accept or 
contribute to the use of the guidelines; features of the social setting and social network of 
the professionals; and features of the organizational, economic, and administrative context. 
Remarks by professionals will be classified into categories of potential determining factors 
following this theoretical framework. The ‘prevalence’ of the features mentioned in the 
focus group interviews will be quantified in a survey with questionnaires among the 
different professionals. 
 
Similarly, depending on the outcome of the current care study, semi-structured interviews 
will be held with patients in a detailed study to discover relevant factors that influence the 
patients’ decision to choose a CS or vaginal delivery. 
Study population and setting 
In different hospital types (university, non-university teaching, and non-university non-
teaching hospitals) interviews will be held among healthcare professionals (obstetricians, 
residents and midwives) as well as patients. Focus group interviews among 8 to 12 
healthcare professionals will be planned. To assess whether the factors mentioned in the 
focus group interviews are structural, the ´prevalence´ of these factors will be assessed using 
a survey with questionnaires among obstetric gynaecologists, residents, and midwives in the 
Netherlands. The questionnaires will be sent to the professionals via email addresses we will 
obtain from the national professional organisations of both professions. Among patients, 
semi-structured interviews will be held. These patients will be selected in the 
abovementioned hospitals from the current care study. The interviews will be conducted 
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with those women belonging to the non-adherence subgroups (such as breech, non-
progressing labour, or maternal request) to whom a possible implementation should be 
directed. Approximately ten to fifteen women will be interviewed until no new information 
emerges during the interviews.  
Outcome measures  
The main outcome measures are the barriers and facilitators for adherence to the quality 
indicators for performing a CS. 
Data analysis 
Using Atlas, the qualitative software package, a qualitative analysis will be performed on the 
barriers and facilitators that are presented in the interviews among healthcare professionals 
and patients. The transcribed interview will be marked and coded with barriers and 
facilitators according to the framework used to structure the interviews: features of the 
guidelines, professionals, patients, social setting, and organization. These influencing factors 
will be quantified among all Dutch gynaecologists and midwives by means of 
questionnaires. The analyses of the questionnaires will be descriptive (e.g., frequencies and 
means). 
Controlled before-and-after study  
Design and methods 
Based on the results of the current care study and the barrier and facilitator study, one or 
more target groups for a tailor-made implementation strategy will be identified. Target 
groups will be selected with focus on women with both a high incidence of the indicator 
(our hypothesis is that this will include, for example, non-progressing labour and previous 
CS) and low indicator adherence. A tailor-made implementation strategy will be developed 
in order to increase adherence to the CS quality indicators. This strategy will be executed 
and evaluated in a clustered CBA study in 12 hospitals (six intervention, six control 
hospitals) (see sample size calculation) in terms of effectiveness, experiences, and costs. It is 
likely that a strategy with different implementation elements is needed because several 
barriers for implementation of recommendations may exist at different levels. This will 
probably result in a combined intervention directed at the level of professionals, patients, 
and the organisation.  
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Study population and setting 
The implementation strategy will be executed and evaluated in 12 hospitals (see sample size 
calculation) that also participated in the current care study: six intervention hospitals in 
which the newly developed strategy will be applied; and six control hospitals in which care 
as usual will be offered. In order to select these 12 hospitals, all 20 hospitals of the current 
care study will be categorized into university, non-university teaching, and non-university 
non-teaching hospitals (three categories). Within these three categories, possible hospital 
pairs will be made based on pre-intervention adherence to quality indicators and CS rates, as 
measured in the current care study. To get a sample representative for the Dutch setting, in 
total two university hospitals, six non-university teaching hospitals and four non-university, 
non-teaching hospitals will be asked to participate. Subsequently, the participating hospitals 
have to be assigned to the intervention and control group. This will be done per stratum 
and based on geographic region. The evaluation will include an effect, process, and cost 
analysis. Just as in de current care study, the effects will be measured both at medical 
outcome level (i.e., CS rates and complication rates) and on guideline adherence level. 
Satisfaction with and applicability of the tailor-made implementation strategy for both 
patients and healthcare professionals will be measured in a process evaluation. Information 
regarding the process will be gathered in a qualitative study in the hospitals in which the 
implementation strategy was applied. Individual interviews will take place among the 
involved healthcare professionals and patients to gather data about experiences with the 
changed care. During the interview, they also will be asked about which elements of the 
tested strategy they specifically used to implement the evidence-based guidelines; how 
satisfied they are with the different elements; and their opinion about the feasibility of the 
different elements.  
 
Furthermore, a cost analyses of the tested implementation strategy will take place with 
respect to three aspects: 1) the rate at which the guideline recommendations are already 
applied; 2) the costs of the implementation strategy (taking into account the development of 
the strategy, training of healthcare professionals, and possible extra costs regarding both 
time and medical costs) and 3) the effectiveness of the implementation strategy. In order to 
measure the effectiveness of the implementation strategy both the effects on medical 
outcome (i.e., CS rates, complication rates) and adherence to CS quality indicators will be 
measured. The cost-effectiveness of the implementation strategy will be expressed as the 
incremental costs per extra patient treated according to the CS quality indicators, compared 
to the ‘do-nothing’ strategy.   
 SIMPLE study design 
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Outcome measures  
The primary outcome is effectiveness of the implementation strategy, which is defined as 
the observed increase in adherence to the developed quality indicators with regard to the 
chosen target group (for example non-progressing labour or previous CS) between the 
intervention and control hospitals and the actual CS rates in both groups. Secondary 
outcome measures are experiences and satisfaction of healthcare providers and patients with 
the implementation strategy as well as applicability and costs. 
Sample size considerations  
For a sample size calculation, the target group and the adherence to the quality indicators 
regarding this target group are necessary. These data will be available after performing the 
current care as well as the barrier study. Based on these data, the sample size can be 
calculated. In this calculation, we will take into account clustering of patients within 
professionals and hospitals. We expect most of the clustering at professional level and 
presume an inclusion of a number of professionals per hospital and a number of patients 
per professional. For pragmatic reasons, we will include at most 12 out of the 20 hospitals 
of the current care measurement. This sample of hospitals has to be representative for the 
Dutch setting, i.e., a total of two university hospitals, six non-university teaching hospitals, 
and four non-university, non-teaching hospitals. 
Data analysis 
To assess the effectiveness of the implementation strategy, the proportion of patients that 
are treated in accordance with the guidelines before and after implementation of the 
guidelines in both the intervention and control hospitals will be measured. Medical outcome 
measures will include CS rates and maternal as well as neonatal complications related to 
vaginal delivery or CS. Multilevel multivariate analysis will be carried out to assess the 
independent effect of the implementation strategy on adherence to the CS quality indicators 
and medical outcome measures. A qualitative descriptive analysis will be done in order to 
evaluate the process. Furthermore, by means of a questionnaire, the experiences of 
healthcare providers and patient satisfaction with the implementation strategy will be 
evaluated, and the outcomes will be descriptive. 
 
The costs analysis will be performed from a healthcare perspective. The costs of the 
implementation process will be calculated on the basis of the time and materials invested 
based on activity-based costing (ABC) approach, focusing on activities performed with 
costs accumulated at the activity level(s) of the healthcare implementation processes. The 
costs of implementation of the guidelines and consolidation consist of personnel and 
material costs. The input of resources will be assessed by collecting volumes of consumed 
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resources, and multiplying these by the price of each resource unit. For collecting 
information on the input of the resources, registration forms will be completed by the 
people involved in the implementation and consolidation process. The prices of each 
resource unit will be based on standard costs22, market prices, or self-determined costs. The 
medical costs used in de cost analysis will include CS rates and maternal and neonatal 
complications related to vaginal delivery or CS. The costs of implementation and costs of 
the changed medical care will be weighed against the proportion of patients that are treated 
according to the CS guideline, after implementation. The cost-effectiveness of 
implementation will be expressed as the incremental costs per extra patient treated 
according to the CS guideline, compared to the ‘do-nothing’ strategy (i.e., no 
implementation, for which data before implementation will be used). 
Ethical considerations  
The Medical Ethical Committee (CMO) of Maastricht (azM/UM) declared that no ethical 
approval was necessary for this study protocol. 
Discussion  
The CS rate in The Netherlands is comparatively low compared to other countries, but it is 
increasing especially in the group of healthy women with a singleton pregnancy in vertex 
position at term. One would expect this to coincide with improved outcomes for mothers 
and children, which is, however, not the case.5 Although many suggestions considering the 
reason for this rise have been made, the answer is not yet clear. We hypothesize that 
incomplete guideline adherence is a possible cause for the current increase in CS rate. In this 
study we will determine current Dutch care regarding CS using quality indicators. We will 
use national as well as international guidelines to select the recommendations, resulting in at 
least a set of internationally accepted indicators. Because we will also report the current CS 
rates by classification into the internationally accepted Robson Criteria, international 
comparison of incidences of CS rates in different subgroups will be possible. In that way, 
specific indicators and incidences of those indicators might be applicable elsewhere. 
Furthermore, we will focus on factors that influence guideline implementation, and thus 
optimal care in the barrier and facilitator analysis.  
 
Although earlier reviews claimed that multifaceted strategies (combinations of many 
different interventions) are often effective, Grimshaw found that a higher number of 
intervention components was not related to higher effectiveness.23 It seems plausible that 
combined interventions are only more effective than single interventions, if these are 
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addressed at the specific barriers to change. This is also the conclusion of Chaillet et al.: in 
the obstetric setting in general and the CS setting in particular, prospective identification of 
efficient strategies and barriers to change is necessary to achieve a better adaptation of 
intervention and to improve clinical practice guideline implementation.24  
 
This study will hopefully result in one or more target groups with high incidence and low 
guideline adherence and the evaluation of an implementation strategy to improve care. For 
example, non-progressing labour is known to be one of the major reasons to perform a CS. 
Should guideline adherence in these women be low, an intervention based both on 
informing women and reminders on optimal care for caregivers could be an option. 
Another possible target group might be women with a previous CS. Although in general, 
the VBAC rate was previously reported higher in the Netherlands than in some other 
countries, recent data are lacking. Improvement of care for these women could consist of a 
decision aid to improve counselling. Both types of interventions are also possibly effective 
outside the Netherlands. The ultimate aim of our study is to implement the national and 
international evidence-based guidelines on CS in all Dutch hospitals in order to reduce the 
incidence of CS and improve the outcome for mother and child. Furthermore, this study 
provides a framework for future studies to enable improvement of guideline adherence and 
reduction of the CS rate.   
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Abstract 
Objective 
Development and measurement of quality indicators to determine guideline adherence and 
target groups for improvement on care with direct effect on caesarean section (CS) rates.  
 
Design 
RAND-modified Delphi method and a retrospective medical chart review. 
 
Setting 
Multi-centre study, including twenty-one hospitals.  
 
Population 
Eighteen obstetricians and midwives participated in an expert panel for indicator 
development. Charts of 1024 women with a CS and a stratified and weighted randomly 
selected group of 1036 women with a vaginal delivery (VD) were analysed.  
 
Method 
A RAND-modified Delphi method was used to systematically develop quality indicators, 
with focus on counselling and preventive measures in CS care. Quality indicators frequency 
and adherence were scored in 2060 women with CS or VD. 
 
Main outcome measures 
Indicator adherence, defined as the number of women in a specific obstetrical situation in 
which care was performed as recommended in both planned and emergency CS care. 
 
Results 
The expert panel developed 16 indicators on planned CS and 11 indicators on emergency 
CS. The most frequently occurring situations with low indicator adherence were: 
1) suspected fetal distress (frequency 17%, adherence 46%), 2) non-progressive labour 
(frequency 12%, CS performed too early in over 75%), 3) continuous support during labour 
(frequency 88%, adherence 37%) and 4) previous CS (frequency 12%), with adequate 
counselling in 15%.   
 
Conclusions 
Based on 27 developed quality indicators, we identified four target groups for improvement 
of care. 
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Background 
There is a worldwide rise in caesarean section (CS) rates. Although the Netherlands has a 
relatively low CS rate (16.7%) compared to the United Kingdom (24.6%), the most 
impressive rise in CS rate is found in ‘low risk pregnancies’: healthy women with a singleton 
in vertex position at term.1-4 Furthermore, rising CS rates are not associated with improved 
outcome for mother and neonate. Although a CS is a relatively safe procedure, it is 
associated with increased short term morbidity and mortality, with an increased risk of 
abnormal placentation and uterine rupture in future pregnancies.5-10 The World Health 
Organization estimates a CS rate between 10-15% to be optimal.11. A CS costs twice as 
much as a vaginal delivery, (1256 to 9652 euro extra depending on the country of origin 
(Daily Mail July 2013)). Adding all costs of future morbidity and increased risk of future 
repeat CS, the estimated additional costs of one CS are 7500 euro.  
The cause of the increasing CS rate is still unknown. Previous studies mostly focus on 
epidemiological data such as rising maternal age, maternal request for CS and decline in 
attempt of vaginal birth after CS.12,13 Our hypothesis is, that incomplete adherence to 
guidelines regarding the decision when to perform a CS might be an important explanation 
for the rising CS rate. This hypothesis is supported by hospital-level variation in CS rates, 
which cannot be explained by socio-demographic or clinical factors.12 
In recent decades, several international obstetrical organizations have developed evidence-
based guidelines with recommendations for optimal care regarding the decision when to 
perform a CS. However, the crucial issue remains whether these recommendations are 
actually followed. In order to improve current CS care, it is of importance to gain insight 
into the extent of guideline implementation in daily practice. Before this can be measured, 
valid quality indicators for optimal care have to be systematically developed.14,15 
In the present study, we apply a systematic method for development of evidence-based 
quality indicators. Based on these indicators, we compare current Dutch care to optimal 
care as described in international evidence-based guidelines. This will allow the 
identification of target groups of women in which a tailor-made implementation strategy 
might improve care and reduce CS rates. 
Methods 
Development of CS quality indicators 
A systematic RAND-modified Delphi method was used to select a set of key 
recommendations appropriate for transcription into quality indicators.15,16 These 
recommendations were extracted from national guidelines (NVOG: Dutch Society of 
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Obstetricians and Gynaecologists, CBO: Centraal Begeleidings Orgaan, a Dutch 
organization aiming at improving the quality of care by health care professionals), 
international guidelines (RCOG: Royal College of Obstetricians and Gynaecologists, 
ACOG: American Congress of Obstetricians and Gynaecologists, and SOGC: Society of 
Obstetricians and Gynaecologists of Canada) and literature.15 The national expert panel 
consisted of both obstetricians (N=13) and midwives (N=4) and were members of either 
the Dutch Society of Obstetrics and Gynaecology (NVOG) or the Royal Dutch 
Organization of Midwives (KNOV). The experts rated and discussed indicators on planned 
CS (including mode of delivery counselling and CS prevention) as well as indicators on 
emergency CS in an iterative way. The exact procedure for indicator development is 
described in Appendix S1 (Stepwise procedure of CS quality indicators). 
Measurement of CS current care 
Design and setting 
We conducted a retrospective multi-centre cohort study. This study was situated within the 
Dutch Obstetric Consortium, which is a research collaboration of obstetric clinics in The 
Netherlands (http://www.studies-obsgyn.nl). 
Study population  
In order to obtain a representative view of current CS care, this study was conducted in 21 
hospitals: 5 university hospitals, 10 non-university teaching hospitals and 6 non-university, 
non-teaching hospitals located in different regions of The Netherlands. To gain real insight 
in current obstetrical care and measure quality indicator adherence, women with a CS and 
women with a vaginal delivery (VD) were included. For example, consider the situation of 
breech presentation. In such a situation, an external cephalic version should be offered. In 
order to study guideline adherence, all women with a fetus in breech presentation after 34 
weeks need to be identified. In this case, adequate care is offering external cephalic version 
to women with a breech presentation after 34 weeks, independent of their acceptance or the 
result of the attempt. 
Per hospital, the medical charts of 50 consecutive women who underwent a caesarean 
delivery as well as a random selection of 50 women who underwent a VD in the same 
period, were analysed. Since it was inefficient to include and analyse all women with a VD, a 
randomization list was developed per hospital based on the local CS rate. For example, if 
the CS rate was 20%, VD sampling rate was 0.25 (0.25*80%=20%). We excluded cases with 
major fetal abnormalities (defined as ‘abnormalities that interfere with standard obstetrical 
care or vaginal birth’), birth prior to 24 weeks of gestation and fetal demise prior to onset of 
delivery. 
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Data collection 
The data were gathered by trained research nurses from the Dutch Obstetric Consortium 
(http://www.studies-obsgyn.nl). We extracted basic obstetrical data for all women from 
their individual medical charts; including data on previous deliveries (previous VD, CS) and 
current pregnancy (parity, singleton/ multiple gestation). Furthermore, we gathered 
indicator specific data for all women to enable calculation of adherence to each indicator. 
These data included conditions that might influence mode of delivery and existed prior to 
delivery (diabetes, hypertension) or developed either during pregnancy (suspected fetal 
macrosomia, intrauterine growth restriction) or during delivery (suspected fetal distress, 
non-progressive labour). Indicator specific data included ultrasound results, mode of 
delivery counselling, delivery specifics (eg. use of ST-analysis or fetal scalp blood sampling, 
pain medication and oxytocin). We assessed indicator specific data for all women in order to 
evaluate whether care was provided according to guidelines. 
Sample size 
We assumed a mean adherence to the guidelines of 75%, an alpha of 0.05, and a precision 
of the estimation of 5%. Next, we assumed an intra-cluster correlation (ICC) of 0.2 and 80 
professionals in 20 hospitals. Taking clustering of data across clinicians and within 
obstetrical departments into account, 960 medical charts were needed for analyses. In order 
to compensate for loss to follow-up or incomplete data, at least 1,000 women with a CS 
needed to be included. 
In order to enable the calculation of specific events (frequencies) as described in 
‘measurement of CS quality indicators’, a random selection of 1000 women with a vaginal 
delivery were included. This resulted in the analysis of 50 women with a VD and 50 women 
with a CS per hospital.   
Statistical analysis 
To assess guideline adherence, performance scores per indicator were calculated, ranging 
from 0 to 100%. This was done as follows: the number of women to whom the indicator 
applied and actual care was consistent with the indicator (numerator) was divided by the 
total number of women to whom the indicator applied (denominator). When an indicator 
was composed of aggregated items (e.g. the indicator ‘request for CS without medical 
grounds’), we calculated additional sub percentages for each item. In this case, sub 
percentages were calculated for 3 additional items: 1. explore reason for CS request, 2. 
discuss (dis)advantages to CS delivery and 3. Offer psychological counselling in case of fear 
of delivery. Analyses were performed using SPSS statistics 21.  
Percentages were weighted for the hospital-specific sampling fractions used in sampling 
VDs. For example, if a sampling fraction of 0.25 was used in a particular hospital, data for 
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each VD from that hospital counted four (1/0.25) times in the calculation of numerators 
and denominators. 
Results 
Development of CS quality indicators  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1  Development of quality indicators. 
 
 
Based on 51 recommendations, extracted from the guidelines, the stepwise procedure of 
indicator development (figure 3.1) resulted in a set of 27 CS quality indicators, including 16 
indicators on planned CS (mode of delivery counselling (CS versus VD) and prevention) as 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Step 1: Selection of the recommendations from the (inter)national guidelines 
and literature 
National 
guidelines 20 
  International 
guidelines 18 
 Literature 2  International + 
national 
guidelines 5 
51 recommendations
Step 2: Questionnaire round: prioritization on criteria health gain and overall 
efficiency  
Recommendations  
high potential 15 
Recommendations 
uncertain potential 18 
Additional 
recommendations 5  
56 recommendations 
Step 3: Consensus meeting 
27 recommendations
Step 4: Critical evaluation, operationalization and final approval 
14 indicators on mode of delivery 
counselling (CS versus VD) 
13 indicators on prevention of 
planned and emergency CS 
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well as 11 indicators on emergency CS. The final indicator set is given in Table 3.1. The 
indicators on planned CS are shown in Table S3.1 (Quality indicators: planned CS is 
advised) in the appendix of this paper. 
 
Table 3.1 Quality indicator set. 
1) Quality indicators on planned CS 
 a) General counselling, CS is not mentioned (VD is the normal conduct) 
  1. Twin pregnancy and first child cephalic position 
  2. Fetal macrosomia (<4.5kg in maternal diabetes, <5kg no maternal diabetes) 
  3. Preterm labour, cephalic position 
  4. Small for gestational age without fetal distress 
  5. Previous shoulder dystocia without impaired perinatal outcome  
 b) Counselling directed at VD (VD and CS are options, VD is preferred) 
  6. Position of the placenta at 1-2cm of the internal os 
   Request for CS without medical grounds:  
  7. Explore reason for request 
  8. Discuss (dis)advantages to CS delivery 
  9. In case of extreme fear: offer psychological counselling 
  10. Preterm breech delivery (frank, complete breech) 
 c) Counselling mentioning both VD and CS as equal options 
  11. Breech presentation at term 
   Previous CS (Inform on risks and chance for successful VBAC) 
  12. Inform on low risk of uterine rupture 
  13. Inform on high chance of successful VBAC 
  14. Inform on increased risk and lower success rate in case of need for labour induction 
 d) Prevention of planned CS 
  15. Offer external cephalic version in case of non-cephalic position 
  16. Use of internal audit on CS 
2) Quality indicators on emergency CS 
  17. In case of suspected fetal distress use STAN (ST analysis) or micro blood analysis  
   In case of non-progressive labour first stage:  
  18. Rupture of membranes,  
  19. Urinary catheterization,  
  20. Use of pain medication, preferably epidural analgesia,  
  21. Adequate contractions or augmentation of labour 
   In case of non-progressive labour second stage in nulliparous women:  
  22. Active pushing recommended,  
  23. Adequate contractions recommended,  
  24. Consider vacuum extraction if the head is <1/5th palpable per       
         Abdomen 
  25. Continuous support during labour for women with or without prior training 
  26. Use of partogram  
  27. Involvement of consultant obstetrician in decision making for CS 
 
Study population  
All 21 hospitals were asked to provide data of 50 VD as well as 50 CS, which would result 
in a study population of 2100 women. There were 22 women who met the exclusion 
criteria. Not every hospital analysed the requested 100 women, resulting in an analysis of 
 42 
C
ha
pt
er
 3
C
ha
pt
er
 3
2060 women. When adjusting for the random selection of vaginal deliveries, these 2060 
women represent a total study population of 4687 women. 
Measurement of current care 
Table 3.2 shows the frequency of specific obstetrical events, as described by the indicators, 
as well as the performance scores (indicating adequate care) in the total study population 
(N=4687 women) concerning: 1. planned CS and 2 emergency CS.  
 
Table 3.2 Weighted frequencies of CS quality indicators. 
Quality indicators on planned CS  Frequency of 
occurrence 
Perfomance 
score 
(adherence) 
General counselling, CS is not mentioned (VD is the normal conduct) 
Twin pregnancy and  first child in cephalic position 1.3% 16% 
Fetal macrosomia (<4.5kg in maternal diabetes, <5kg no maternal diabetes) 4.3% 33% 
Preterm labor and cephalic position 4.7% 45% 
Small for gestational age without fetal distress 3.3% 43% 
Previous shoulder dystocia no impaired outcome child 1.1% 22% 
Counselling directed at VD (VD and CS are options, VD is preferred) 
Position of the placenta at 1-2cm of the internal os 0.02% 100% 
Request for CS without medical grounds:  
Discussion on reason request  
Discussion on (dis)advantages to CS 
Offer psychological counselling 
1.0%  
80% 
66% 
62% 
Preterm breech delivery (frank, complete breech) 1.7% 1.3% 
Counselling mentioning both VD and CS as equal options 
Breech position at term 4.1% 56% 
Previous CS (inform on risks and success rates) 11.7% 4% 
Previous CS and medical reason for induction of labor (inform on risks and success 
rates) 
2.2% 18% 
Prevention of planned CS 
Offer external cephalic version for non-cephalic position 6% 77% 
Quality indicators on emergency CS:   
Use of partogram  6.9% 54% 
Use of STAN (ST analysis) or micro blood analysis in case of suspected fetal distress 16.9% 46% 
In case of non-progressive labor, perform or provide: 
A AROM (artificial rupture of membranes) 
B Urinary catheterization 
C Use of pain medication 
D Preferably use of epidural analgesia 
E Adequate contractions 
Before performing a CS, an optimal situation (A-E) >2 hrs  
Before performing a CS, an optimal situation (A-E) >4 hrs 
11.1%  
95% 
61% 
78% 
49% 
93% 
23% 
15% 
In case of a primipara and non-progressive labor second stage the following needs to 
be done:  
Active pushing  
Adequate contractions 
Vacuum extraction considered if the head is 
<1/5th palpable per abdomen    
12.7%  
 
98% 
72% 
 
45% 
Continuous support during labor  88.3% 37% 
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1. Planned caesarean section 
Table 3.2 shows that for planned CS, the frequency of the occurrence of the specific events 
ranged from 0.02% to 11.7% and adequate care (performance scores) ranged from 4 to 
100%. Although in many obstetric situations caregivers do not follow guidelines, the impact 
on total caesarean section rate is not likely to change since the frequency of the situation is 
very low. This is the case for twin pregnancies with the first fetus in cephalic position, 
preterm breech and previous shoulder dystocia, occurring in less than 2% in the general 
population. The population with a high incidence and a low performance are women with a 
previous CS. In an average obstetric population, 11.7% of all women have a previous CS 
and in only 15% counselling regarding estimated success rates of a VD, next to risks and 
benefits involved with CS and VD according to the guidelines was documented. In addition, 
in only 4% of the medical charts of these women, comments informing on risks and 
benefits were detailed. The highest performance scores for this group of women were 
found for mode of delivery counselling in case of placenta position at 1-2 cm of the internal 
os (100%), to offer external cephalic version for non-cephalic position (77%) and 
counselling on CS without medical grounds (62-80%). 
2. Emergency caesarean section 
Unlike the indicators for planned caesarean sections, the indicators for emergency caesarean 
sections have a much higher frequency of occurrence, ranging from 11 to 88.3%. In these 
indicators, guideline adherence in general is higher ranging from 23 to 98%.  
Continuous support during labour was advised for all women starting vaginal birth. In 37% 
of these women the support was actually provided. It was advised to apply additional 
diagnostics such as ST-analysis or fetal scalp blood sampling to all women with suspected 
fetal distress, if this was technically possible and no contraindications existed to the 
procedure. In 46% of the women with suspected fetal distress, additional diagnostics were 
applied before proceeding to a CS. In women with non-progressive labour, the performance 
scores of the separate quality indicators (artificial rupture of membranes, urinary 
catheterization, use of pain medication (preferably epidural analgesia and adequate 
contractions), ranged from 61% to 95%. However, the expert panel advised to proceed to a 
CS based on non-progression, not earlier than 2- 4 hours after all previous measures were 
fulfilled. Only in a small proportion of women, these criteria were met and in more than 
77% CS were performed to soon. 
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Discussion  
Main findings 
This study resulted in a set of 27 evidence-based quality indicators on both planned as  
emergency CS. Current care measurement in the Netherlands identified four major  target 
groups for future implementation strategies due to their high prevalence and low adherence 
rate: improvement of counselling in women with a previous CS, improvement of 
implementation of continuous support during labour, additional diagnostics before 
proceeding to a CS in case of suspected fetal distress and allowing a longer waiting period 
before proceeding to a CS in case of non-progressive labour.   
Strengths and limitations  
Our study offers the first set of CS indicators covering entire obstetrical care, thereby 
enabling measurement of quality of obstetrical care in situations that exist antepartum (e.g. 
breech presentation), intrapartum (e.g. non-progressive labour) as well as postpartum (e.g. 
internal audit on CS). This is in contrast to previously developed indicators which only 
focussed on peripartum care.17  
By including 21 hospitals, including different types of hospitals in several regions, and 
analysing more than 1000 women per group, our results are a good representation of actual 
care in The Netherlands.  
 
Although a standardised method for the development of quality indicators was used, there 
are several limitations to this study. To date no study compared the different methods used 
for quality indicator development. However, the RAND-modified Delphi method offers a 
systematic approach to indicator development and is a frequently used method that has 
proven to result in valid quality indicators.18 
 
Another limitation is that the expert panel consisted of Dutch healthcare providers. One 
can challenge whether all quality indicators are usable and accepted in different and specific 
obstetrical settings. However, the obstetrical situations described (e.g. macrosomia, previous 
CS) are comparable world-wide and the basis of the quality indicators consists of 
recommendations derived from international guidelines and literature. Although there may 
be a different approach in obstetrical care in some cases (e.g. preterm breech delivery), we 
expect a similar approach by most obstetrical healthcare professionals to the identified 
major categories. Therefore, we believe that the most important quality indicators are likely 
to be adopted by most obstetrical healthcare professionals.  
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The data collection from medical charts was performed by trained research nurses from the 
Dutch consortium, which could introduce bias. It was shown by Luck et al.19 that medical 
chart review somewhat underestimates the actual care given. Not every detail of a 
consultation is noted in the medical chart. Secondly, despite the fact that the data were 
extracted by trained research employees, there might be interpretation bias. However, when 
considering the adherence percentages for the main categories (fetal distress, non-
progressive labour and previous CS) in our study, we do not expect our results to change 
substantially.  
Interpretation 
In case of a rare situation like triplets, discussing the necessity of CS will only lead to 
marginal improvement of general care. However, an improvement strategy will have a 
considerably larger effect in case of a situation with a relatively high frequency and low non-
adherence rate, such as non-progressive labour. The CS quality indicators allowed us to 
analyse obstetrical care in the Netherlands, thereby identifying groups of women in whom a 
high frequency of a certain quality indicator is observed in combination with low adherence. 
The next step in improvement of care will be to determine factors that influence the mode 
of delivery decision, by either facilitating or hindering quality indicator adherence. Based on 
these influencing factors, a tailor-made implementation strategy is expected to have a high 
impact on obstetrical care.   
 
When the Dutch results are compared to international data, it is expected that for most 
indications for performing a CS, incidences are not very different. Therefore, interventions 
that are directed to these situations are likely to have a high impact internationally. Non-
progressive labour is globally a very common problem and a high CS rate is observed. 
Intervention in this group is likely to have a high impact on current care. In women with 
suspected fetal distress, the incidence of the problem is likely to be comparable as well, but 
management in the United States can probably be improved with the introduction of ST-
analysis or fetal blood sampling.  
Our findings on adherence in the (preventive measures of) emergency CS (continuous 
support during labour, suspected fetal distress and non-progressive labour) are consistent 
with the idea that it is important to prevent the first caesarean delivery. A low adherence 
rate in these cases could, in part, explain the rising CS rate for healthy women with a 
singleton in vertex position at term.20-23  
In general, the cost of a CS is about double that of a vaginal delivery. After a first CS, a large 
majority of women have a CS in the subsequent pregnancy, ranging from 18 to 72% 
depending on the country women live in.24 For each repeated CS, the morbidity increases, 
with higher risks of operative complications, blood transfusions, IC admittance and 
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hysterectomy, adding  extra costs.  Therefore, with on average one subsequent pregnancy, 
the extra costs are estimated to approach 7500 Euro. In Europe, 5.2 million women 
delivered in 2012, with on average a 30% CS rate. With a reduction of 1%, in Europe alone 
390 million Euro can be saved. The WHO advocates a CS rate between 10-15%, although 
this has been challenged. This would result in a cost reduction of 3.9 billion euro every year, 
with no likely harmful effect on maternal or neonatal outcomes. 
 
Beside the use of the presented indicators for local improvement, a subset could be used for 
international comparison of CS care. Until now, international comparison was directed at 
classification and numbers of CS, but this does not reflect quality of care.25-27 We believe 
that international comparison of CS care could be directed at the subset of indicators that 
have the highest impact: 1) in women with a previous CS, structured information on risks 
and benefits on vaginal delivery compared to planned CS should be given and women 
should be given a choice; 2) women should be offered continuous support during vaginal 
delivery 3) before performing CS for suspected distress, fetal blood sampling or ST- analysis 
should be performed; 4) before performing  CS for non-progressive labour, a 2-4 hour 
waiting period should be installed after a situation with ruptured membranes, adequate 
contractions and adequate pain relief is established.  
Conclusion 
This study provides a framework for future studies for improvement of guideline adherence 
and reduction of CS rates, thereby possibly improving the outcome for mother and child. 
Due to the relatively high frequency of occurrence in combination with a low adherence 
rate, we identified 4 possible target groups of women where a tailor-made implementation 
strategy could improve CS care. The next step will be to identify barriers and facilitators that 
influence guideline adherence. We identified several quality indicators that are likely to be 
used for improvement of care on an international basis, after measurement of local current 
care as well as local facilitating and hindering factors. 
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Appendix S1. Stepwise procedure of CS quality indicators 
Methods 
The method of indicator development was carried out according to four consecutive steps: 
1) identification of recommendations, 2) questionnaire round, 3) consensus meeting and 4) 
critical evaluation and operationalization.  
Step 1: Identification of recommendations 
Five international guidelines were used to extract recommendations: guidelines of the 
ACOG (n=1), RCOG (n=3) and SOGC (n=1). In addition, all national guidelines of the 
Dutch Society of Obstetricians and Gynaecologists (NVOG) with recommendations that 
may affect CS rates were used (e.g. fetal surveillance during labour, breech presentation, 
twin pregnancy etc.). Furthermore, the guideline on antiretroviral therapy by the CBO 
(Centraal BegeleidingsOrgaan), a Dutch organization aiming at improving the quality of care 
by health care professionals, was selected. In addition, the articles of Silverberg et al. and 
Robson et al. were used for their information on condyloma treatment in pregnancy and 
medical audit to reduce CS rates, respectively.14,15  
Subsequently, the recommendations were categorised as follows: 1) planned CS (including 
recommendations on  counselling on vaginal delivery (VD) versus caesarean section (CS) in 
different situations and prevention of planned CS) 2) emergency CS. The recommendations 
considering counselling include situations in which a) general counselling is advised without 
mentioning the possibility of choosing CS (VD is the normal conduct); b) counselling is 
advised directed at VD (VD and CS are both options but VD is preferable; c) counselling is 
advised mentioning both VD and CS as equal options; and d) planned CS is advised.   
Step 2: Questionnaire round 
The identified recommendations were subdivided according to the abovementioned 
categories and were transformed into a questionnaire that was sent to the expert panel. If 
available, the questionnaire contained the evidence level per recommendation in order to 
support the decision-making process. The experts were asked to rate each recommendation 
on a nine-point Likert scale with respect to their value for both health gain and overall 
efficacy. In order to be able to distinguish between recommendations with a high score on 
the Likert scale, a ranking of recommendations per category was used. Furthermore, the 
experts were requested to add complementary recommendations. This part of the procedure 
resulted in an allocation of the recommendations for the consensus meeting into 
recommendations with high, uncertain or low potential as quality indicator.  
 
Recommendations were considered ‘high potential’ if: 1) the median rating of the 
recommendation was 8 or more; 2) the recommendation was in the 
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top ranking of the specific category and had at least 20% of the maximum score and 3) 70% 
or more of the expert panel ratings were in the highest tertile on the Likert scale (7, 8 or 9). 
There were three possible appraisal combinations that rated the recommendation as 
‘uncertain potential’: 1) a median score of 8 or more and a top ranking for less than 20% of 
the maximum score; 2) a median score less than 8 and a ranking for at least 20% of the 
maximum score or 3) a rating of 30% or more in the highest (7, 8 or 9) and lowest tertile (1, 
2 or 3) on the Likert scale (=disagreement). The recommendation was determined to have 
‘low potential’ if none of the abovementioned criteria were applicable.16 
Step 3: Consensus meeting  
In a face-to-face consensus meeting the results of the questionnaire round were discussed. 
In order to improve the debate each expert was provided with the overall results from the 
questionnaire round, as well as their own ratings and additional remarks. Firstly, the experts 
were asked if they agreed that the recommendations marked ‘high potential’ indeed had to 
be selected as potential quality indicators to assess and monitor quality of care, and whether 
or not they could agree to the dismissal of those recommendations considered ‘low 
potential’ as quality indicators. In addition, the experts were requested if there were any 
recommendations marked as ‘uncertain potential’ they would strongly advise to consider as 
an indicator. The members of the expert panel were finally asked which additional 
recommendations proposed by an expert would be suitable as quality indicator. 
Step 4: Critical evaluation and operationalization  
After the consensus meeting the results were offered to all the members of the expert panel 
for final approval. Subsequently, the selected recommendations were translated into 
indicators by defining numerators and denominators, i.e. the number of women in whom a 
certain test or intervention should have been performed and has been performed, divided 
by the number of women in whom a certain test or intervention should have been 
performed. Using this method, an adherence percentage could be calculated in order to 
assess current care.  
Results 
Step 1: Identification of recommendations  
In the first step, 51 recommendations on CS were identified: 16 situations where VD was 
the preferred mode of delivery (category 1a and 1b); 9 situations in which counselling was 
advised on the possibility of choosing either vaginal or caesarean delivery (category 1c); 2 
recommendations on prevention of planned CS (category 1d), and 14 situations where 
planned CS was advised. Furthermore, there were 8 recommendations on emergency CS.  
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Step 2: Questionnaire round  
The 17 experts each received a questionnaire, of which 16 were returned (1 non-responder, 
94% response rate). Out of the 51 recommendations, 14 had ‘high potential’, 18 had 
‘uncertain potential’ and 19 had ‘low potential’. The experts suggested 5 additional 
recommendations.  
Step 3: Consensus meeting  
Eight experts attended the consensus meeting (47%), 5 obstetricians and 3 midwives. This 
meeting resulted in a consensus-based set of 27 key recommendations labelled according to 
two categories [See Table 3.1]. Category 1 comprised 14 recommendations on mode of 
delivery counselling: 1a) general counselling is advised without mentioning the possibility of 
choosing CS (VD is the normal conduct) (N=5); 1b) counselling is advised directed at VD 
(VD and CS are both options but VD is preferable) (N=5), 1c) counselling is advised 
mentioning both VD and CS as equal options (N=4). There were 2 recommendations on 
prevention of planned CS (1d). The experts approved of 11 recommendations on the 
prevention of emergency CS (category 2). 
With regard to the situations were planned CS was advised (category 1d), the 12 indications 
were not considered to be of high potential for measuring quality of care. For example, in 
case of placenta praevia, it is not likely that an obstetrician would proceed with VD. 
Consequently, it is not expected that adherence to such an indicator would be low, and 
improvement of care would be necessary.   
Step 4: Critical evaluation, operationalization and final approval 
The 27 key recommendations were sent to the expert panel for final approval, which was 
obtained from 16 experts; there was 1 non-responder.  
Finally, the selected recommendations were translated into indicators by defining 
numerators and denominators: i.e. the number of women in whom a certain intervention or 
counselling method should have been performed and has been performed, divided by the 
number of women in whom a certain intervention or counselling method should have been 
performed. For example: one of the indicators states that in case of breech presentation 
after 34 weeks, external cephalic version should be offered. Guideline adherence then is 
measured by dividing the number of women in the study group with a fetus in breech 
presentation after 34 weeks in whom external cephalic version is offered by the total 
number of women with a fetus in breech presentation after 34 weeks.  
This stepwise procedure resulted in a set of 27 CS quality indicators, including 16 indicators 
on planned CS as well as 11 indicators on emergency CS. The process of development of 
quality indicators on CS by using the RAND-modified Delphi method is depicted in figure 
3.1, the final indicator set is given in Table 3.1.  
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Appendix S2. Quality indicators: planned CS is advised 
 
Table S3.1 Quality indicators: planned CS is advised. 
Planned CS is advised:  
             Suspected placental abruption and viable fetus 
             Vasa praevia  
             Placenta praevia  
             Placental localization less than 1cm from the internal os 
             Relevant scar in the uterus (e.g. vertical incision during previous CS) 
             Monoamniotic twin pregnancy 
             Breech presentation at term and maternal pelvic abnormality 
             Breech presentation at term and previous non-progressive labor  
             First genital herpes outbreak in the third trimester of pregnancy 
             Impossible vaginal birth (e.g. due to cervical myomas, congenital malformations) 
             Uterine rupture in previous pregnancy 
             Persistent transverse presentation, despite external cephalic version 
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Abstract 
Objective 
To analyse practice variation of vaginal birth after caesarean (VBAC) and successful 
intended VBAC,  adjusted for differences in case mix.  
 
Study design 
This nationwide registry based cohort study was performed amongst a representative group 
of Dutch hospitals (n=17). Women with one prior caesarean section (CS) without a 
contraindication for intended VBAC were included. We used backwards stepwise 
multivariate logistic regression analysis to develop models for case mix correction. One 
model was derived to adjust the elective repeat caesarean section (ERCS) rates; a second 
model was derived to adjust successful intended VBAC rates. Standardized rates of ERCS 
and successful intended VBAC per hospital were established and compared. R-squared 
measures were obtained for estimation of the total percentage of practice variation 
explained by the models. 
 
Results 
We reviewed 9833 consecutive medical records, 1068 women (11%) had a history of CS of 
whom 763 (71%) were eligible for inclusion. Five-hundred-fifteen women (67%) had an 
intended VBAC of whom 72% successfully delivered vaginally. Amongst the 17 
participating hospitals, the ERCS rate ranged from 6% to 54%, with a mean of 29.8, 
standard deviation (SD) 11.8%. The mean observed successful intended VBAC rate ranged 
from 52.7% to 90.0% (mean 71.8%, SD 11.1%)). More than 85% of the observed practice 
variation could not be explained by case mix. 
 
Conclusions 
In The Netherlands intended VBAC is common practice, but the a priori probability of 
having a CS independent of woman’s individual risk factors varies strongly per hospital. 
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Introduction 
In 1985, the World Health Organization stated that the ideal caesarean section (CS) rate is 
around 10-15%.1 Nevertheless, the frequency of CS’s has continued to rapidly increase in 
many parts of the world. Consequently, the number of women who are pregnant following 
a CS increased concordantly resulting in more women at risk for a (repeat) CS.2 The debate 
concerning birth after CS centres around safety in terms of the unlikely but severe event of 
occurrence of uterine rupture. On the other hand, an elective repeat caesarean section 
(ERCS) is, in comparison to an intended vaginal birth after caesarean (VBAC), associated 
with an increased risk of morbidity in future pregnancies and higher costs.2 Hence, for the 
United States (US), one of the ‘Healthy People 2020’ goals is to reduce the amount of 
ERCSs from 90.8% to 81.7%.3 In order to achieve this goal, clear guidelines were developed 
that advice on how to counsel women on mode of birth after CS and how to organize 
care.4-8 In this counselling, women should be given information including benefits and risks 
of both options and ideally, shared decision making has to take place. However, studies 
show large practice variation in intended VBAC rates2,9 both at national and international 
level, suggesting large variation in implementation of contemporary guidelines. Yet, these 
studies did not correct for case mix, hence these results should be interpreted with caution 
as variation in patient populations might induce this practice variation. In order to 
accurately analyse practice variation we aim to  evaluate practice variation in mode of 
section after CS and particularly to what extent it can be explained by factors on patient 
level. 
Materials and methods 
Design and setting 
In a nationwide registration based cohort study we compared care regarding mode of 
section for women who are pregnant after a CS, amongst 17 Dutch hospitals in terms of 
practice variation. 
 
All enrolled hospitals participated in the Dutch consortium of obstetrics and gynaecology 
and were representative for Dutch geographic regions and hospital types. The present study 
was performed in academic teaching hospitals (n=5), teaching non-academic hospitals (n=7) 
and non-teaching non-academic hospitals (n=5). Consecutive deliveries were recorded per 
site starting at January 1st 2010 . All enrolled sites were requested to include 30 consecutive 
women who had an intended VBAC and all women who had an ERCS in the same time-
interval. This resulted in an overview of all women who had delivered within the set time-
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interval and had 0, 1 or ≥2 prior CS’s. Subsequently, a database was constructed that 
included all women who had one prior CS. 
Study population 
We included women with a history of one prior CS and a vertex singleton pregnancy who 
delivered at ≥37 weeks gestational age (GA). Women were excluded when they had an 
unknown indication of prior CS, or in the current pregnancy an intra-uterine fetal demise or 
a contraindication for an intended VBAC. A contraindication for intended VBAC was 
defined as a previous uterine rupture, a placenta previa or a relevant uterine scar. 
Outcome measures 
The main outcome measures of this study were the amount of variation in ERCS- and 
successful intended VBAC rates between hospitals corrected for variables on patient level 
(i.e. case mix). Secondary outcome measures were the differences in practice variation 
between hospital types and whether there was a correlation between standardized ERCS- 
and intended VBAC-success rates.   
Data collection 
We collected data on frequencies of mode of section after CS per hospital. To correct for 
case mix in each case, data were gathered with regard to demographic factors (maternal age 
and ethnicity), past obstetric factors and pre-existing and current obstetric factors. Obstetric 
factors included variables that are predictive for mode of birth after CS and for successful 
intended VBAC. These variables were chosen based on published prediction models on 
successful intended VBAC, original research articles that report on predictors for mode of 
birth after CS, VBAC and on expert opinion.10,11 The variables considered relevant for case 
mix correction included maternal age, pre-pregnancy body-mass-index (BMI), ethnicity, 
prior non-progressive labour, any prior VBAC, any prior vaginal delivery, estimated fetal 
weight ≥p90, estimated fetal weight ≤p10, diabetes mellitus, hypertension, preeclampsia/ 
HELLP syndrome. Pre-pregnancy BMI was defined as kg/m2 obtained pre-pregnancy or 
within the first trimester. Estimated fetal weight was measured in the third trimester by 
either ultrasound or upon physical examination. Diabetes mellitus and hypertension could 
be either pre-existent or pregnancy-induced. For prediction of successful intended VBAC 
we added to this set whether labour was induced and labour parameters upon presentation 
to the labour ward (cervical dilation, cervical effacement and fetal station). Cervical dilation 
was registered per centimetre (range 0-10). Cervical effacement was categorized in three 
measures: 0-25%, 25-50%, >50%. Fetal station was recorded using the in the Netherlands 
customary ‘Hodge classification system’ (range H0 – H4) and converted to the American 
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classification system ranging from ballotable (B) to +5. This variable was defined as follows: 
H0=-5, H1=-3, H2=-1, H3=0, H4=+3. 
 
Data were extracted from medical records by trained research staff using customized case 
report forms. Data were checked for completeness and inconsistencies. Inconsistent and 
incomplete data were double-checked directly with the hospital concerned. 
Statistical analyses 
Missing data were imputed using stochastic regression imputation since omission of 
incomplete cases can result in loss of precision and may bias the results.12,13 For imputation, 
all quantitative baseline characteristics were used for estimation of the missing values.  
 
For case mix correction, we derived two multivariate logistic regression models that 
predicted  ERCS and successful intended VBAC, respectively. One model was used to 
correct ERCS rates for case mix, while the second model was used to correct successful 
intended VBAC rates for case mix. The multivariate logistic regression models were 
developed using a backwards stepwise elimination method. At first, we performed 
univariate analyses to assess which case mix variables could be related to the outcome 
variables. In order to minimize the risk of exclusion of important variables, we used a liberal 
p-value of 0.210 to estimate which variables were univariate significantly related to the 
outcome variables. Subsequently, the multivariate logistic regression formula was applied to 
the dataset to calculate both the probability of ERCS and successful intended VBAC per 
woman. Mean predicted outcomes per hospital represented the expected ERCS- and 
successful intended VBAC rates per hospital. Expected ERCS and successful intended 
VBAC rates per hospital were compared to the ‘true’, ‘observed’ rates. Accordingly, for each 
hospital, standardized rates were computed by dividing observed rates by expected rates and 
multiplying it by the population mean. The standardized rate represents the ERCS and 
intended VBAC rates that the hospital would have if all hospitals had a similar patient 
population. R-squared measures were obtained for estimation of the total percentage of 
practice variation that was explained by the models. Subsequently correlation between 
standardized ERCS rates and successful intended VBAC rates was tested using Spearman’s 
rank correlation test (reference p<0.05) (since the data was not normally distributed) and by 
visually inspecting the plot.  
Statistical analyses were performed using SPSS (SPSS version 20.0). 
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Ethical approval 
Approval for this study was obtained at the Medical Ethical Committee (CMO) of 
Maastricht University Medical Centre+ (MUMC+) in The Netherlands (MEC number 09-4-
047-13). 
Results 
Study population 
We reviewed 9833 consecutive medical records, and 1068 women (11%) had a history of CS 
of whom 763 (71%) met the inclusion criteria. The baseline characteristics of this study 
cohort are shown in Table 4.1.  
 
Table 4.1 Baseline characteristics of study population.  
Characteristic (n=763) Missing data intended VBAC; ERCS
(n ; n) 
Women 
n=763 
Maternal age (years, mean±SD)  2 ; 4 32.5 (4.5) 
Ethnicity (n, (%)) 
Caucasian 
Mediterranean 
African 
Indo-Surinamese 
Asian 
Other 
Unknown 
15 ; 12  
608 (79.7) 
48 (6.3) 
30 (3.9) 
8 (1.0) 
19 (2.5) 
23 (3.0) 
27 (3.5) 
Previous CS due to failure to progress (n, (%)) 0 ; 0 336 (44.0) 
Any previous vaginal delivery (n, (%)) 0 ; 0 152 (19.9) 
Previous VBAC (n, (%)) 0 ; 0 107 (14.0) 
First trimester BMI (kg/m², mean ± SD) 124 ; 79 26.1 (5.9) 
PE/HELLP (n, (%)) 0 ; 2 15 (2.0) 
Hypertension (n, (%)) 1 ; 3 50 (6.6) 
Diabetes mellitus (n, (%)) 2 ; 1 34 (4.5) 
EFW ≤p10 (n, (%)) 201 ; 105 38 (5.0) 
EFW ≥p90 (n, (%)) 201 ; 105 22 (2.9) 
Induction of labour (n, (%)) 0 ;  b 132 (26) / b 
Cervical dilation (cm, mean ± SD) 11 ;  b 3 ± 2/ b 
Cervical effacement (%, mean ± SD) 56 ;  b 64 ± 19/ b 
Fetal station (B, -5 - +5, mean ± SD) 57 ;  b -2 ± 2/ b 
VBAC: vaginal birth after caesarean, ERCS: elective repeat caesarean section, SD: standard deviation; CS: caesarean 
section; BMI, body mass index; PE: pre-eclampsia; HELLP: HELLP syndrome – hemolysis, elevated liver-
enzymes, low platelets; EFW: estimated fetal weight B, ballottement. 
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On average, maternal age, ethnicity and having preeclampsia/HELLP or hypertension or an 
EFW ≤ p10 did not differ between ERCS and intended VBAC.  
In our cohort, 248 (33%) women had an ERCS. The other 515 women (67%) had an 
intended VBAC of whom 371 (72%) had a successful intended VBAC, resulting in a VBAC 
rate of 49%. Women who chose ERCS had more often a prior CS due to failure to 
progress, had diabetes mellitus, had a higher BMI or an EFW ≥ p90. Women who chose 
ERCS had less often a prior vaginal delivery or prior VBAC. 
ERCS rates corrected for case mix 
We entered all preselected variables in the regression model in order to develop a model for 
case mix correction. These results are shown in Table 4.2. The variables that showed 
significance for case mix correction of the ERCS rates were pre-pregnancy BMI, prior non-
progressive labour, prior VBAC and diabetes mellitus.  
 
Table 4.2 Overview of multivariate logistic regression model for predicting ERCS. 
Variable Coefficient SE p-value Odds ratio 95% CI 
Intercept -3.012 0.897 0.001 0.049 - 
Maternal age (years) 0.034 0.023 0.144 1.034 0.989-1.082 
Pre-pregnancy BMI (kg/m2)  0.038 0.016 0.016 1.039 1.007-1.072 
Prior non-progressive labour (yes/no) 0.578 0.199 0.004 1.783 1.207-2.634 
Prior VBAC (yes/no) -1.454 0.399 0.000 0.234 0.107-0.510 
Diabetes mellitus (yes/no) 1.391 0.466 0.003 4.020 1.613-10.018 
Hypertension (yes/no) -0.550 0.406 0.175 0.577 0.260-1.278 
ERCS: elective repeat caesarean section, SE: standard error, CI: confidence interval, BMI: body mass index, VBAC: 
vaginal birth after caesarean. 
 
 
Table 4.3 shows the number of included deliveries per hospital, the observed ERCS rates, 
expected ERCS rates and standardized ERCS rates. Also, the mean differences between the 
expected and standardized rates are shown, which represent the amount of CSs that a 
hospital deviates from its expected rate when it would be presented with the mean patient 
population. Amongst the 17 participating hospitals, the mean crude observed ERCS rate 
was 29.8% ± 11.8% (range 6.0% to 54.0%). After correction for case mix, 86.1% of the 
observed practice variation remained unexplained.  
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Table 4.3 Standardized ERCS rates. 
Hospital 
type 
Hospital 
number 
Included 
deliveries 
Observed 
rate (%) 
Expected 
rate (%) 
Standardized 
rate (%) 
Mean difference 
(%) expected - 
standardized 
1 1 61 54.0 34.7 51.4 -16.8 
1 2 51 39.0 33.3 38.7 -5.5 
1 4 45 33.0 33.6 32.4 1.3 
1 12 55 38.0 34.7 36.1 -1.4 
1 15 40 43.0 29.0 47.8 -18.7 
2 5 28 32.0 33.9 31.1 2.8 
2 7 36 17.0 31.5 17.8 13.7 
2 9 39 28.0 30.6 30.2 0.5 
2 10 41 24.0 29.6 26.8 2.8 
2 11 48 35.0 32.9 35.1 -2.2 
2 13 24 17.0 28.1 19.9 8.2 
2 16 42 26.0 31.7 27.1 5.7 
3 3 39 23.0 29.3 25.9 3.4 
3 6 100 41.0 32.4 41.8 -9.4 
3 8 36 17.0 31.5 17.8 13.7 
3 14 46 35.0 31.9 36.2 -4.2 
3 17 32 6.0 28.6 6.9 21.7 
Hospital types: 1: non-teaching non-academic hospital, 2: teaching non-academic hospital, 3: academic teaching 
hospital  
 
Successful intended VBAC rates corrected for case mix 
The from univariate analyses derived significant variables for correction of VBAC-rates 
were maternal age, pre-pregnancy BMI, prior non-progressive labour, prior vaginal delivery, 
Caucasian ethnicity, cervical dilation and cervical effacement. These data are shown in more 
detail in Table 4.4.  
 
 
Table 4.4 Overview of multivariate logistic regression model for predicting successful intended VBAC. 
Variable Coefficient SE p-value Odds ratio 95% CI 
Intercept 1.886 1.259 0.134 6.591 - 
Maternal age (years) -0.045 0.030 0.130 0.956 0.903-1.013 
Pre-pregnancy BMI (kg/m2) -0.047 0.021 0.025 0.954 0.916-0.994 
Prior non-progressive labour (yes/no) -0.426 0.259 0.100 0.653 0.393-1.085 
Prior vaginal delivery (yes/no) 1.612 0.402 0.000 5.011 2.278-11.026 
Caucasian (yes/no) 0.582 0.349 0.096 1.790 0.903-3.550 
Cervical dilation (yes/no) 0.104 0.067 0.122 1.110 0.973-1.267 
Cervical effacement (yes/no) 0.292 0.157 0.063 1.339 0.984-1.821 
VBAC: vaginal birth after caesarean, SE: standard error, CI: confidence interval, BMI: body mass index 
 
 
Table 4.5 shows observed, expected and standardized intended VBAC rates, as the amount 
that a hospital deviates from its expected rate when it would be presented with the mean 
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patient population. Amongst the 17 included hospitals, the mean crude observed VBAC 
rate was 71.8% ± 11.1% (range 50.0% to 90.0%). After correction for case mix, 85.3% of 
the observed practice variation remained unexplained. 
 
Table 4.5 Standardized successful intended VBAC rates. 
Hospital 
type 
Hospital 
number 
Included 
deliveries 
Observed 
rate (%) 
Expected 
rate (%) 
Standardized 
rate (%) 
Mean difference 
(%) expected - 
standardized 
1 1 28 60.7 72.1 60.7 11.4 
1 2 31 71.0 68.3 74.9 -6.6 
1 4 30 83.3 74.5 80.7 -6.2 
1 12 34 70.6 73.2 69.5 3.8 
1 15 23 50.0 68.5 54.9 13.6 
2 5 19 68.4 62.0 79.6 -17.6 
2 7 30 86.7 77.1 81.1 -4.0 
2 9 29 71.4 73.2 67.9 5.3 
2 10 31 86.7 70.1 89.1 -19.0 
2 11 31 71.0 65.8 77.8 -12.0 
2 13 20 90.0 71.2 91.2 -19.9 
2 16 31 77.4 71.5 78.1 -6.6 
3 3 30 70.0 72.3 69.8 2.5 
3 6 59 76.3 75.3 73.1 2.3 
3 8 30 56.7 73.4 55.7 17.8 
3 14 30 56.7 65.7 62.2 3.5 
3 17 30 73.3 70.1 75.5 -5.4 
Hospital types: 1: non-teaching non-academic hospital, 2: teaching non-academic hospital, 3: academic teaching 
hospital  
 
Standardized rates per hospital type 
Figures 4.1 and 4.2 show standardized ERCS rates and successful intended VBAC rates, 
respectively, per hospital type. Figure 4.1 illustrates that a wider range of ERCS rates exists 
amongst academic teaching hospitals. Also, the hospitals with the highest ERCS rates 
appear to be amongst the non-academic non-teaching hospitals. Figure 4.2 shows that with 
regard to VBAC, hospital types are more similar in terms of intended VBAC success rates. 
The highest success rates appear to be amongst non-academic teaching hospitals. 
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Figure 4.1 Standardized ERCS rate per hospital type. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2 Standardized successful intended VBAC rate per hospital type. 
 
Correlation between ERCS and successful intended VBAC  
Since data was not normally distributed, correlation was tested using the Spearman’s rank 
correlation test. The test for correlation between ERCS and successful intended VBAC 
resulted in a rho of -0.46 with a p-value of 0.065 showing that there was no correlation 
between successful intended VBAC and ERCS (Figure 4.3).  
 VBAC practice variation 
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Figure 4.3 Correlation successful intended VBAC- and ERCS rates. 
 
Comment 
Main findings 
In The Netherlands, the majority of women who are eligible for intended VBAC deliver 
vaginally. However, this study showed that in spite of its high mean VBAC rate, there is a 
striking amount of practice variation on mode of birth after CS in the Netherlands 
regardless of case mix. Hence, the a priori risk of having a CS independent of woman’s 
individual risk factors varies per hospital. Amongst the 17 participating representative 
Dutch hospitals, ERCS rates corrected for case mix even varied between 6.0% and 54.0%. 
For successful intended VBAC, this variation was less distinct but still 52.7% to 90.0%. Yet, 
we showed that correcting for case mix only partly explained the observed practice 
variation. Accordingly, we can conclude that variables other than patient characteristics, like 
factors on hospital or provider level, play a more significant role in the development of 
practice variation. When estimating the effect of hospital type, it appeared that the largest 
variation exists amongst non-academic teaching hospitals. Also we showed that, although 
one could think that better risk selection leading in hospitals with higher ERCS rates would 
lead to lower emergency CS rates and thus higher successful intended VBAC rates, we 
showed that no correlation was found. 
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Strengths and weaknesses 
A strength of this study is that this is the first study to examine practice variation in vaginal 
birth after CS in a European country with correcting for case mix. We compared different 
levels of hospitals, from tertiary to small rural hospitals. The distribution of the different 
levels of hospitals is representative for the national distribution. Another strength is that 
data-selection occurred systematically by checking every single patient. In addition, the 
selection process of predictive variables for successful intended VBAC was in line with 
contemporary insights within prediction research.10,11 We chose to correct only for 
predictive variables for successful intended VBAC as every woman should be counselled the 
same way. Furthermore, this study provides insight in on which level possible interventions 
would be meaningful.     
 
A drawback of the chosen methodology for predictor selection is that it implies the risk of 
missing contributing predictors. Hence, we assume that the developed models are capable 
of explaining practice variation and that the remaining variation can be attributed to policy. 
Yet, the remaining variation could also be explained by an incomplete model. For example, 
the predictor ‘thickness of lower uterine segment’ appears to be a probable independent 
predictor for failed intended VBAC but was not taken into account during data-collection.14 
Another limitation is that, due to lack of data, we could not further specify the exact 
amount of practice variation that is derived from factors on hospital- and provider level. 
However, by performing an additional analysis in which we clustered types of hospital we 
were able to mainly visualize variation on hospital-level. Still, this implies the assumption 
that hospitals within the clusters are comparable and is therefore less precise.  
Interpretation 
In line with other studies, our study showed a large variation in intended VBAC rates 
between different hospitals.2,9 Large variation in intended VBAC rates is seen between 
countries, but at a national level there is large variation as well.2  Even in a small country 
with high intended VBAC rates as The Netherlands there is a remarkable amount of 
practice variation, comparable to countries with lower intended VBAC rates.2 Our results 
are in line with the cohort study of Kwee et al.15 In this study, performed in The 
Netherlands, practice variation was studied in 38 hospitals and showed a variation in 
intended VBAC from 46 to 87%.15 
The review of Guise et al reports a range from 28-70% in the US2 intended VBAC was 
more often performed in hospitals with a high birth-rate which are tertiary and teaching 
hospitals. Besides differences in attempting intended VBAC, there is a large variation in 
VBAC as well from 52 to 85% in the US. However, the review of Guise included mainly 
studies performed in academic- and non-academic teaching hospitals.2 Hence, this may 
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cause a distorted view and the results may not be representative for rural hospitals, because 
retrospective studies show intended VBAC is less attempted in small rural hospitals.16 Our 
results confirm these findings and show 33-54% in ERCS-rate in rural hospitals compared 
to 6-41% in academic- and non-academic teaching hospitals.   
Toohill et al.9 distinguished hospitals based on a public or private setting and birth rates in 
Australia. This study revealed that women attempting intended VBAC in a public hospital 
with high birthrates have a higher chance of a successful intended VBAC. These findings 
are also similar to our results regarding the association between high birth rates and high 
successful intended VBAC.  
For predicting successful intended VBAC, induction of labour was included as variable 
because it is known as an independent predictor.17,18 However, there might be practice 
variation in offering induction to a woman pregnant after CS as well. Yet, there is a lack of 
evidence to confirm this. 
We can debate whether the observed ERCS rate is appropriate in relation to the type and 
abilities of specific hospitals. From the viewpoint of feasibility, it is understandable that 
obstetricians in small rural hospitals rather perform an ERCS than an intended VBAC as 
obstetric and theatre staffs are not on hand 24/7. In the United States guidelines even 
advice that hospitals attempting intended VBAC require equipment and staff able to 
perform an emergency CS immediately.2  
At the same time, differences in the doctor’s perspective can cause practice variation as 
well. In a tertiary hospital doctors could feel more comfortable in performing intended 
VBACs because they have more experience. Furthermore, doctors have to cope with an 
increased risk of liability, which may result in a decreased performance of intended VBAC.2 
These factors may influence or induce practice variation as well.  
In our study we chose to perform unilevel multivariate logistic regression analysis, because 
we assumed practice variation correlates with case mix. Future research could focus on 
multiple levels.  
 
Overall, practice variation in mode of section after prior CS can only partly be explained by 
case mix. Besides effects of availability of medical staff and level of experience, methods of 
counselling and shared decision making may play a role as well, despite the guidelines. The 
practice variation resulting from this can probably be reduced and the quality of healthcare 
can be enhanced by more structured general information. We developed a decision aid and 
a prediction model to calculate the probability of a patient having a successful intended 
VBAC. By implementing this decision aid and model in daily healthcare, and informing 
women about their chances and the risks, and benefits of both options in a structured way, 
we anticipate reducing practice variation on patient level, provider level and hospital level.  
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In conclusion variation between hospitals is large and can only for the smaller part be 
explained by case mix which indicates that local policy plays a more important role in the 
derivation of practice variation. Hence in order to enhance guideline implementation and to 
reduce practice variation, further research in for example the benefit of better counselling 
and shared decision making by using the developed prediction model and decision aid  is 
essential. 
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Abstract 
Objective 
To externally validate two models from the United States (entry-to-care (ETC) and close-to-
delivery (CTD)) that predict successful intended vaginal birth after caesarean (VBAC) for 
the Dutch population.  
 
Design and setting 
A nationwide registration-based cohort study. Seventeen hospitals in the Netherlands. 
 
Population 
Seven hundred and sixty-three pregnant women, each with one previous caesarean section 
(CS) and a viable singleton cephalic pregnancy without a contraindication for an intended 
VBAC. 
 
Methods 
The ETC model comprises the variables maternal age, pre-pregnancy body mass index 
(BMI), ethnicity, prior vaginal delivery, prior VBAC and prior nonprogressive labour. The 
CTD model replaces pre-pregnancy BMI with third-trimester BMI and adds estimated 
gestational age at delivery, hypertensive disease of pregnancy, cervical examination and 
induction of labour. We included consecutive medical records of eligible women who 
delivered in 2010. For validation, individual probabilities of women who had an intended 
VBAC were calculated. 
 
Main outcome measures 
Discriminative performance was assessed with the area under the curve (AUC) of the 
receiver operating characteristic and predictive performance was assessed with calibration 
plots and the Hosmer–Lemeshow (H-L) statistic. 
 
Results 
Five hundred and fifteen (67%) of the 763 women had an intended VBAC; 72% of these 
(371) had an actual VBAC. The AUCs of the ETC and CTD models were 68% (95% CI 
63–72%) and 72% (95% CI 67–76%), respectively. The H-L statistic showed a P-value of 
0.167 for the ETC model and P = 0.356 for the CTD model, indicating no lack of fit.  
 
Conclusion 
External validation of two predictive models developed in the United States revealed an 
adequate performance within the Dutch population. 
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Introduction 
After a first caesarean section (CS), a pregnant woman can opt for an elective repeat CS 
(ERCS) or an intended vaginal birth after caesarean (VBAC) (i.e. a trial of labour), which 
will result in an actual (successful) VBAC or an emergency CS (unsuccessful VBAC). 
Discussing the risks of both options is a substantial part of counselling on mode of delivery, 
and obviously the probability of having an actual VBAC is a key component.1,2 Published 
success rates for VBAC worldwide vary between 60 and 80%.3 However, these rates are not 
necessarily applicable for counselling, since individual probabilities may vary due to factors 
relating to demography, obstetric history and current pregnancy of the woman.3,4 Hence, a 
personalised prediction of VBAC may lead to a more refined counselling. Furthermore, 
with regard to clinical outcomes, personalised prediction could contribute to risk estimation 
because actual incidences of major maternal morbidity are lowest in women who have a 
VBAC (0.2%), followed by women having an ERCS (0.8%), and are highest in women 
having unsuccessful VBAC (3.8%).5 In addition, several studies have shown that low 
probabilities of successful VBAC are related to relatively high risks of major feto-maternal 
morbidity.6,7 Several scoring models that aim for a personalised prediction of successful 
intended VBAC have been published.3,8 In this work, the predictive models of Grobman et 
al.9,10 are evaluated. These models can be used early in pregnancy9 and at the onset of 
labour10 in order to estimate the probability of successful intended VBAC during an at term 
delivery. Both models have previously been successfully validated in an independent cohort 
in the United States and were called the ‘entry-to-care model’ (ETC) and the ‘close-to-
delivery model’ (CTD).11, 12 Additionally, the ETC model has been successfully validated for 
a Japanese population.13 However, differences in, for example, population characteristics 
and setting may affect the validity of the predictive models in European countries like the 
Netherlands. For instance, in the United States, the VBAC rate when the predictive models 
were derived was 12–22%;14 this declined to approximately 8.3% in 2007.15 In most 
European countries reported VBAC rates are higher, for example 54% in the Netherlands16 
and 30–37% in the United Kingdom.2,17 Hence, in this study we aim to externally validate 
the prediction models of Grobman et al. 9,10 for the Dutch population. 
Methods 
Setting 
This nationwide registration-based cohort study was performed in 17 hospitals in the 
Netherlands, with a good representation of all geographic regions and hospital types. 
Hospitals types included university teaching hospitals (n=5), nonuniversity teaching 
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hospitals (n=7) and nonuniversity nonteaching hospitals (n=5). Approval for this study was 
obtained at the Medical Ethical Committee (CMO) of Maastricht University Medical 
Centre+ (MUMC+) (MEC number 09-4-047-13). 
Population 
The two predictive models were designed for women who have a vertex singleton 
pregnancy and a history of one low-transverse CS and who delivered at term (gestational 
age ≥37 weeks), therefore only women who met these criteria were included in the present 
study. As in the studies of Grobman et al.,9,10 women with an unknown indication for 
previous CS, an antepartum intrauterine fetal demise or a contraindication for vaginal 
delivery were excluded. Contraindications for vaginal delivery were defined as placenta 
praevia and a uterine scar with extension into the fundus.  
Since we expected a large difference between the VBAC rate in the United States and the 
current VBAC rate in the Netherlands, we collected data from women who had an intended 
VBAC and from women who had an ERCS. The main consideration was to estimate the 
current VBAC rate in the Netherlands and subsequently to fully evaluate the applicability of 
the models in the Dutch population by comparing the baseline characteristics of the 
intended VBAC group and the ERCS group.  
Sample size 
The sample size was calculated according to the ‘rule of thumb’ of at least ten events per 
variable in the predictive model.18 An event was defined as an unsuccessful intended VBAC. 
Based on previously published data, it was assumed that the percentage of unsuccessful 
intended VBACs in the Netherlands would be 24%.16 As the predictive models contained as 
many as 12 variables per model, the calculated minimum sample size was 500 subjects 
(12 × 10/0.24). 
Data collection 
At all participating sites, data were extracted from consecutive birth records according to a 
standardized operating procedure by using customized case report forms. Information was 
obtained on all predictive indicators included in the predictive models. Data were obtained 
by trained research nurses, medical doctors or senior medical students. In order to achieve 
the required sample size, each participating hospital was asked to include 30 consecutive 
cases of intended VBAC and all ERCSs in the same time interval, starting from 1 January 
2010.  
 External validation of two VBAC-prediction models 
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Variables 
Variables were defined as described in the original articles of Grobman et al.9,10 The 
outcome variable used for validating the predictive models was the outcome of the intended 
VBAC, i.e. either successful intended VBAC (vaginal birth) or unsuccessful intended VBAC 
(emergency CS).  
To be able to incorporate all variables despite the different units and definitions used in the 
two countries, some of the collected data had to be converted or redefined. All decisions on 
the conversion and redefinition of variables were approved by both a Dutch and an 
American obstetrician (HS and WG). The variables that had to be adapted were ‘ethnicity’ 
(in the United States the categories were African-American/Hispanic/White and others), 
‘fetal station’ and ‘cervical effacement’. In the Netherlands seven categories of ethnicity are 
used (Dutch, other European, Mediterranean, African, Indo-surinamese, Asian and ‘other’). 
To correspond to the categories in the original prediction models, the variable ‘African-
American’ was set equal to the Dutch variable ‘African’. The variable ‘Hispanic’, did not 
match any of the Dutch categories and was therefore abolished. Subsequently, the variable 
‘White and others’ comprised all Dutch ethnicity categories except for ‘African’. The 
variable ‘fetal station’ was collected according to the ‘Hodge classification system’, which 
ranges from Hodge 0 (H0) to Hodge 4 (H4). Fetal station was converted into the American 
classification system, which ranges from ballottable (B) to +5. It was redefined as follows: 
H0=–5; H1=–3; H2=–1; H3=0; H4=+3. The variable ‘cervical effacement’ was collected in 
three categories, namely (1) ≤25%, (2) 25–50% and (3) ≥50%, as these are the categories in 
which these data are registered in the Netherlands. For analysis we set category 1 equal to 
20%, category 2 equal to 40% and category 3 equal to 75%. Furthermore, the variable ‘third 
trimester body mass index (BMI)’ was approximated by adding 15 kg to ‘pre-pregnancy 
weight’; this was considered appropriate for the Dutch population based on expert opinion. 
Data quality and missing data 
Data were entered and checked for inconsistencies. Inconsistent and incomplete data were 
double-checked directly with the hospital concerned. As shown in Table 5.1, for most 
variables there was only a small quantity of missing data. However, pre-pregnancy BMI was 
missing in 24% of women. A multiple imputation strategy was used for data analysis, since 
complete case analysis alone can result in a large loss of power and might yield biased 
parameter estimates. 
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Data analysis 
Study cohort characteristics 
Characteristics of the women who had an ERCS and women who had an intended VBAC 
were compared. To compare proportions, the chi-squared test, or when appropriate Fisher’s 
exact test, was used. For continuous variables, an independent sample t test was used for all 
samples as data were normally distributed. A P-value < 0.05 was used to indicate statistical 
significance.  
Predicted probabilities 
To validate the prediction models, for each patient who had an intended VBAC an 
individual probability of achieving VBAC was calculated with the following prediction 
equations obtained from the research articles of Grobman et al.:9,10 
1. The ETC model:9 
exp(w)/[1 + exp(w)] 
where 
w=3.766–0.039 (age, years)–0.060 (pre-pregnancy BMI)–0.671 (African-American 
ethnicity)–0.680 (Hispanic ethnicity)+0.888 (previous vaginal delivery)+1.003 (vaginal 
delivery after previous CS)–0.632 (previous CS due to nonprogressive labour). 
2. The CTD model:10 
exp(w)/[1 + exp(w)] 
where 
w=7.059–0.037 (age, years)–0.044 (third-trimester BMI)–0.460 (African-American 
ethnicity)–0.761 (Hispanic ethnicity)+0.955 (previous vaginal delivery)+0.851 (vaginal 
delivery after previous CS)–0.655(previous CS due to nonprogressive labour)-0.109 
(estimated gestational age at delivery)–0.499 (hypertensive disease of pregnancy) +0.044 
(cervical effacement, deciles)+0.109 (cervical dilation, 0–6 cm)+0.082 (fetal station, B to 
+5, entered as 0 to 11)–0.452(labour induction). 
 
Additionally, using the ETC model we calculated the mean predicted probability of 
achieving VBAC for women in the ERCS group and compared it with the mean predicted 
probability in the intended VBAC group. The purpose of this comparison was to evaluate 
whether the variables of the predictive models are already being taken into account during 
counselling. As data were not normally distributed, the mean predicted probabilities of 
achieving VBAC were compared using a Mann–Whitney U test. We only performed this 
analysis with the ETC model because the CTD model includes intrapartum factors and was 
therefore not applicable to the ERCS group.  
 
 External validation of two VBAC-prediction models 
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Discriminative and predictive performance 
The discriminative performance of the predictive models was assessed using a receiver 
operating characteristic (ROC). The ROC was obtained by plotting sensitivity against 
1-specificity. Sensitivity was defined as the fraction of VBACs that were correctly predicted 
for a particular cut-off point, whereas specificity was defined as the fraction of unsuccessful 
intended VBACs that were correctly predicted. The ability of the models to discriminate 
between women with a high and low probability of achieving a VBAC was assessed using 
the area under the curve (AUC) of the ROC. The AUC can vary between 0.5 and 1.0, in 
which a value of 0.5 represents no discriminative capacity and 1.0 represents excellent 
discriminative capacity. 
The predictive performance of the models was assessed by a calibration curve. The 
calibration curve was computed to show the relation between predicted probability of 
achieving VBAC and the observed VBAC rate. To obtain these values, the predicted 
probability was categorized into quantiles. In each quantile, the mean predicted VBAC rate 
was calculated and plotted against the observed VBAC rate in the corresponding quantile. 
In addition, to assessing goodness-of-fit, we computed the Hosmer–Lemeshow (H-L) 
statistic. The H-L statistic measures the fit of the calibration curve with the assumption (null 
hypothesis) that observed and predicted values are equal. A P-value <0.05 was considered 
to show lack of fit of the tested prediction models.   
Distribution of probabilities 
In order to determine the clinical utility of the models, we evaluated whether the model 
could classify a notable portion of women away from the VBAC population mean. Hence, 
we evaluated the distribution of probabilities amongst the cohort. The distributions were 
plotted in bar charts on the x-axis in the calibration plot. Additionally, we computed the 
percentage of the cohort that can be classified away from the VBAC population mean; we 
used cut-off values of 60% or less and 80% or higher.  
Software 
Statistical analyses and plots were performed using SPSS (SPSS v. 18.0) software and R, a 
language and environment for statistical computing. 
Results 
Inclusions 
We reviewed 9833 consecutive medical records of women who had delivered in the 
participating hospitals since January 2010. One thousand and sixty-eight women (11%) had 
a history of CS, 763 of whom (71%) met the inclusion criteria. Of these 763 women eligible 
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for intended VBAC, 515 (67%) had an intended VBAC and 248 (33%) had an ERCS. Three 
hundred and seventy-one women (72%) delivered vaginally, resulting in an actual VBAC 
rate in our study cohort of 49% (371/763).  
Study cohort characteristics 
The population distributions with respect to the variables contained in the two predictive 
models are shown in Table 5.1. Women who had a previous vaginal delivery and/or a 
previous VBAC were more likely to attempt a VBAC. Women who had an intended VBAC 
also had a significantly lower BMI, although the actual difference between groups was small. 
On the other hand, women with a previous CS due to nonprogressive labour more often 
opted for ERCS. Women who had an ERCS delivered at a significantly lower gestational 
age. Based on the ETC model, women who chose a VBAC had a significantly higher mean 
predicted probability (P<0.00) of successful intended VBAC (72±14%) than women who 
chose an ERCS (64±14%). 
 
Table 5.1 Baseline characteristics of study cohort of women with a previous caesarean section. 
Variable Missing data intended 
VBAC /ERCD (n/n)
Intended VBAC
(n=515) 
ERCS 
(n=248) 
P-value a 
 
Maternal age (years, mean ± SD)  2/4 32 ± 5 33 ± 4 0.15 
Ethnicity (n, (%)) 
   Dutch 
   Mediterranean 
   Other European 
   African 
   Indo-Surinamese 
   Asian 
   Other 
 
15 /12 
 
 
388 (75) 
37 (7) 
17 (3) 
24 (5) 
7 (1) 
12 (2) 
15 (3) 
 
192 (77) 
11 (5) 
11 (4) 
6 (3) 
1 (0) 
7 (3) 
8 (3) 
 
0.53 
0.14 
0.44 
0.14 
0.45 
0.68 
0.81 
Pre-pregnancy BMI (kg/m², mean ± SD) 124/79 25 ± 6 27±7 <0.00 
Previous CS due to failure to progress (n, (%)) 0/0 201(39) 135(54) <0.00 
Any previous vaginal delivery (n, (%)) 0/0 127(25) 25(10) <0.00 
Previous VBAC (n, (%)) 0/0 99(19) 8(3) <0.00 
PE/HELLP (n, (%)) 0/2 9(2) 6(2) 0.58 
Gestational age  at delivery (days, mean ± SD) 0/0 279 ± 8 273 ± 9 <0.00 
Cervical dilation (cm, mean± SD) 11/ b 3 ± 2 b b 
Cervical effacement (%, (mean ± SD)) 56/ b 64 ± 19 b b 
Fetal station (B, -5 - +5 , mean ± SD) 57/ b -2 ± 2 b b 
Induction of labour (n, (%)) 0/ b 132(26) b b 
a Results of χ²-tests/ Fisher’s exact test / t-tests; b Not applicable. SD: standard deviation, VBAC: vaginal birth 
after caesarean, ERCS: elective repeat caesarean section, CS: caesarean section, BMI: body mass index, PE: 
Preeclampsia HELLP syndrome: haemolysis, elevated liver-enzymes, low platelets, B: ballottement. 
Discriminative performance 
The discriminative performance of the predictive models is shown in Figure 5.1. The ROC 
of the ETC model has an AUC of 68% (95% CI 63–72%). The ROC of the CTD model 
has an AUC of 72% (95% CI 67–76%). 
 External validation of two VBAC-prediction models 
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Figure 5.1 ROC of the entry-to-care model (AUC 68%; 95% CI 63–72%) and the close-to-delivery model 
(AUC 72%; 95% CI 67–76%), indicating the discriminative performance of both models 
concerning the probability of a successful vaginal birth after caesarean section. 
 
Predictive performance 
The overall calibration of both predictive models was good. The mean successful intended 
VBAC rate in this study cohort was 72%. The mean predicted probabilities for successful 
intended VBAC in the ETC and the CTD models were 72±14% and 70±16%, respectively. 
The predictive performances of the models are shown in the calibration curves in Figures 
5.2 and 5.3.  
Both models show acceptable calibration; the calibration in the high-probability ranges was 
particularly good. The CTD shows better calibration than the ETC model. The H-L statistic 
showed a P-value of 0.17 for the ETC model and 0.36 for the CTD model, which indicates 
reasonable calibration of both predictive models. 
Distribution of probabilities 
The bar charts on the x-axes of Figures 5.2 and 5.3 show the distribution of probabilities of 
successful VBAC amongst the cohort. Figure 5.2 shows that when the ETC model is 
applied, the majority of the cohort has a predicted probability around or above the VBAC 
population mean of 60–80%. In our cohort, 27% had a predicted probability above the 
VBAC population mean as these women had a predicted probability of 80% or higher. 
Furthermore, 19% of the women had a predicted probability below 60%. As shown in 
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Figure 5.3, with application of the CTD model the distribution of predicted probabilities is 
also concentrated around and above the VBAC population mean. In total, 31% of women 
had a predicted probability above 80%, and 26% had a predicted probability below 60%. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.2 Calibration plot of the entry-to-care model with the observed frequency of a successful 
vaginal birth after caesarean section by the predicted probability. The triangles indicate 
quantiles of women with a similar predicted probability of success. 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.3 Calibration plot of the close-to-delivery model with the observed frequency of a successful 
vaginal birth after caesarean section by the predicted probability. The triangles indicate 
quantiles of women with a similar predicted probability of success. 
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Comment 
Main findings 
External validation of two predictive models developed in the United States revealed 
adequate performance of both models within the Dutch population. Although overall 
calibration was acceptable, it was particularly good in the range of high predicted probability 
of successful intended VBAC. Discriminative capacity was reasonable for both models. 
Most women had a score within the population mean of 60–80%,3 yet a notable minority 
was classified away from this population mean. Further, this study shows that in the 
Netherlands intended VBAC is still common practice, as shown by the intended VBAC rate 
of 67%. Our results also suggest that preselection already occurs to some extent without 
applying a model. 
Interpretation 
According to guidelines on prognostic research, even a predictive model that seems 
promising requires external validation in different populations and settings.19 Ethnicity and 
the probability of attempting VBAC were the main observed differences between the Dutch 
and American settings, although other factors like intrapartum policy may also exist. We 
consider our results to be roughly generalizable to most other western European countries 
with comparable ethnicities and VBAC rates. External validation in our Dutch cohort 
showed some loss of discriminative performance, as the original AUCs were 75% (95% CI 
74–77%) instead of 68% (95% CI 63–72%) for the ETC model and 77% (95% CI 76–78%) 
instead of and 72% (95% CI 67–76%) for the CTD model. As shown, this finding was 
more pronounced for the ETC model. These findings are consistent with the previous 
validation studies performed in an American cohort by Costantine et al.11,12 who used a 
validation method comparable to our study. However, the results contrast with the findings 
in a Japanese cohort where an AUC of 80% (95% CI 72–89%)13 was obtained. However, 
because no information was provided in that article on variable conversion and there 
appeared to be an additional selection criterion regarding whether women were actually in 
labour, no actual comparison with our results could be made.  
 
A review by Kaimal et al.20 highlighted that most women would like to be involved in 
decision-making about mode of birth.20 Also, women expressed their wish for personalised 
information.20 Hence, implementation of a predictive model could provide this tailored 
information by allowing estimation of the risk of emergency CS and the related risk of feto-
maternal morbidity.6,7 The ideal predictive model would distinguish between a successful 
intended VBAC and a failed intended VBAC by polarising the cohort into two groups: 
women with a very high predicted probability and women with a very low predicted 
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probability of achieving a VBAC. In comparison with other models that predict successful 
VBAC, the performance of the ETC and CTD models is average to good.4,8 However, for 
decision-making about mode of delivery after previous CS we consider it helpful to also 
distinguish women with a high or low probability of VBAC from those with an average 
probability. The ETC and CTD models show the potential to classify a notable portion of 
women away from the population mean, which might induce better a distribution with 
regard to risk classification of women amongst intended VBAC and ERCS. Therefore we 
think that a predictive model could not only contribute to more personalised counselling 
but also to a reduction in feto-maternal morbidity. However, the actual usefulness of such a 
model in terms of usability, applicability, change in birth preferences and feto-maternal 
morbidity should be further explored in a randomised controlled trial.   
Strengths and weaknesses 
A strength of this study is that it was performed in a multicentre setting with a good 
representation of types of hospitals and geographic regions in the Netherlands, which 
increased the external validity of our results. Furthermore, our data collection provides 
insight into the current (intended) VBAC rates in the Netherlands and into the prognostic 
profiles of women who opt for an intended VBAC and ERCS. By performing classification 
analysis we are able to show the subgroup of women who will have a probability of VBAC 
that is different from current population means.1,2  
 
We also recognise some limitations to our study. Firstly, there was a possible loss of 
discriminative performance of the validated models due to the necessary redefinition and 
conversion of variables into Dutch units. We had to redefine fetal station from a scale 
consisting of 12 steps ranging from B to –5 to +5 to the Dutch scale that consists of five 
steps and ranges from 0 to 4. Redefinition could induce misclassification and loss of 
refinement within variables, and thereby compromise model performance. Furthermore, in 
both models ethnicity is an important predictor. Though ethnicity has been recognized as an 
important demographic factor with regard to the probability of successful VBAC,4 the 
underlying mechanism is unknown and might be influenced by socioeconomic factors. 
Therefore, the ethnicity categories might not be compatible in other settings. Hence, we 
recommend re-estimation of ethnicity and the intrapartum variables before application of 
the models in an impact study or clinical practice. A second drawback is that we had to 
approximate the variable ‘third trimester BMI’ as it could not be obtained from the charts. 
This may have led to imprecision and impairment of the performance of the models. 
Thirdly, the models would ideally be evaluated through application in a prospective setting. 
Application of the models might induce different birth preferences in women, selecting 
women with more favourable prognostic profiles for successful VBAC. This might alter 
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model performance. Furthermore, a limitation with regard to the validated models that must 
be addressed concerns the timing of counselling. We consider that, from a medical point of 
view, counselling on mode of delivery should ideally occur in the third trimester of 
pregnancy, because then other factors can be incorporated that are known in late pregnancy 
such as estimated fetal weight (EFW) and whether labour needs to be induced. The ETC 
model does not take these factors into account whilst the CTD model is applicable when 
there is an indication for induction of labour or when labour has already started. In this 
regard, in terms of practical use, a predictive model that can be used in the third trimester 
would be more suitable for the Dutch setting.  
Conclusion 
External validation of two predictive models developed in the United States revealed 
adequate performance of both models within the Dutch setting. The predictive models can 
classify a notable portion of women away from the VBAC population mean. However, 
whether women indeed perceive the information on probability of successful VBAC as 
useful and whether the models hold when applied in a prospective setting should be 
additionally evaluated. Additional redefinition of the ‘ethnicity’ variable for a western 
European setting and transformation of both models into one model for third-trimester 
counselling could enhance model performance and increase applicability to the Dutch 
setting. 
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Abstract 
Objective 
To develop and internally validate a model that predicts the outcome of an intended vaginal 
birth after caesarean (VBAC) for a West European population which can be used to 
personalize counselling of deliveries at term.  
 
Design and setting 
Registration-based retrospective cohort study.  
Five university teaching hospitals, seven non-university teaching hospitals and five non-
university non-teaching hospitals in The Netherlands. 
 
Population 
515 women with a history of one caesarean section, a viable singleton pregnancy without a 
contraindication for intended VBAC, who delivered at term.  
 
Methods 
Potential predictors for a vaginal delivery after caesarean section (CS) were chosen based on 
literature and expert opinions. We internally validated the prediction model using 
bootstrapping techniques.  
 
Main outcome measures 
Predictors for VBAC; for validation, the area under the receiver operating characteristic 
curve (AUC) for discriminative capacity and calibration-per-risk-quantile for accuracy. 
 
Results 
371 out of 515 women had a VBAC (72%). Variables included in the model were: estimated 
fetal weight ≥P90 in the third trimester, previous non-progressive labour, previous vaginal 
delivery, induction of labour, pre-pregnancy body-mass-index and ethnicity. The AUC of 
receiver operating characteristic was 71% (95% confidence interval (CI)=69–73%), 
indicating good discriminative ability. The calibration plot shows that predicted probabilities 
are well calibrated, especially from 65% up, which accounts for 77% of the total study 
population.  
 
Conclusion 
We developed an appropriate Western-European population based prediction model that is 
aimed to personalize counselling of term deliveries. 
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Introduction 
In pregnancies following a caesarean section (CS), women should be offered counselling for 
both an intended vaginal birth after caesarean (VBAC) (i.e. trial of labour) and an elective 
repeat CS (ERCS). A substantial part of counselling is discussing the probability that an 
intended VBAC results in an actual vaginal delivery of a healthy child.1 In comparison to a 
CS, a successful VBAC (i.e. actual vaginal delivery) is associated with fewer major 
complications2, a shorter recovery period and high maternal satisfaction.3,4 However, if an 
intended VBAC results in an emergency CS, it is in comparison to an ERCS associated with 
a higher risk of major complications as hysterectomy and operative injury2 and with a 
relatively low maternal satisfaction.3, 4 Published success-rates of intended VBAC vary 
between 49% and 87%5 but it is evident that factors on patient, provider, and hospital level 
can influence the probability of success, and VBAC related morbidity.5-7 Hence, prediction 
of a woman’s individual probability of successful intended VBAC is a potentially useful tool 
to aid the decision-making process. Although many prediction tools that predict successful 
or unsuccessful intended VBAC have been published over the past two decades5,6,8, only a 
few of these models are externally validated in other cohorts6-8, while impact studies have 
not been performed at all. Consequently, current guidelines on pregnancy and childbirth 
after CS still recommend counselling with the use of the overall probability of success, 
instead of using a personalized one.1 It is remarkable that the majority of the prediction 
models were developed in a non-European population. These models cannot be directly 
translated to European settings as differences in obstetrical policy and the entirely different 
mix of ethnicities may impair the performance and validity of the models. For the European 
setting, only one non-externally validated model was available7, and two models9,10 
developed in North-American cohorts were previously externally validated for a Dutch 
population by our researchgroup.11 However, these models are less applicable for 
counselling since they either include factors that are only known intrapartum7,10 or the 
variables have yet to be adjusted for a West European population.9, 10 Hence, this study aims 
to develop a new prediction model by combining and improving existing models which 
predicts successful intended VBAC more reliably, and which is suitable for a Western 
European population and can be applied as a tool to personalize counselling on mode of 
delivery after CS for deliveries at term. 
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Methods 
Setting 
This registration-based retrospective cohort study was conducted in 17 Dutch hospitals 
which were involved in the Dutch research consortium for women’s health (www.studies-
obsgyn.nl. The enrolled hospitals covered all Dutch geographic regions. Included hospitals 
types were university teaching hospitals (n=5), non-university teaching hospitals (n=7) and 
non-university non-teaching hospitals (n=5). Approval for this study was obtained at the 
Medical Ethical Committee (CMO) of Maastricht University Medical Centre+ (MUMC+) 
(MEC number 09-4-047-13). 
Population 
Women were included when they had a history of one previous CS with any number of 
prior vaginal deliveries and had a vertex singleton pregnancy as well as a delivery at term 
(≥37 weeks gestational age (GA)) in their current pregnancy. We excluded women with an 
unknown indication of prior CS, or more than one previous CS, or in the current pregnancy 
either an intra uterine fetal demise or a contraindication for an intended VBAC. A 
contraindication for an intended VBAC was defined as a previous uterine rupture, a 
placenta praevia or a uterine scar with extension into the fundus. 
Potential predictors 
Contemporary methodological guidelines for prognostic modelling state that potential 
predictors should be preselected based on clinical reasoning and evidence from previous 
reports instead of observed significant relations with outcome variables in the same dataset. 
This method results into higher external validity and less overfitting of the developed 
model.12-14 Therefore, we preselected potential predictors based on previously published 
prediction models, expert opinions and articles reporting on risk factors for a successful 
intended VBAC.5,8-10 We preselected predictor variables from obstetrical history, medical 
history and demography of the patient. The final set of potential predictors that was 
considered for the model included estimated fetal weight (EFW), previous CS due to non-
progressive labour, any former vaginal birth, the occurrence of preeclampsia or the 
syndrome of haemolysis, elevated liver enzymes and low platelet count (HELLP) during 
current pregnancy, induction of labour in the current pregnancy, chronic and/or gestational 
hypertension, pre-pregnancy body mass index (BMI), maternal age and ethnicity. Non-
progressive labour was defined as arrest of descent, dilation or labour.  If no pre-pregnancy 
BMI measurement was available, we used the routinely measured first trimester BMI. 
Ethnicity is reported as one of the strongest of the demographic predictors for successful 
intended VBAC15, with women of European descent having a higher probability of 
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successful intended VBAC than women of Hispanic and African ethnicity.6 The underlying 
cause however, has remained unexplained.15 We hypothesized that the effect of ethnicity on 
successful VBAC might both be explained by socio-cultural aspects as well as by biological 
differences and could therefore vary between countries. As there was no available literature 
on the relation between ethnicity and VBAC for a Dutch or another West European 
population, we performed a univariate analysis to evaluate the association between different 
ethnicity strata and the probability of successful VBAC, using a liberal p-value of 0.20. In 
The Netherlands, ethnicity is documented within seven predefined categories: Dutch, 
Mediterranean, other European, African, Asian, Indo-Surinamese, and ‘other’. For the 
prediction model development we defined Caucasian ethnicity as Dutch or ‘other 
European’.  
Further, we aimed to incorporate EFW as a variable that is customized to gestational age in 
order to enable use of the model at any term within the third trimester of pregnancy. In The 
Netherlands, the curves of Snijders et al. 199416 are often used which were established along 
the curve of Yudkin et al.17 Hence after calculation of the fetal weight using the Hadlock 
formula18, fetal weight was customized to gestational age. Subsequently, we chose to create 
two dummy variables, one indicating EFW is equal to or below the 10th percentile, the other 
indicating that EFW is equal to or higher than the 90th percentile (P). We obtained EFW 
measurements performed in the third trimester between 33 and 37 weeks GA and measured 
by either ultrasound or abdominal palpation.  
Sample size 
There is consensus about the maximum number of predictors that can be validly included in 
a prediction model. It is recommended that at least ten events are collected for each 
potential predictor that is evaluated in the multivariable regression analysis.19 An event is 
defined as the least frequent outcome status, which is in our case an unsuccessful intended 
VBAC. In The Netherlands the estimated event rate, i.e. intended VBAC failure rate, is 
24-28%.11,20 Therefore, in order to develop a model with nine potential predictors, at least 
90 events were required. Hence, a sample size of at least 321 subjects was required 
(90/28 *100).   
Data collection  
Patient data regarding demography of the patient and potential predictors regarding 
obstetrical and medical history were extracted from medical records according to a 
standardized operating procedure by using customized case report forms (CRF) at all 
participating sites. Data were obtained by trained research nurses, medical doctors or senior 
medical students. Subjects were consecutively selected and included from the hospitals’ 
birth registers. To meet the required sample size, we requested each participating hospital to 
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include 30 subsequent cases of intended VBAC that matched the inclusion criteria, starting 
at the first of January 2010 until 31 December 2010.  
Data quality and missing data 
Data were checked for completeness and inconsistencies. Inconsistent and incomplete data 
were double-checked directly with the hospital concerned. Values we were unable to collect 
were imputed using a multiple imputation strategy, since the omission of patients who have 
one or more predictor variables missing from the analysis can cause a considerable loss of 
precision and may bias results.12,21 The number of imputations was set to five. Subsequently, 
we performed a sensitivity analysis by comparing outcomes of the imputed dataset with the 
use of complete cases analysis only. The purpose of this analysis was to determine whether 
imputation led to radically different results or a different conclusion. 
Model development  
We used restricted cubic splines and graphs to determine whether continuous potential 
predictors could be analysed as linear terms. In each of the five imputed datasets, we 
introduced all of the potential predictors in a multivariable logistic regression model, using 
successful intended VBAC as the outcome variable. To reduce the amount of predictors in 
these models, we used backward stepwise deletion based on the Wald test. We used a liberal 
p-value of 0.20, as recommended by prediction modelling guidelines.13 Predictors that 
remained in at least three out of five imputed datasets were included in the final model, and 
were re-estimated in all imputed datasets separately. Results of these five models were 
combined into a single prediction model.22 
Internal validation 
Stepwise selection methods such as backward stepwise deletion are often discouraged to use 
because they can introduce selection bias, since predictors that are by chance overestimated 
are more likely to be included than predictors that are by chance underestimated. This can 
result in a prediction model that may be overfitted to the derivation data, i.e. it performs 
well in the data it was derived on, but performance will degrade considerable when applied 
to future patients. Generally, predictions will be too extreme. In order to reduce the risk of 
overfitting, we internally validated the model using bootstrapping. In this internal validation 
step, B-bootstrap samples of the same size as the original sample (we used B=1000) were 
drawn with replacement from the original data, which reflects drawing of samples from the 
underlying population. This was performed to estimate the likely performance in future 
patients, and adjust the model so future predictions will be less extreme. 
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Performance of the model 
To assess the performance of the internally validated model, we quantified measures of 
discrimination and calibration. The models ability to discriminate between women who had 
a successful intended VBAC and women who had a failed intended VBAC (emergency CS), 
was quantified as the area under the receiver operating characteristic (ROC) curve. This 
ranges from 50% (no discriminative capacity) to 100% (perfect discriminative capacity). The 
agreement between predicted probabilities and observed frequencies of the outcome 
(accuracy) was assessed by visually inspecting the calibration plot. Furthermore, we 
computed the Hosmer and Lemeshow (H-L) goodness-of-fit statistic as a quantitative 
measure of accuracy. A high H-L statistic is related to a low p-value and indicates lack of fit. 
All statistical analyses were performed using SPSS version 20.0 and R version 2.12.2; 
http://www.r-project.org). 
Results 
Patient population 
A total of 515 women with a history of one CS were identified as eligible for the present 
study. Baseline characteristics of the cohort are presented in Table 6.1. The overall 
successful intended VBAC rate was 72.0% (in total 371 women). 
 
Table 6.1 Baseline characteristics of who attempt a vaginal birth after caesarean section. 
Characteristic Missing values Women intended VBAC N=515 
Maternal age (years, mean ± SD) 2 (0) 32.2 ± 5.0 
Ethnicity (n,(%)) 
- Caucasian 
- Mediterranean 
- African 
- Asian 
- Indo-Surinamese 
- Other 
15 (3.0) 
 
405 (81.0) 
37 (7.4) 
24 (4.8) 
12 (2.4) 
7 (1.4) 
15 (3.0) 
Parity (mean ± SD) 0 (0) 1.4 ± 0.8 
Pre-pregnancy BMI (kg/m², mean ± SD) 124 (24.1) 25.3 ± 5.7 
Previous CS due to non-progressive labour (n,(%)) 0 (0) 201 (39.0) 
Any previous vaginal delivery (n,(%)) 0 (0) 127 (24.7) 
Previous VBAC (n,(%)) 0 (0) 99 (19.2) 
PE/HELLP 0 (0) 9 (1.7) 
Diabetes Mellitus 0 (0) 13 (2.5) 
Hypertension 0 (0) 37 (7.2) 
Induction of labour (n,(%)) 0 (0) 132 (25.6) 
Estimated fetal weight ≤ p10 201 (39.0) 26 (8.3) 
Estimated fetal weight ≥ p90 201 (39.0) 11 (3.5) 
Estimated gestational age at delivery (weeks, mean ± SD) 0 (0) 39.8 ± 1.2 
VBAC: vaginal birth after caesarean, SD: standard deviation, BMI: body mass index, CS: caesarean section, PE: 
Preeclampsia HELLP syndrome: haemolysis, elevated liver-enzymes, low platelets, p: percentile. 
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Model development and internal validation 
The number of missing values per predictor variable are shown in Table 6.1. For the 
majority of the potential predictors, there was only a small amount of missing data. 
However, pre-pregnancy BMI was missing in 24% of women and estimated fetal weight 
(EFW) was missing in 39% of women. After imputation, all 515 women were available for 
multivariable modelling. Subsequently, based on univariate analyses for the variable 
‘ethnicity’, we selected Caucasian ethnicity (yes/no) as potential predictor (95% confidence 
interval (CI) odds ratio(OR) 0.92–2.32, p-value 0.11). We entered all potential predictors in 
the model and identified six predictors that met our selection criteria. These six predictors 
were: pre-pregnancy BMI, obstetrical history (previous vaginal delivery and previous non-
progressive labour), Caucasian ethnicity, induction of current labour and EFW ≥P90. These 
six variables were combined into one model. Maternal age and BMI are continuous 
variables; all other predictors are dichotomous variables. Table 6.2 shows the original 
prediction model (i.e. after variable selection and estimation of parameters in five imputed 
datasets) that estimates a successful intended VBAC. The bootstrap validation yielded a 
shrinkage factor of 0.78, which was used to multiply the regression coefficients by. After the 
adjustment of regression coefficients, the intercept was re-estimated (Table 6.2).  
 
Table 6.2 Prediction model for the estimation of a successful intended VBAC with regression 
coefficients and odds ratio’s before and after internal validation. 
Variable  Regression coefficient 
(crude) 
* Regression 
coefficient (adjusted) 
OR (crude) (95%CI) 
Intercept  1.876 1.647 - 
Caucasian  yes/no 0.476 0.371 1.61 (0.97 – 2.66) 
Pre-pregnancy BMI  kg/m² -0.041 -0.032 0.96 (0.92-1.00) 
Previous CS due to non-
progressive labour  
yes/no -0.688 -0.537 0.50 (0.33-0.76) 
Any previous vaginal delivery yes/no 1.339 1.045 3.81 (2.10-6.92) 
Induction of labour yes/no -0.660 -0.515 0.52 (0.33-2.10) 
Estimated fetal weight ≥ p90 yes/no -0.624 -0.487 0.54 (0.14 – 2.02) 
* Regression coefficients after adjustment for overfitting by shrinkage (shrinkage factor=0.78), the intercept was 
re-estimated. To calculate the absolute risk of a successful intended VBAC: P(success)=1/ (1+e-(Linear part)) * 100%. 
Linear part=1.647+(0.371*Caucasian)–(0.032*pre-pregnancyBMI)–(0.537*Previous_non-progressive_labour)+(1.045 
*Previous vaginal delivery)–(0.515* Induction of labour)–(0.487*EFW≥p90). CI: confidence interval, BMI: body 
mass index, CS: caesarean section, PE: Preeclampsia HELLP syndrome: haemolysis, elevated liver enzymes, low 
platelets, p: percentile. 
 
The final predictive equation that can be used to estimate the individual probability of a 
successful intended VBAC for future patients is: P(success)=(1/(1+exp(-(1.647+0.371* 
Caucasian–0.032*pre-pregnancy BMI–0.537*Previous non-progressive labour+1.045* 
Previous vaginal delivery–0.515* Induction of labour–0.487*EFW≥P90))))*100%. For 
example, a woman of Caucasian ethnicity, a BMI of 26 kg/m2,  a previous CS due to non-
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progressive labour, no previous vaginal delivery, no induction of labour and the in the third 
trimester EFW is smaller than P90 has a predicted probability of successful intended VBAC 
of 65.7%. When an indication for induction presents, the probability of this patient shifts to 
53.3%, this information can be used for a re-evaluation of chosen mode of birth.  
Performance of the model 
Discriminative performance of the prediction model is shown in figure 6.1. The area under 
the ROC curve (AUC) was 70.8% (95% confidence interval (CI)=68.6–72.9%), which 
indicates good discriminative ability. Calibration was good, indicated with a non-significant 
H-L statistic (0.13). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.1 Receiver operating characteristic (ROC) of the prediction model (AUC: 70.8%; 95% CI: % 
68.6-72.9), indicating reasonable discriminative performance of the model. 
 
The corresponding calibration curve that represents accuracy of the model is shown in 
Figure 6.2. Predicted probabilities ranged from 39% to 93%, with a mean of 72% (SD: 
11%). Overall, the developed prediction model has a good fit to reference curve, i.e.. 
predicted probabilities agree observed probabilities. The calibration plot shows that 
predicted probabilities are especially well calibrated from about 65% up, which accounts for 
77% of the target group. However, in women who have a probability of success of lower 
than 50%, the model generally underestimates their probability of successful intended 
VBAC.  
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Figure 6.2 Calibration plot with the observed frequency of a successful intended vaginal birth after 
caesarean section by the predicted probability. The triangles indicate quantiles of women 
with a similar predicted probability of success. 
Discussion 
Main findings 
In this study we developed and internally validated a prediction model in accordance with 
contemporary methodological guidelines in prognostic modelling.12-14 The prediction model 
estimates successful intended VBAC and is aimed for application for personalized 
counselling in the third trimester of pregnancy, i.e. for women with an expected term 
delivery. The final model for predicting successful intended VBAC consists of six variables 
including demographic variables (pre-pregnancy BMI, Caucasian ethnicity), obstetrical 
history (previous vaginal delivery and previous non-progressive labour) and current 
pregnancy variables (induction of current labour and EFW ≥ P90). The developed 
prediction model has reasonable discriminative capacity and is accurate, especially for 
women with a predicted probability of 65% and higher. In order to determine whether the 
amount of missing values within EFW and BMI led to different conclusions and/or results, 
we performed a sensitivity analysis by comparing outcomes of the imputed dataset with the 
use of complete cases analysis only. This analysis showed similar results for both datasets, 
therefore we concluded that imputation did not lead to radically different results.  
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Strengths and weaknesses  
A strong point of this study is that we obtained consecutive cases based on the hospitals’ 
birth registers in various geographic regions and hospital types in The Netherlands. This 
method results into a representative, high quality dataset. Another strength is that we aimed 
for maximal applicability of the model in current care on pregnancy after CS. As both 
expert opinions and literature were part of the predictor selection process, we developed a 
model that is actual appropriate and easy to use. Therefore, unlike other models, we 
included only factors that can be known prior to delivery. For instance, models have been 
described that include birth weight, which is only known postpartum, and we chose not to 
include intrapartum factors like cervical examination since we aimed for decision-making in 
the early third trimester. Several limitations in this study should also be addressed. Firstly, 
though for most variables we have collected a complete dataset, we had a significant 
amount of missing values mainly for BMI and EFW because these data were not available in 
the charts. Since the amount of missing data for BMI was merely resulting from a few 
particular hospitals, these missing values were considered to be missing at random and we 
consider the effect on model development and performance to be minor. This was 
confirmed by comparing performance parameters calculated with complete case analysis to 
the imputed dataset. Another drawback of our study is that we were not yet able to assess 
the next steps within prognostic modelling: determining external validity, usefulness and 
clinical impact of the model. Therefore, though model development was thorough and 
based on contemporary guidelines within prognostic modelling, our current results should 
be interpreted with caution. 
Interpretation  
This is the first model for prediction of successful intended VBAC that includes EFW. The 
other selected predictor variables have been described other studies.5,6,8 Also, the 
discriminative capacity of our model was comparable to those reported in other studies.5, 8 
An exception to all published models might be the model of Naji et al.23 which showed 
promising results with a model incorporating ultrasound evaluation of the CS-scar in the 
lower uterus segment. Also a recent published study of Verhoeven et al.24 showed, as the 
study of Smith et al.7, that maternal height may be an independent predictor for emergency 
CS. Hence our predictor selection methods did not lead to inclusion of these variables at the 
moment of model development. Future studies should evaluate whether inclusion of CS-
scar variables and maternal height increase accuracy of VBAC prediction. Concerning other 
VBAC prediction studies, it was stated in a systematic review of Eden et al.8 that most 
models have the lack to predict failure of intended VBAC. Our model achieved the highest 
accuracy for predicted probabilities in the higher probability ranges as well, though overall 
performance parameters are good. However unlike other tools, our model is targeted on a 
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Western European population and prediction in the early third trimester, incorporating both 
factors that are known prior to pregnancy and factors that occur during pregnancy. Though 
our dataset was smaller than some other prediction models9,10 we achieved an adequate 
sample size for model development and by preselecting potential predictors using other 
studies reporting on VBAC prediction, it is likely that our results are generalizable. 
Therefore, this new prediction model may provide a more appropriate and applicable 
alternative for countries with a West-European population than existing models.  
 
Concurrently with the globally rising primary CS rates25, increasing numbers of women are 
pregnant with a history of CS. The need for healthcare interventions in order to enhance 
decision-making on mode of birth after CS has been addressed in several studies.5 We think 
that a prediction model can be applied to enhance shared decision making and in order to 
place risks of morbidity of intended VBAC into context. Usefulness of such a model is 
likely as the prediction model could contribute to more unbiased and accurate counselling; 
and might lead to a reduction of emergency CSs. In order to test this hypothesis, we 
currently carry out a prospective study in which we evaluate the developed prediction model 
through application in order to determine external validity, usefulness and clinical impact. 
To the knowledge of the authors, no clinical impact studies have been published of other 
existing models on this topic. However, we think that this is essential since model 
application might lead to different birth preferences resulting in a different selection of 
women undergoing intended VBAC. This selection might alter performance parameters of 
the model.26 Consequently, models should be evaluated through application before 
implementation into clinical practice. The prediction model is tested in a prospective 
controlled setting in twelve hospitals in The Netherlands. In six intervention hospitals we 
apply the model as a part of a patient decision aid (PtDA) on mode of delivery after 
previous CS and in six control hospitals we evaluate the prediction model without actually 
applying the model. For the intervention hospitals, the model is adapted into an easy to use 
calculator that is used in the early third trimester. Pretesting of this prediction model and 
PtDA in 25 women within the target group showed that the majority of the women judged 
the prediction model to be relevant for decision-making.  
Conclusion 
We developed an appropriate Western-European population based prediction model that is 
aimed for counselling on mode of birth after CS for term deliveries. The model holds 
promise as a tool that personalises decision-making on mode of birth after CS and could be 
applied to place potential risks of intended VBAC into context. 
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Abstract 
Background 
There is an increasing number of women with a prior caesarean section (CS) who deliver by 
elective repeat CS (ERCS) instead of intended vaginal birth after caesarean (VBAC). The 
probability of successful VBAC plays a central role within risk estimation for mode of birth. 
We aimed to determine predictive performance of clinicians for successful VBAC compared 
to a prediction model and used actual clinical outcomes as a benchmark. 
 
Methods 
Clinical vignettes were constructed from actual patients with known outcomes of intended 
VBAC (successful or failed). We randomly drew 450 clinical cases in order to create 
vignettes. For each vignette, the probability of successful VBAC was estimated both by a 
clinician and prediction model, and compared to the actual outcome. Discriminative 
performance was assessed by obtaining the areas under the curve (AUC) of the receiver 
operator characteristic; predictive performance was assessed by calibration per-risk-quantile 
and Hosmer-Lemeshow (H-L) statistics. 
 
Findings 
Four-hundred-and-six vignettes were completed. For clinicians, the AUC was 0.60 (CI 95% 
0.54–0.67) while the AUC for the prediction model was 0.70 (CI 95% 0.64–0.76) (p-value 
for difference P<0.003). Calibration-per-risk-quantile showed that clinicians generally 
underestimated the probability of successful intended VBAC below 70.0%. Calibration-per-
risk-quantile for the prediction model was good in all probability ranges. The corresponding 
H-L statistic confirmed lack of fit for clinicians (P=0.024), no evidence was found for lack 
of fit for the prediction model (P=0.42). 
 
Interpretation 
Compared to the model, clinicians performed poorly with regard to prediction of successful 
intended VBAC whilst the majority counsels with a self-derived probability. Hence, in 
comparison to clinical judgement, the use of the VBAC prediction model can be beneficial. 
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Introduction 
Worldwide rising caesarean section (CS) rates are a major burden on healthcare. Reported 
contemporary CS rates are as high as 25% in England and 33% in The United States (US)1, 
with a range of 17% in The Netherlands to 44% in Mexico.2,3 It is remarkable that the 
largest increase in CSs has been observed amongst nulliparous women with a singleton in 
vertex position who deliver at term.4 With these rising numbers, the debate on safety and 
practice of childbirth after CS becomes more pressing. It is concerning that increasing 
numbers of women with a prior CS deliver by elective repeat caesarean section (ERCS) 
instead of intended vaginal birth after caesarean (VBAC) (i.e. trial of labour after 
caesarean).5 Though some hospitals entirely banned VBAC because of fear for litigation6,7, 
most experts do not consider ERCS to be superior to intended VBAC. In fact, 
contemporary guidelines on pregnancy and childbirth after CS state that women should be 
counselled in order to empower them to choose between the birth options.8-11 This difficult 
decision-making process is influenced by many factors.12 Amongst these factors, the 
probability of successful intended VBAC (i.e. actual VBAC) plays a central role. Reports 
have linked a low probability of success to a high risk of major foeto-maternal 
morbidity.13-15 Generally, reported successful VBAC-rates vary between 49% and 87%.16 
However, it is evident that individual probabilities vary due to demographic factors, 
obstetrical history and events occurring during pregnancy.17 Many attempts have been made 
to develop scoring tools that should support the decision-making process by individual risk 
estimation of successful intended VBAC16,18 and the majority achieves reasonable predictive 
performance.18 To what extent these models could contribute to current care is not clear as 
data that compares performance of these tools to clinical judgement are not available. 
Hence, the aim of this study is to determine clinicians’ predictive performance for 
successful intended VBAC in terms of calibration and discrimination and to compare this to 
a recently developed prediction model. 
Methods 
Study design 
This study was designed as a vignette study with vignettes constructed from a retrospective 
cohort of real patients with known outcomes of intended VBAC (successful or failed). 
Vignettes were regarded as actual clinical situations. The main outcome measures of this 
study are performance parameters of clinical judgement and the prediction model in terms 
of discriminative capacity and calibration.  
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Setting 
This study was carried out within the Dutch research consortium for Women’s health. 
Patient data for the construction of the vignettes were derived from a nationwide 
registration-based cohort study amongst women with a prior CS who delivered in 2010. 
Data were collected in 17 independent Dutch hospitals, representative for geographical 
regions in The Netherlands. Participating hospitals consisted of university teaching hospitals 
(n=5), non-university teaching hospitals (n=7) and non-university non-teaching hospitals 
(n=5). 
After construction of the vignettes,  gynaecologists, residents and midwives were 
approached for participation through email via the Dutch research consortium for Women’s 
health and during a national conference of the Dutch Society of Gynaecology and 
Obstetrics (NVOG). 
Population 
The cohort used for the construction of the vignettes and the prediction model consists of 
women who were consecutively included according to the hospitals birth registers. We 
included women with one prior low-transverse CS and a singleton pregnancy in vertex 
position. Exclusion criteria were breech presentation or an intrauterine foetal demise or a 
contraindication for intended VBAC. A contraindication for intended VBAC was defined as 
placenta previa or a relevant uterine scar with extension into the fundus. For this study, we 
selected only women from the database who had an intended VBAC.  
Sample size considerations 
The sample size calculation was based on a difference in discriminative capacity between the 
clinicians and the prediction model. A difference of 10% in the areas under the curve 
(AUC) of the receiver operator characteristics (ROC) was considered clinically relevant. 
Therefore, with an alpha of 0.05 and a beta of 0.20, the estimated required sample size was 
400 vignettes.  
Vignette derivation 
Patient characteristics included in the vignettes were selected based on prior research 
findings, an evidence report on VBAC16, expert opinions and availability in the database. 
The selected variables were: third trimester estimated foetal weight (EFW) ≥ percentile (p) 
90 (yes/no), EFW ≤ p10 (yes/no), prior CS due to non-progressive labour (yes/no), one or 
more previous vaginal deliveries (yes/no), induction of labour in current pregnancy 
(yes/no), BMI (kg/m²), ethnicity, maternal age (years), hypertension (HT) (yes/no), diabetes 
mellitus (DM) (yes/no) and the occurrence of pre-eclampsia (PE) or HELLP syndrome 
during current pregnancy. A prior CS due to non-progressive labour was defined as a failure 
 Vignette study 
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of dilation or descend in the first or second stage of labour. Pre-pregnancy body mass index 
(kg/m2) (BMI) was defined as BMI prior to, or in the first trimester of the current 
pregnancy. DM and HT could be either pre-existent or gestational induced. Before these 
data were copied to standardized clinical vignettes, missing data were imputed since 
omission of incomplete cases can result in loss of precision and may bias the results.19, 20 
For imputation, all quantitative baseline characteristics were used for estimation of the 
missing values, the number of imputations were set to five. Subsequently for vignette 
derivation, 450 cases were randomly drawn with replacement from the database.  
Survey 
We aimed to obtain a sample of clinicians, representative of providers working within 
obstetrics and gynaecology in The Netherlands, by using national networks (see setting) for 
recruitment. Participants were approached face-to-face on a conference or through mass-
email. Non-responders received a reminder email. No compensation was provided for 
participation. Participants completed one to three vignettes where they were asked to 
predict a probability of successful intended VBAC ranging from 0% and 100%. In order to 
obtain insight in possible participation bias, we collected data on experience and views of 
the participants on counselling on mode of birth after caesarean. Questions were directed at 
the number of years of experience as registered obstetrician, the frequency of counselling 
and the place of the probability of successful intended VBAC within counselling practice.  
Participants were subdivided in obstetricians, and non-obstetricians (residents, midwives). 
Prediction model 
Our prediction model was developed for third trimester counselling amongst 515 women 
with a history of one CS. Potential predictors for successful intended VBAC were chosen 
based on literature and expert opinion; the model was internally validated using 
bootstrapping techniques. The development, interval validation and performance of this 
model is described in more detail elsewhere.21 The final predictive equation is as follows: 
P(success)=(1/(1+exp(-(1.647+0.371*Caucasian –0.032*pre-pregnancy body mass index–
0.537*Previous non progressive labour +1.045*Previous vaginal delivery – 0.515* Induction 
of labour –0·487*third trimester estimated foetal weight≥p90)))) *100%. Definitions match 
those of the clinical vignettes.  
Statistical analyses 
For each clinical vignette, the probability of successful intended VBAC was calculated with 
the prediction model, and assessed by one or more clinicians. Subsequently, parameters of 
discriminative and predictive performance were obtained for both the prediction model and 
for the clinicians. Discriminative performance was assessed with a ROC-analysis by 
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obtaining the corresponding AUC. The ROC was obtained by plotting sensitivity against 1-
specificity. Within this analysis, sensitivity was defined as the fraction of successful intended 
VBAC that was predicted correctly per corresponding cut-off value. Specificity was defined 
as the fraction of unsuccessful intended VBAC that was correctly predicted per 
corresponding cut-off value. The AUC reflects the ability of the prediction tool (i.e. model 
or clinicians) to discriminate between women who have a high probability of successful 
intended VBAC and women who have a low probability of successful intended VBAC. 
Predictive performance, the agreement between predicted and observed values, was 
assessed per risk quantile. Calibration was assessed by visually inspecting the agreement 
between observed and predicted frequencies in the calibration plots. Goodness-of-fit to the 
ideal calibration curve was quantified with the Hosmer-Lemeshow (H-L) statistic. A high H-
L statistic is related to a low p-value and indicates lack of fit. Additionally, a subgroup 
analyses was performed concerning differences in predictive ability of obstetricians and 
non-obstetricians (residents/midwives). We evaluated the difference in AUC’s using the 
method of DeLong, extended for non-correlated ROC-curves. Additional sensitivity 
analysis was performed to determine whether the presence of double vignettes biased 
results. Estimated probabilities of VBAC for one clinical case were combined to recalculate 
the outcome measures. 
All statistical analyses were performed using SPSS (version 20·0) and R (version 2·12.2; 
http://www.r-project.org). 
Results 
Study population 
The patient cohort comprised 515 women with a prior CS who had an intended VBAC of 
whom 371 (72.0%) actually delivered vaginally. Baseline characteristics of the cohort are 
summarized in Table 7.1. 
 
Mean age was 32.2 years (standard deviation (SD) 5.0). 405 (81%) women were of 
Caucasian ethnicity. In this cohort, mean BMI was 25.3 (SD 5.7). In total, 127 (24.7%) 
women had a previous vaginal delivery, 201 (39%) had a prior CS because of non-
progressive labour. In the current pregnancy, 132 (25.6%) women were induced, nine 
(1.7%) women had PE or HELLP, 13 (2.5%) had DM and 37 (7.2%) had HT. EFW was 
lower or equal to P10 in 26 (8.3%) cases and higher or equal to P90 in 11 (3.5%) cases.  
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Table 7.1 Study cohort. Baseline characteristics of study cohort of women with a trial of labour after 
caesarean used for derivation of the clinical vignettes. 
Characteristics Missings 
N (%) 
Cohort 
(n=515) 
Maternal age (years, mean±SD) 2 (0·0) 32·2 ± 5 
Ethnicity    
Caucasian 15 (3·0) 405 (81·0) 
Mediterranean  37 (7·4) 
African  24 (4·8) 
Indo-Surinamese  12 (2·4) 
Asian  7 (1·4) 
Other   15 (3·0) 
BMI (kg/m², mean ± SD) 124 (24·0) 25·3 ±5·7 
Previous CS due to non progressive labour, n (%) 0 (0·0) 201 (39) 
Previous vaginal delivery, n (%) 0 (0·0) 127 (24·7) 
PE/HELLP, n (%) 0 (0·0) 9 (1·7) 
Diabetes Mellitus, n (%) 0 (0·0) 13 (2·5) 
Hypertension, n (%) 0 (0·0) 37 (7·2) 
EFW, n (%)   
P≤10 201 (39·0) 26 (8·3) 
P≥90 201 (39·0) 11 (3·5) 
Induction of labour, n (%)  0 (0·0) 132 (25·6) 
SD: standard deviation, BMI: body mass index, CS: caesarean section, PE: Preeclampsia, HELLP syndrome: 
haemolysis, elevated liver-enzymes, low platelets, P: percentile. 
 
Participants 
In total, 406 vignettes were completed of which 255 (62·8%) by obstetricians and 147 
(36·2%) by non-obstetricians (residents and midwives). Characteristics of the participants 
are summarized in Table 7.2. 
 
Table 7.2 Participants. Characteristics of the study participants, i.e. clinicians. 
Characteristics 
n=406* 
Missings 
n / n 
Obstetrician 
n=255 
Non-obstetrician 
n=147 
Sex, n (%)  0 / 0   
Male  111 (43·5) 15 (10·2) 
Female  144 (56·5) 132 (89·8) 
Age, (years, mean ± SD) 3 / 0 45·1 ± 7·8 31·0 ± 5·7 
Setting, n (%) 0 / 2   
Academic teaching hospital  54 (21·2) 59 (40·7) 
Non academic teaching hospital  138 (54·1) 81 (55·9) 
Non academic non-teaching hospital  63 (24·7) 1 (0·7) 
Midwivery practice  0 (0·0) 4 (2·8) 
Experience, n (%) 0 (0·0)   
<5 years  72 (28·2) N/A 
5-10 years  85 (33·3) N/A 
>10 years  98 (38·4) N/A 
* Of four participants it was unkown whether they were obstetrician or non-obstetrician. SD: standard deviation ; 
N/A not applicable 
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In Table 7.3, data with regard to the views and experiences of the participants with risk 
counselling on mode of birth after CS are summarized. A majority of the participants 
counselled on mode of birth more than 20 times per year, and a majority of the participants 
always provided a probability of successful intended VBAC during every counselling. 
Obstetricians provided in 57.0% a self-estimated probability of successful intended VBAC, 
while residents and midwives more often provided the probability that was stated in the 
Dutch guidelines.  
 
Table 7.3 Risk-counselling. Overview of experience and views of the participants on risk counselling 
on mode of birth after caesarean. 
Questions 
n=406* 
Missings 
n / n 
Obstetrician
n=255 
Non-obstetrician 
n=147 
How frequently do you counsel on mode of birth after CS?    4 / 20   
< 5 times/year, n (%)  36 (14·3) 23 (18·1) 
5-20 times/year, n (%)  66 (26·3) 52 (40·9) 
> 20 times/year, n (%)  149 (59·4) 52 (40·9) 
How often do you provide a probability of successful 
intended VBAC during counselling? 7 / 11   
Always, n (%)  151 (60·9) 63 (46·3) 
Sometimes, n (%)  66 (26·6) 49 (36·0) 
Never, n (%)  31 (12·5) 24 (17·6) 
What probability of successful intended VBAC do you 
generally provide during counselling?  41 / 41   
A self-estimated individual probability, n (%)  122 (57·0) 34 (32·1) 
Conform Dutch guidelines (70-75%), n (%)  48 (22·4) 53 (50·0) 
Other , n (%)  44 (20·6) 19 (17·9) 
* Of four participants it was unknown whether they were obstetrician or non-obstetrician. CS: caesarean section; 
ERCS: elective repeat caesarean section; VBAC: vaginal birth after caesarean 
 
Main results  
The discriminative capacities of clinicians and the prediction model are shown in Figure 7.1. 
The ROC of the clinicians has an AUC of 0.60 (CI 95% 0.54–0.67), indicating poor 
discriminative capacity. The ROC curve of the prediction model has an AUC of 0.70 (CI 
95% 0.64–0.76) which indicates fair discriminative capacity. The difference between the 
AUC’s of the predictive ability of clinicians and the model is 10.0% (P<0.003).  
Additional comparison of the AUC’s of obstetricians (0.61) to non-obstetricians (0.60) 
showed no meaningful difference (P=0.8). In Figure 7.2, calibration-per-risk-quantile for 
predictive performance of clinicians is shown. Clinicians generally underestimated the 
probability of successful intended VBAC below 70.0%. Above 70.0%, calibration was fair. 
The corresponding H-L statistic however, shows that accuracy was poor (P=0.024). 
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Figure 7.1 Receiver operating characteristics. Receiver operating characteristics of clinicians (AUC 
0.60; 95% CI: 0.54–0.67), and the prediction model (AUC 0.70; 95% CI: 0.64–0.76). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.2 Calibration clinicians. Calibration plot with the observed frequency of a successful trial of 
labour after caesarean section in the study cohort by probabilities estimated by the 
clinicians. 
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Figure 7.3 shows calibration-per-risk-quantile for the prediction model. The prediction 
model was well calibrated over the whole range of probabilities. The corresponding H-L 
statistic shows a p-value of 0.42, which indicates a good fit of the model. Vignettes were 
multiple drawn with a maximum of three times; sensitivity analysis revealed that the 
presence of double or triple vignettes did not lead to radically different results or 
conclusions. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.3 Calibration prediction model. Calibration plot with the observed frequency of a successful 
trial of labour after caesarean section in the study cohort by probabilities estimated with the 
prediction model. 
Discussion 
Both obstetricians and residents/midwifes had experience with counselling on mode of 
delivery after CS. However, our results show that clinicians do not perform well with regard 
to prediction of successful intended VBAC. Both accuracy and discrimination between 
women with a high probability and a low probability was poor. In general, clinicians 
underestimate the actual probability of success, this may lead to more ERCS prone 
counselling. Subgroup analysis revealed no meaningful difference in performance between 
obstetricians and non-obstetricians, while obstetricians clearly counsel more often with a 
self-perceived probability instead of the risk-numbers of contemporary guidelines. This 
study also shows that the use of the  developed prediction model can be beneficial as with 
the prediction model a higher predictive and discriminative performance was achieved.  
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The findings in this paper are consistent with the conclusions of Grove and colleagues22, 
who performed a systematic literature review on studies that compare ‘statistical’ prediction 
and ‘clinical’ prediction. In this review it was concluded that in general, prediction models 
are 10% more accurate than clinical judgement.22 The prediction model that was used as a 
reference in this study performs similar to other models for prediction of successful 
intended VBAC.18 The majority of women get a score with the prediction model of 70% or 
higher. Studies showed that for this group, risks on severe foeto-maternal morbidity for 
intended VBAC are similar to those of ERCS.14, 15 Therefore, women with an estimated 
chance of actual VBAC of >70% could proceed with intended VBAC, preventing morbidity 
for future pregnancies that results from each extra CS-scar.23 Also, this could reduce 
healthcare costs as failed intended VBAC is more expensive in comparison to ERCS and 
successful intended VBAC respectively.24 However, before a prediction model is 
incorporated into clinical practice, we recommend a thorough prospective evaluation 
through application.  
 
To the knowledge of the authors, this is the first study that estimates to what extent 
clinicians use the probability of successful intended VBAC within counselling and whether 
they are able to estimate a reliable chance of success based on knowledge i.e. ‘skilled 
intuition’. A strong point of this study is that the design enables us to compare predictive 
performance of clinicians to a reference, as provided with the prediction model and the 
actual outcomes. This approach is in concurrence with a recent review of Bachmann and 
colleagues on vignette studies who stated these studies should compare outcomes to a 
benchmark.25 Therefore, we were able to determine ‘correctness’ of the prediction very 
accurately. However, the ideal design for this study is a prospective study with ‘actual’ 
patients instead of vignettes in a fixed format. The main concern is that it is questionable 
whether professionals in reality indeed behave and judge as they do in the hypothetical 
context of a clinical vignette.25 Furthermore, the predefining of variables might have 
resulted in loss of information relevant to individual clinicians and could therefore have 
induced a loss of precision of our results. Another drawback of our design was related to 
the retrospective nature of our study as well, as we were not able to obtain all patient data. 
Therefore, we were required to impute missing values up to 39.0% of all data regarding 
EFW and 24.0% for BMI which may have impaired precision of predicted probabilities of 
VBAC. Further, though we obtained a representative sample of clinicians for the Dutch 
setting, the additional ‘gain’ of using a prediction model for individual risk estimation might 
be varying across countries based on clinical training and local practices.   
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In conclusion, our results show that clinicians perform poorly with regard to the estimation 
of the probability of successful VBAC. Our results are in favour of the prediction model 
since it is more reliable than clinical prediction and is easy to use. Implementation of the 
prediction model in current care might lead to a more standardized care. Also, as clinicians 
generally underestimated the VBAC success rates, the usage of a prediction model might 
lead to a different, more VBAC prone, mind-set within counselling in both clinicians and 
patients. 
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Abstract 
Objective To develop a patient decision aid (PtDA) for mode of delivery after caesarean 
section (CS) that integrates personalised prediction of vaginal birth after caesarean (VBAC) 
with elicitation of patient preferences and evidence-based information. 
 
Design and setting 
A PtDA was developed and pilot tested using the International Patients Decision Aid 
Standards (IPDAS) criteria.  
Obstetric healthcare in the Netherlands. 
 
Population 
A multidisciplinary steering group, an expert panel and 25 future users of the PtDA, i.e. 
women with a previous CS.  
 
Methods 
Development consisted of a construction phase (definition of scope and purpose, selection 
of contents, framework and format) and a pilot-testing phase by interview. The process was 
supervised by a multidisciplinary steering group. 
 
Main outcome measures 
Usability, clarity, relevance. 
 
Results 
The construction phase resulted in a booklet including unbiased balanced information on 
mode of birth after CS, a preference elicitation exercise and tailored risk information 
including a prediction model for successful VBAC. During pilot testing, visualisation of 
risks and clarity formed the main basis for revisions. Pilot testing showed the availability of 
tailored structured information to be the main factor involving women in decision-making. 
The PtDA meets 39 out of 50 IPDAS criteria (78%): 23 out of 23 criteria for content 
(100%) and 16 out of 20 criteria for the development process (80%). Criteria for 
effectiveness (n=7) were not evaluated. 
 
Conclusions 
An evidence-based PtDA was developed, with the probability of successful VBAC and the 
availability of structured information as key items. It is likely that the PtDA enhances the 
quality of decision-making on mode of birth after CS. 
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Introduction 
Decision-making in pregnancy is particularly complex because women must consider not 
only their own health but also that of their unborn babies. In the decision on mode of 
delivery after caesarean section (CS), the importance of involving and supporting pregnant 
women has been highlighted by various international guidelines.1-4 When no 
contraindications are present, women should be provided with a choice between an elective 
repeat CS (ERCS) and an intended vaginal birth after caesarean (VBAC) (i.e. a trial of 
labour).1-4 It is recommended that this decision is based on a discussion of the risks, benefits 
and implications of both options.1-5 Mean reported intended VBAC success rates are as high 
as 72–76%,6 and a successful VBAC is associated with fewer major complications,7 a 
shorter recovery period and higher perceived maternal satisfaction scores.8,9 In addition, an 
intended VBAC is in general more cost-effective than ERCS.10 However the drawback of 
intended VBAC is possible failure leading to an emergency CS, which is associated with a 
higher risk of major complications including hysterectomy and operative injury,7 and lower 
levels of maternal satisfaction8,9 than with either ERCS or successful VBAC. The existence 
of major international differences in (intended) VBAC rates suggests that choices for mode 
of delivery after CS do not always reflect women’s preferences but may result from 
nonmedical factors like hospital policy, concerns about medical liability or provider 
preference.6 The question is how guideline recommendations on mode of birth after CS can 
be implemented in practice. Due to the complex nature of the decision-making process, and 
because it concerns a preference-sensitive decision, mode of delivery should be discussed 
within a shared-decision making (SDM) setting. SDM can be enhanced by the use of patient 
decision aids (PtDA), which provide unbiased information in a clear and comprehensive 
way. PtDAs have proven to be effective tools for facilitating communication between 
patient and healthcare provider and for increasing patients’ knowledge and involvement.11 
Individualized prediction of successful intended VBAC may contribute to personalisation of 
the decision-making process and could place potential risks into context. Although there are 
several prediction models6,12,13 and two PtDAs14,15 on mode of birth after CS, there has as 
yet been no published integration of a prediction model with a PtDA. In this study we aim 
to develop and pilot test a PtDA for mode of delivery after previous CS that integrates 
personalised prediction of successful VBAC with clarification and elicitation of patient 
preferences and evidence-based information. 
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Methods 
Construction of the PtDA 
The PtDA was developed using the systematic process illustrated in Figure 8.1.16 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8.1 The process of developing the patient decision aid (PtDA) consisted of four steps: (1) definition of 
the scope and purpose of the PtDA, (2) content selection, (3) selection of the framework, format 
and decision support methods, and (4) pilot testing (i.e. alpha testing) of the prototype amongst the 
target audience.16 The development process was supervised by a steering group and a nationwide 
expert panel. The steering group consisted of two obstetricians and experts in epidemiology, shared-
decision making and guideline implementation. The expert panel consisted of nine independent 
obstetricians, one midwife and one professor of midwifery science. 
 
Scope and purpose  
Its purpose was to improve decision-making on mode of birth after previous CS, as part of 
a guideline implementation strategy for the improvement of current Dutch care on CS.17 
The target audience, i.e. future users of the PtDA, were defined as pregnant women with a 
history of one previous CS without a contraindication for an intended VBAC. 
Contraindications were determined in accordance with current international guidelines on 
pregnancy and childbirth1–5 and included: previous uterine rupture or other relevant uterine 
scar or a contraindication for vaginal labour such as malpresentation or placenta praevia.1–4 
It was decided not to include information in the PtDA on twin or breech pregnancies or in 
cases when more than one CS had already been performed, as we considered counselling in 
these cases to be essentially different.  
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Content selection 
Based on current international guidelines on pregnancy and childbirth after CS,1–5 literature 
and expert opinion, we identified eight domains to be important for decision-making on 
mode of birth after prior CS: (1) risks and (2) benefits of intended VBAC and ERCS, (3) 
induction of labour, (4) the consequences of the decision for future pregnancies, (5) 
predictors of successful intended VBAC, (6) the woman’s preference for a vaginal or CS 
delivery, (7) the possibility of a birth plan (i.e. a document containing the woman’s 
preferences when giving birth) and (8) previous birth experiences. Current guideline 
recommendations dictated the level of detail of the medical contents of domains 1 to 5.1–5 
Current data on risk estimates was included, based upon the principle of best available 
evidence. For domain 5, a prediction model was included that estimates the probability of 
successful intended VBAC. This prediction model was developed by our research group in a 
western European cohort of women with high rate of intended VBAC. As prescribed by 
current methodological guidelines for prediction research, we selected potential predictors 
based on clinical reasoning and evidence from the literature.18,19 The final set of predictors 
included in the model are: estimated fetal weight ≥90th percentile, previous CS due to 
failure to progress, previous vaginal delivery, induction of labour, pre-pregnancy body mass 
index and ethnicity. The development and internal validation of this prediction model is 
described elsewhere.20 Domains 6, 7 and 8 were elaborated based on expert opinion and a 
review of the literature.  
Selection of framework and format  
Based on the content selection, a practical framework was derived that consisted of the 
above mentioned eight domains. A prototype of the PtDA was developed in accordance 
with the international quality criteria of the International Patients Decision Aid Standards 
(IPDAS).21More information regarding the selection process for the framework and the 
format can be found in Appendix S1 in the Supporting Information. 
Pilot testing and revision 
Pilot testing (i.e. alpha testing) comprised several rounds of review and revision of the 
prototype based on information gathered during development (MEC number 12-4-034). We 
recruited women in 2012 at an obstetric outpatient clinic of a Dutch university teaching 
hospital. Inclusion criteria were: pregnancy with a history of one CS and a current singleton 
cephalic pregnancy and a minimum age of 18 years. Women with a contraindication for an 
intended VBAC or who could not read Dutch were excluded. The primary outcome 
measures were usability, clarity, relevance of the content and relevance of the PtDA in 
general. After informed consent was obtained, women participated in a 30-minute face-to-
face audio-recorded interview. The first part of the interview was unstructured according to 
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the ‘think aloud method’.22 This method allowed us to obtain data using observation and 
without interrupting participants’ thinking processes. The second part of the interview was 
conducted using a questionnaire. Issues of particular interest to us were the opinions of 
women on the stage at which the PtDA was introduced, opinions about the prediction 
model, whether there was a minimum outcome of the prediction model that women 
considered acceptable when deciding to try for a VBAC, unwanted adverse effects of the 
PtDA (such as increased anxiety), and opinions regarding the way in which risk was 
communicated and the preference elicitation tool.  
The interviews were transcribed verbatim and translated into a thematic framework. 
Interviews were analysed by two independent researchers (ES and BA or MdK). Data 
collection and revision of the PtDA was continued over several rounds until data saturation 
was achieved. 
Results 
Construction of the PtDA 
The practical framework, i.e. the outline of the PtDA, was constructed on the basis of the 
selected medical contents and our eight domains. Due to the availability of an evidence-
based report on birth after CS by Guise et al.,6 the quantification of risk was mainly based 
on data from meta-analyses. We included four additional papers because they either 
provided data that were more applicable for the target audience of the PtDA, based on 
population characteristics,23 were recently published and therefore not included in Guise et 
al.’s report6 or were included in that report but not in the form of a meta-analysis.24 The risk 
of uterine rupture was shown to range from 2.1 to 15 per 1000; we used 8 per 1000 (for 
spontaneous onset of labour) as a mean since this was more appropriate for the Dutch 
setting. This was based on data from a Dutch prospective cohort study23 which reported a 
higher incidence (8 to 15 per 1000) of uterine rupture in women who attempt VBAC than 
was reported by the meta-analysis6 (4.3 per 1000) and a recent large cohort study by 
Fitzpatrick et al. (2.1 per 1000).25 Our final selection of the risks of intended VBAC and 
ERCS is shown in Table 8.1. 
The PtDA was subdivided into a general introduction, seven steps (chapters) that guide the 
decision-making process and a supplement that clarifies induction of labour after previous 
CS. The introduction to the PtDA describes its aim, explains the choice that has to be made 
regarding mode of delivery and lists the options. 
‐ Step one of the PtDA consists of a question regarding any existing preference for 
either VBAC or ERCS before reading the PtDA. This enables the woman to identify 
preliminary thoughts, beliefs and decisions, but this preference can also be discussed 
with the provider.  
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‐ Step two includes two questions which can be used to evaluate previous birth 
experiences, fear of vaginal delivery and other external influences which the woman 
regards as relevant.  
‐ In step three the woman is shown a fact sheet laying out the risks and benefits of both 
modes of delivery. Risks are illustrated by using pictographs on a scale of per 1000 
women.26 This level of detail with regard to the risks led us to give careful and 
extensive consideration to the method of risk visualisation. We derived several formats 
of the pictographs and elaborated these during pilot testing. Step three also includes the 
prediction model for successful intended VBAC. This element of the PtDA is shown in 
Figure 8.2. Providers enter variables into the prediction formula using a computerised 
calculator and the outcome is noted on the corresponding (empty) pictograph within 
the PtDA. In order to provide context to the outcome of the prediction model, a mean 
probability of 70–75% of successful VBAC is included.1,23 All risks and benefits are 
explained using plain language, pictographs and summaries, in a balanced, unbiased 
manner. 
 
Table 8.1 Risks of intended vaginal birth after caesarean and elective repeat caesarean section: 
estimates that were selected for the contents of the patient decision aid based on literature 
research. 
Risk Intended VBAC ERCS 
Maternal mortality 0.04 per 10006 0.13 per 10006 
Severe maternal morbidity* 2 per 1000 (VBAC)7 
38 per 1000 (CS)7 
8 per 10007 
Uterine rupture, general 8 per 1000 (range 2.0 to 15 per 1000)6,23,24 0.3 per 10006 
Uterine rupture, IOL:   
Prostaglandins  20 per 10006 NA 
Oxytocin 11 per 10006 NA 
Future pregnancies, risk per number of 
previous CS: 
  
Placenta praevia NA 2: 17 per 10006 
3: 30 per 10006 
Placenta accreta NA 2: 6 per 100025 
3: 21 per 100025 
Hysterectomy NA 2: 9 per 100025 
3: 24 per 100025 
ICU admission NA 2: 5 per 100025 
3: 16 per 100025 
Blood transfusion ≥ 4 units NA 2: 8 per 100025 
3: 16 per 100025 
Operative injury** NA 2: 13 per 100025 
3: 24 per 100025 
Neonatal mortality 1.3 per 10006 0.5 per 10006 
Severe neonatal morbidity No evidence for a significant difference in the long term6 
*Composite of uterine rupture, hysterectomy and surgical injury; **Composite of cysthotomy, bowel injury, 
uretheral injury and bowel obstruction. CS, caesarean section; VBAC, vaginal birth after caesarean section; ERCS, 
elective repeat CS; IOL, induction of labour; ICU, intensive care unit; NA, not applicable. 
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Figure 8.2 Prediction model for successful intended vaginal birth after caesarean. This is the element 
of the patient decision aid that explains the prediction model and can be used to show the 
individualized probability of successful intended vaginal birth after caesarean. 
 
Step four involves a preference elicitation tool, which was designed as a list of statements 
that women (and their partners) can consider to clarify their values and thoughts around 
several aspects of the decision. The statements can be scored on a four-point Likert scale to 
show level of agreement with the statements. Statements were derived from the entire 
contents of the PtDA and were completed with data from qualitative studies of women’s 
   
What is my chance of achieving a vaginal birth? 
The total risk of complications is smaller for women who have a vaginal delivery. About 70 to 75 
percent of the women who start labour with the intention to have a vaginal delivery, indeed 
achieve a vaginal delivery.  
 
Calculator: your individual chance of a vaginal delivery (>32 weeks gestational age)  
For some women, their individual chance of a vaginal delivery is higher or lower than the general 
mean of 70 to 75 percent. After 32 weeks of gestational age we can calculate your individual 
chance of a successful vaginal birth based on your medical history and current medical condition. 
Your gynaecologist will calculate your individual chance.   
 
If you choose for an intended vaginal delivery, your chance of a successful vaginal 
delivery is: 
 
 
When labour starts before the due date, the chance of a successful vaginal delivery might be increased. However, 
when labour needs to be induced, the chance of a successful vaginal delivery is, to some extent, decreased. Therefore, 
when the medical conditions change, the calculator needs to be re-entered. 
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views on deciding about mode of birth after CS.27,28 The preference elicitation tool can be 
viewed in Appendix S2. 
‐ Step five of the PtDA explains the option of making agreements on the delivery (birth 
plan), such as an epidural analgesia. This step facilitates discussion of a birth plan 
between the woman and healthcare provider.  
‐ Step six requires is preliminary decision.  
‐ Step seven is aimed to encourage the woman and healthcare provider to agree on 
follow-up.  
‐ In the supplement, induction of labour after CS is considered: risks and methods of 
induction are explained and this encourages recalculation of the probability of 
successful intended VBAC.  
Pilot testing and revision 
Pilot one  
In total, 16 eligible women with a history of one previous CS were included in the first pilot. 
The baseline characteristics are described in Table 8.2. The mean age of the participants was 
33 years; all were native Dutch speakers and 14 out of 16 (87%) had the median socio-
economic status (SES). Pilot one consisted of three rounds in which interviews were 
conducted and the PtDA was revised. The majority of the revisions concerned wording and 
clarity. Many women stated that they experienced a lack of information within the current 
care set-up. With regard to timing of exposure to the PtDA, a range of 12 weeks gestational 
age to 36 weeks gestational age was considered appropriate. Further, 15 out of 16 
participants thought that the outcome of the prediction model for successful intended 
VBAC helped their decision-making process. Two women would choose an ERCS if their 
predicted probability of successful VBAC was 50% or less, and one woman set the cut-off 
value at 60–65%. Thirteen women noted that they could not define a minimum outcome of 
the prediction model that they considered acceptable for trying a VBAC.  
In general, all women thought that the PtDA was clear and informative. The PtDA was 
considered relevant by all participants. The stepwise approach of the decision-making 
process was repeatedly cited as a positive point. Also, most women felt that the PtDA was 
complete, balanced and objective. An aspect that was repeatedly mentioned to require 
improvement was the pictographs of the health outcomes. In rounds one and two, many 
women stated that one or more of the pictographs did not clarify the risks. They thought 
that the pictographs were distracting and added nothing to the decision-making process. In 
the third round, women thought that the presented figures were clear, but two out of seven 
women still thought that the pictures could be omitted.   
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In the third round of pilot one, no new information was obtained. Subsequently, we 
presented the PtDA to an expert panel for critical review and comments. Eight out of 11 
experts approved this version. However, three out of 11 experts expressed concerns 
regarding the presentation of risks. A new outline was suggested for the pictographs that 
involved using cubes instead of pregnant women and means instead of ranges.26 Based on 
this feedback, the PtDA was revised and this new version was tested in pilot two. 
Pilot two 
Nine eligible women were included. The baseline characteristics are summarized in Table 
8.2. The mean age of the participants was 36 years; eight out of nine (89%) women were 
native Dutch speakers and four out of nine (44%) had the median SES.  
 
Table 8.2 Baseline characteristics of pregnant women with a history of one caesarean section who 
participated in pilot testing of the patient decision aid. 
Characteristic Pilot one (n=16) Pilot two (n=9) 
Maternal age (years, mean ± SD) 33 ± 3 36 ± 4 
Native Dutch speakers (n, %) 16 (100) 8 (89) 
Socio-economic status* (n, %) 
   High  
   Median 
   Low 
   Unknown 
 
2 (13) 
14 (87) 
0 (0) 
0 (0) 
 
1 (11) 
4 (44) 
2 (22) 
2 (22) 
Previous CS (n, %) 
   Emergency CS 
   Planned CS 
 
10 (63) 
6 (38) 
 
5  (56) 
4 (44) 
Previous vaginal delivery (n, %) 2 (13) 1 (11) 
Preferred mode of birth 
   Intended VBAC 
   ERCS 
 
12 (75) 
4 (25) 
 
5 (56) 
4 (44) 
SD, standard deviation; CS, caesarean section; VBAC, vaginal birth after caesarean section; ERCS, elective repeat 
CS. *Derived from post-code related socio-economic status scores, based on data on income, educational level and 
profession. 
 
Pilot two resulted in minor additional changes regarding the wording and clarity of the 
PtDA. The revised pictographs were considered clear, and seven out of nine women 
thought that the pictographs supported the information in the tables. Eight out of nine 
women thought that the PtDA was relevant. After pilot two, no major revisions were 
required. After final adjustments were made, the PtDA was presented to the expert panel. 
The PtDA was approved by all members of the expert panel.  
IPDAS criteria 
We used the checklist of the IPDAS collaboration21,29 to estimate the quality of the 
developed PtDA. Of the 64 items on the checklist, 50 quality criteria were applicable to our 
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study based on the scope of the PtDA. The final version of the PtDA met 39 out of the 50 
applicable IPDAS criteria (78%).21,29 With regard to content, all 23 criteria were met. For the 
domain development process, we met 16 out of 20 criteria. The four criteria that we did not 
meet were whether the PtDA is written according to a validated readability score (10.4) and 
if the PtDA is understood by those with limited reading skills (10.6). Though we pilot tested 
the PtDA, we did not actually field test (i.e. beta test) the PtDA in the current study (1.4, 
1.5). The effectiveness of the PtDA was not evaluated in the current development study; 
therefore we have not yet met the seven criteria (12.1–12.8) concerning effectiveness. 
Discussion 
The main findings 
The current study provides insight in the systematic process of developing a decision-
support tool by means of interdisciplinary cooperation of healthcare professionals and the 
critical input of future users, i.e. women and healthcare providers. The agreed format is a 
booklet with a stepwise approach for decision-making. Opinions on the stage at which 
women should be introduced to the PtDA varied widely between individual women and 
providers. Therefore, we agreed on introduction at any gestational age before 36 weeks 
based on the needs of the woman concerned. The PtDA is evidence based and its content is 
in agreement with current recommendations and guidelines. Hence, this PtDA could be 
seen as a guideline implementation tool. The quantification of risks was mainly based on 
data from meta-analyses. Though no studies on this topic with a grade A level of evidence 
were available, many large cohort studies provide insight into relevant risks. The need for 
structured information was confirmed, as women indicated that clear and relevant 
information is currently hard to find. Women emphasized the clarity of the step-wise 
approach to decision-making and of the preference elicitation tool. As risks had to be 
shown on a scale per 1000 women, several versions of the pictographs had to be pilot 
tested. Thanks to the critical input of women and healthcare experts, we established a 
format that was usable and clear. The pilot study confirmed that women value the use of a 
prediction model for decision-making, though many women could not define a minimum 
outcome of the prediction model that they considered acceptable for trying a VBAC. 
However, our results cannot directly show the impact that application of the prediction 
model will have on women’s choices. Actual application of the prediction model requires 
the woman and the gynaecologist to interpret the outcome of the prediction model 
together, and this is necessary in order to measure its effect. Based on the results of pilot 
testing, it is likely that this PtDA supports the decision-making process, but results on the 
effectiveness of the strategy have to be further explored. 
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Strengths and weaknesses  
We developed the PtDA according to a thorough systematic approach. Quality control was 
performed using critical input and review of the expert panel. The opinions of 25 women 
amongst the target audience were taken into account during development. However, readers 
may question the representativeness of the pilot study since it was performed in just one 
tertiary hospital and only included a small number of women with a low SES. We 
acknowledge that results should be confirmed in other settings with a larger study 
population. Other drawbacks of our design are that we did not specifically test the PtDA 
embedded within the routine clinical pathway (field testing). Also, we did not target women 
with limited reading skills, and this may have influenced attitudes about the pictographs, for 
example. Therefore, the results of this pilot study should be interpreted with caution and 
should be confirmed and complemented by the results of a larger, prospective trial. 
Interpretation 
Two other PtDAs on mode of birth after CS have been published. The PtDA of Shorten et 
al.14 was published in 2004 and comprised a booklet with a value clarification exercise. A 
systematic review conducted by Vlemmix et al. estimated the agreement of published 
obstetrics PtDAs with the IPDAS criteria.30 According to this review, the PtDA of Shorten 
et al. meets 34 of 50 IPDAS criteria.30 Another PtDA, developed by Emmett et al. and 
published in 2007,15 comprised a computerised information programme with a decision 
analysis tool. This PtDA meets 29 of 50 IPDAS criteria.30 In the current study, we were able 
to meet 39 out of 50 applicable IPDAS criteria, which compares well with other PtDAs in 
obstetrics,31 especially when taking into account that effectiveness criteria (n=7) will be 
further explored in ongoing research. Our PtDA has similarities to other available PtDAs 
on delivery after CS14,15 in the choice of key issues that are addressed. However, our PtDA 
also provides a new decision-making element, namely the integration of an individualised 
estimation of intended VBAC success with evidence-based information. We consider the 
prediction model to be applicable to other western European populations with comparable 
VBAC rates and ethnicities. With regard to other specific information on risk estimates, the 
PtDA should be evaluated along local guidelines and literature since differences in obstetric 
policy and case-mix may impair the validity of the data. Hence, the PtDA can be adapted 
for different populations. 
 
We expect that the introduction of our PtDA in current care will enhance the involvement 
of women in decision-making on mode of delivery after CS. Subsequently it is hoped that 
this will reduce decisional conflicts and increase patient satisfaction. Application of the 
prediction model might alter birth preferences and reduce emergency CS; if this effect is 
observed we would expect that a reduction in major maternal and neonatal morbidity. 
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Before this PtDA can be incorporated into current care, its effectiveness needs to be 
ascertained in a controlled prospective trial. Currently, a prospective trial amongst 12 Dutch 
hospitals is being carried out in order to determine its effectiveness in terms of CS rates, 
adherence to guidelines, decisional conflict, patient satisfaction, feasibility and costs 
(SIMPLE TRIAL: NCT00800384).  
Conclusion 
This paper provides insight into the systematic development of a PtDA that aims to 
enhance the involvement of women in decision-making on mode of delivery after CS. It has 
uncovered the main issues around the involvement of women in decision-making, namely 
the medical and nonmedical items that women and experts consider relevant for decision-
making, the method of communicating risks, the additive value of using a prediction model 
for successful intended VBAC and the stage at which women are introduced to the PtDA. 
The need for a healthcare strategy for mode of delivery after CS was confirmed. In the 
current format the PtDA is applicable for western European countries, and specific 
information with regard to risk estimates may be adapted for different populations. The 
pilot study suggests that the PtDA and the included prediction model support the decision-
making process. Its effectiveness in terms of CS rates, adherence to guidelines, decisional 
conflict, patient satisfaction, feasibility and costs will be further examined in a prospective 
controlled trial. 
Appendix S1. Selection of the framework and format of the 
‘PtDA’ 
Based on the content selection, a practical framework was derived that consisted of the 
defined eight domains. Several examples of existing PtDAs were studied in order to select 
the appropriate format and decision support method. An important criterion for selection 
of format and decision support method was usability and applicability within current care. 
After construction of the framework and selection of the format and decision support 
methods, a prototype of the PtDA was developed in accordance with the international 
quality criteria of the International Patients Decision Aid Standards (IPDAS).21 The 
practical framework, i.e. outline of the PtDA, was constructed based on the selected medical 
contents. Subsequently, several possible formats were discussed: an online program, a 
booklet and an option grid.32 It was decided that a booklet was most compatible with 
current care. We used the checklist of the IPDAS collaboration21,29 in order to complete the 
outline of the PtDA and to derive the format of the PtDA. 
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Appendix S2. Preference elicitation tool 
This preference elicitation tool of the patient decision aid can be used for value clarification 
and establishing preferences on both options of mode of birth after prior caesarean section 
(intended vaginal birth after caesarean or elective repeat caesarean section). 
 
 
What is important to you (and your partner)?  
V
ery im
portant 
Im
portant 
Less im
portant  
N
ot im
portant 
In a vaginal delivery       
I feel more involved in the birth of my baby 
I will experience a normal childbirth 
The birth will occur the natural way 
I will experience pain/contractions during labour 
I have less control of the labour process 
Episiotomy or tearing might happen  
There is a risk of an (emergency) caesarean section 
The quantity of my individual chance of a successful vaginal delivery  
    
In a caesarean section      
I have more control of when and how the delivery takes place. 
There is definitely an operation  
 I will experience pain after the surgery  
 There is a higher chance of complications like thrombosis, infection and 
bleedings.  
    
Severe risks     
In a vaginal delivery, there is a larger risk of a rupture of the scar in the uterus 
(uterine rupture).  
The overall chance of severe complications for the mother in a vaginal delivery, is 
smaller.  
In a caesarean section, there is a little higher chance of death of the mother. 
For a vaginal delivery and a caesarean section, the chance of permanent injuries 
for the baby is the same.   
In a caesarean section, the chance of death of the baby is a little smaller.  
Every new caesarean section increases risks for a future pregnancy.  
    
After a vaginal delivery      
 I will probably recover faster.   
 I will probably return to home earlier.  
    
 Other important considerations 
…………………………………………………….. 
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Summary and General discussion 
The first part of this thesis comprises the evaluation of current care on caesarean sections 
(CS) in The Netherlands (chapters 2, 3 and 4). In concordance with the analysis of current 
care, the second part of the thesis subsequently presents the development of a tailored 
guideline implementation strategy aiming to improve current care (chapters 5, 6, 7 and 8). In 
this chapter, the background and main findings of the reported studies are summarized. 
Subsequently, the interpretation of the results and the chosen methodology will be 
discussed. Also, this chapter describes the results of this project in terms of implications for 
healthcare. The chapter finalizes with recommendations for further research and the general 
conclusions. 
Summary  
Background 
In part 1 of this thesis, current practice of CS in The Netherlands is discussed. Optimal care 
regarding both preventive measures and decision making with regard to CS is provided in 
contemporary international obstetrical  guidelines.1-3 However, to what extent these 
guidelines are incorporated in current care is not evident. Several studies showed that 
worldwide CS rates are dramatically increasing.4, 5 Disconcerting is that the main part of this 
rise can be explained by an increase in CS rate amongst the relatively ‘low risk pregnancies’.6 
A CS leads to a higher risk in following pregnancies, a risk of operative injury and to higher 
costs.7-9 Hence, an increase in the CS rate is undesirable. The Netherlands used to have a CS 
rate very close to the rate advised by the World Health Organisation (WHO) of 10-15%.10, 11 
However, like the international trend, in The Netherlands the CS rate has risen significantly. 
The rate has increased from 7.4% to 16.4% between 1990 and 2013.11, 12  Striking is that the 
most impressive rise in CS rate is found in ‘low risk pregnancies’ which are  healthy women 
with a singleton in vertex position at term.13 We hypothesized that this development can be 
attributed to poor guideline adherence. Therefore we aimed to analyse current care using 
guideline-based quality indicators in order to detect target points for intervention. 
 
In part two of this thesis, pregnancy following CS in The Netherlands is discussed. After a 
prior CS, women should be counselled on mode of birth in their current pregnancy. The 
options are an elective repeat caesarean section (ERCS), or a intended vaginal birth after 
caesarean (VBAC) (i.e. trial of labour (TOL)). International intended VBAC rates have 
significantly decreased in the past two decades.14 Supposed causes for the decreasing 
intended VBAC rates centre around the safety issue regarding the possible occurrence of 
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uterine rupture during labour.14 Against potential complications of an intended VBAC are 
many benefits such as faster recovery, decreased risk of complications in future pregnancies 
and a lower risk of overall morbidity when an intended VBAC is successful.15 
Contemporary guidelines state that when no contra-indication for an  intended VBAC 
exists, both options should be offered and discussed.16-18 These recommendations are 
emphasized by the WHO who clearly state that sufficient information should be provided.19 
As shown in part 1 of this thesis, in current Dutch care, counselling on birth after CS does 
not occur according to directive guidelines. Also, VBAC rates are decreasing and may 
decrease further when no intervention-strategy is provided. Focus group interviews 
amongst Dutch providers showed however that one of the reasons of poor guideline 
adherence may be that providers fear that involving women in decision-making might lead 
to an increase of repeat CSs.20 Patient interviews on the other hand, showed that women 
did not feel involved in decision-making.20 Hence, based on the results of part 1 of this 
thesis, we developed a tailored implementation strategy targeting both providers and 
patients in order to improve current care on birth after CS in The Netherlands. With regard 
to the contents of the implementation strategy, we chose for a shared decision making tool 
that incorporates a prediction model for successful  intended VBAC.  Literature shows that 
the probability that an intended VBAC will be successful is a key item within decision-
making as the incidence of maternal morbidity is lowest in women who have a VBAC 
(0.2%) in comparison to emergency CS (3.8%) and ERCS (0.8%).21 Other items such as the 
opinions of the providers, women’s own prior experiences and expectations, experienced 
safety and whether information was tailored to their personal situation are also of main 
importance in decision making.22 Consequently, adequate antenatal counselling is essential 
in order to direct this process. Because of the complex nature of this decision-making 
process, mode of birth after CS should be discussed within a shared decision making 
setting. Hence, we hypothesized that implementing the guideline recommendations on birth 
after CS through a shared decision making (SDM) tool not only leads to higher guideline-
adherence but also to ‘better quality’ decisions. In this context it is also relevant to 
personalize decision-making by estimation of individual risks of morbidity per mode of 
birth. We hypothesized that incorporation of a prediction model for successful intended 
VBAC in decision-making is feasible and would contribute to the decision-making process. 
We therefore aimed to develop and pilot-test a SDM-tool that incorporates a prediction-
model for pregnant women who face the decision on mode of birth after CS. 
Main findings 
We used the framework of Grol et al.23 in order to systematically analyse and improve 
current care on CSs (chapter 2). The framework contained four main steps: 1: to develop 
guideline-based quality indicators on the decision when to perform a CS; 2: to analyse 
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adherence to the quality-indicators in current Dutch obstetrical care; 3: to explore barriers 
and facilitators for quality-indicator adherence and 4: to develop, execute, and evaluate a 
strategy in terms of effectiveness, feasibility, and costs. This thesis reports on the results of 
step 1, 2 and the development and pilot-testing of the strategy to improve current care (step 
4 and part 2 of this thesis).  
Chapter 3 describes the actual development and measurement of the guideline based 
quality indicators. We used a systematic RAND-modified Delphi method24,25 in order to 
develop a set of key recommendations that were appropriate for transcription into quality 
indicators. A final set of 27 CS guideline-based quality indicators was approved by the 
national expert panel. Analysis of adherence to these indicators within a multi-centre setting 
uncovered four main categories as possible target for an intervention strategy: 1) suspected 
fetal distress (frequency 17% of the population, CS is performed after fetal blood sampling 
or ST-analysis in 46%), 2) non-progressive labour (frequency 12%, CS is performed too 
early in over 75%), 3) continuous support during labour (frequency 88%, CS is performed 
with continuous support in only 37% of the cases) and 4) previous CS (frequency 12%, with 
adequate counselling observed at a mere 15%). We hypothesize that a guideline 
implementation strategy on these subjects will result in increased guideline adherence, 
‘better care’ and even in a possible reduction of CS without negative impact on the outcome 
for mother and child.  
In chapter 4 we further analysed the quality indicator ‘prior CS’. In this study, we compared 
inter-hospital ERCS rates and VBAC- rates. The intended VBAC rates and actual VBAC 
rates were corrected for case-mix based on variables that are predictive for VBAC using a 
backwards stepwise multiple logistic regression analysis.  Seventeen representative Dutch 
hospitals participated. Women with a history of one prior CS without a contraindication for 
intended VBAC and who delivered in 2010, were included. In total, 763 records were 
included for analysis, amongst these cases there were 248 (33%) ERCSs. Five-hundred 
-fifteen women (67%) had an intended VBAC of whom 371 (72%) delivered vaginally. 
After correction for case-mix, the mean observed ERCS rate was 29.8% ± 11.8% (range 6% 
to 54%). The mean for case-mix corrected observed successful intended VBAC rate was 
71.8% ± 11.1% (range 52.7% to 90.0%). This data shows that there is a large practice 
variation between the hospitals, however, for both outcome measures, the larger part of the 
practice variation remained unexplained. Consequently, we may state that factors on 
hospital- and provider level also play a significant role in the derivation of practice variation.  
In chapter 5 we aimed to externally validate the two prediction models for successful 
intended VBAC of Grobman et al.26,27 for the Dutch population. These models were 
derived and externally validated in an obstetrical population in the Unites States (US).28,29 
The first model, the ‘entry-to-care’ model (ETC), incorporates the variables maternal age, 
pre-pregnancy body mass index (BMI), ethnicity, prior vaginal delivery, prior VBAC and 
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prior non-progressive labour. The second model, the ‘close-to –delivery’ model (CTD) 
replaces pre-pregnancy BMI with third-trimester BMI and complements estimated 
gestational age at delivery, hypertensive disease of pregnancy, cervical examination and 
induction of labour. The two models are designed for women who have a vertex singleton 
pregnancy and a history of one low-transverse CS and who delivered at term (gestational 
age ≥37 weeks). Therefore we included only women who met these criteria for validation of 
the models. Individual probabilities of successful intended VBAC were calculated and 
subsequently outcome parameters in terms of discriminative capacity and predictive 
performance were derived. Both the ETC and the CTD models had a reasonable 
discriminative capacity of 68% (95% CI 63–72%) and 72% (95% CI 67–76%), respectively. 
Analysis of predictive performance showed no lack of fit. Despite the reasonable 
performance of the models, we thought that the two Grobman models27,30 are less 
applicable for clinical practice since they include factors that are only known intrapartum. 
Also, some variables like ‘ethnicity’ were less applicable in the Dutch and accordingly the 
West-European population.  
Hence, in chapter 6 we present a new prediction model which was derived by combining 
and improving existing models. This model was aimed to implement as a tool for 
counselling on mode of birth after CS for a West-European population. In order to reduce 
the chance of overfitting and to increase external validity of the developed model we 
preselected predictors based on clinical reasoning and evidence from previous reports. The 
final model for predicting successful intended VBAC consists of six variables including 
demographic variables (pre-pregnancy BMI, Caucasian ethnicity), obstetrical history 
(previous vaginal delivery and previous non-progressive labour) and current pregnancy 
variables (induction of current labour and estimated fetal weight (EFW) ≥P90). We 
internally validated the model using bootstrapping. The developed prediction model has 
reasonable discriminative capacity (70.8% (95% CI=68.6–72.9%), and is accurate, especially 
for women with a predicted probability of 65% and higher. However, whether the model 
performs better than clinical judgement was still unclear.  
Therefore, in chapter 7 we present a study that compares clinicians’ predictive performance 
for successful intended VBAC in terms of calibration and discrimination to our prediction 
model. In order to compare clinical judgement to the performance of the model we 
constructed vignettes which were regarded as actual clinical situations. We showed that, in 
terms of both discriminative and predictive performance, clinicians perform poorly. 
Moreover clinicians tended to underestimate the actual probability of success.  
Finally, chapter 8 presents the development and pilot-testing of the patient decision aid 
(PtDA). The PtDA is part of the guideline implementation strategy for improvement of care 
on birth after prior CS.  The systematic development process consisted of a construction 
phase (definition of scope and purpose, selection of contents, framework and format) and a 
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pilot-testing phase. The process was supervised by a multidisciplinary steering group and an 
expert panel. The developed PtDA is a booklet with a stepwise approach for decision-
making. The PtDA includes unbiased balanced information on mode of birth after CS, a 
preference elicitation exercise and tailored risk information including the in chapter 6 
presented prediction model. Based on the results of pilot testing, it is likely that this PtDA 
supports the decision-making process. 
General Discussion 
Overall interpretation  
This project used the framework of Grol et al.23 for systematically analysing and improving 
care around CSs, using evidence-based guideline recommendations. The developed quality 
indicators are unique in the fact that they incorporate both antepartum care and intrapartum 
care. With regard to The Netherlands, we have uncovered the main indicators that 
contribute to poor care around CSs (guideline-adherence) and that contribute to overall 
increasing CS rates and overall feto-maternal morbidity (frequencies). The care-
improvement strategy should focus on the indicator with the highest impact in terms of 
possible gain with regard to guideline adherence in combination with a high frequency of 
occurrence of the situation. One of these indicators in The Netherlands is care for women 
with a prior CS. In concordance with the increasing CS rates, the group of women pregnant 
after a CS rises. The indicator on this subject involves counselling on mode of delivery in 
current pregnancy. We showed that indicator adherence on this subject is alarmingly low. 
Also, our analysis showed that though in The Netherlands the majority of women have a 
VBAC, the rates are decreasing. In respect to prior data, the percentage of intended VBAC 
decreased from 78.2% to 67.0% within eight years.31 This observation emphasizes that 
repeat CSs attribute to the national rising CS rates. The large observed practice variation 
independent of case-mix shows that individual provider preferences and hospital policies 
instead of contemporary guidelines play a large role within determining mode of delivery 
after a prior CS. These findings highlight the need for an intervention strategy. 
Enhancing patient involvement in decision making  
The main goals of the intervention are to increase guideline-adherence and to enhance 
patient involvement in decision-making on mode of birth after CS. The second part of this 
thesis provides an overview of the development of the components of this strategy. Step 
one was to create a reliable and applicable prediction model for successful intended VBAC. 
This model is aimed to enhance decision making  for both the professional and the patient. 
Both the validated prediction models and the developed model have reasonable predictive 
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and discriminative performance. Clearly, the ideal prediction model would polarise the 
cohort into two groups: women with a very high predicted probability and women with a 
very low predicted probability of achieving a VBAC. However, in comparison to other 
models that predict successful intended VBAC, the performance of both the developed and 
the validated models is average to good.15, 32 Also, the models showed the potential to 
classify women away from the population mean which increases the chances of clinical 
usefulness. We chose to implement the developed model since it was more applicable in the 
Dutch population and it matches the scope of counselling. By comparing the performance 
of the developed model to the performance of clinicians, we further explored its clinical 
usefulness. We showed that by applying the model, more reliable risk estimations would be 
provided to women of our target group. Furthermore, we showed that most clinicians tend 
to underestimate the probability of successful intended VBAC which may result in more 
ERCS prone counselling. Hence, implementing the prediction model might not only lead to 
more reliable counselling but also to less ERCS’s.  
Step two for enhancing patient involvement in decision making regarding mode of delivery 
after CS was to develop and pilot-test the SDM-tool. We systematically developed a PtDA 
that incorporated the prediction model for successful intended VBAC. Two other PtDA’s 
on birth after CS were published.33, 34 These PtDA’s have similarities to our PtDA with 
regard to key issues that are addressed. However, we are the first to integrate a prediction 
model to a PtDA. The pilot-test confirmed that women value the use of a prediction model 
for decision-making. Based on the result of the pilot-test, we expect that the introduction of 
our PtDA in current care will enhance the involvement of women in decision-making. Since 
the PtDA was developed according to current guidelines, it is likely that implementing the 
PtDA would maximize guideline-adherence. However, the effectiveness of the strategy in 
terms of feasibility, costs and improvement of guideline-adherence needs to be further 
explored in a prospective controlled trial.  
Methodological issues 
A strong point of our study is that we included a large number of deliveries amongst 21 
representative hospitals, hence the data-set is considered representative for The 
Netherlands. In order to increase the external validity of the study, we developed the 
indicator-set on a systematic way using contemporary peer-reviewed international 
guidelines. We consider the developed indicator-set therefore to be appropriate for other 
settings than The Netherlands. Its international acceptability however, needs to be 
established since we did not involve international experts in the indicator development 
process. Since the CS rate in The Netherlands is relatively low in comparison to other 
countries11, it is plausible that this reflects a different mind-set which may impair external 
applicability and acceptance of the indicator-set. Therefore, before the indicators are applied 
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in other countries, a local expert panel should evaluate them and if necessary, adapt the set 
to the local situation according to a systematic guideline adaptation process.3,35 
 
Factors that may impair the internal validity of the guideline-adherence study mainly involve 
the methods of data-collection. By retrospectively collecting data on guideline adherence 
using medical charts, we may underestimate indicator-adherence mainly due to recording-
bias.36, 37 Also, it has also been shown that in particular with regard to physical examination, 
false positives have been reported in charts.37, 38 Furthermore, results may be biased due to 
misinterpretation from the charts. These factors may impair the internal validity of our 
study. However, all methods of measuring quality of care implicate bias to a certain level. 
The chosen method allowed us to obtain information on both frequencies and adherence, 
which implied to be an effective method to determine the focus of the implementation 
strategy. Also, due to the increasing availability of electronic patient files, we think that it is 
likely that chart review becomes a more reliable method of data-collection on quality of 
care. Furthermore, because data collection was performed by trained research nurses, the 
probability of misinterpretation was minimized. The subsequent performed barrier study 
allowed us to further analyse the observed non-adherence in depth. 
 
The practice variation study supports the results of the guideline-adherence study. In this 
study we showed that guideline-adherence on counselling is low regardless of correction for 
case-mix. A strength of this study is that data-selection occurred systematically and involved 
a representative set of hospitals. The selection process of predictive variables for successful  
intended VBAC was, in line with contemporary insights within prediction research39-41, 
based on literature and expert opinion. A limitation of the chosen method is that we assume 
that the developed models are capable of explaining practice variation and that the 
remaining variation can be attributed to policy. Yet, the remaining variation could also be 
explained by an incomplete model.  Another limitation is that, due to lack of data, we could 
not further specify the exact amount of practice variation that is derived from factors on 
hospital- and provider level. 
 
Both of the prediction model studies were carried out within a multicentre setting with a 
good representation of types of hospitals and geographic regions in The Netherlands which 
increases external validity of the studies. A factor that may impair internal validity involved 
the handling of missing data. This element within the methodology was present in all 
prediction studies since we used one dataset. Fortunately, for most variables there was only 
a small quantity of missing data. We considered the missing data to be missing at random 
(MAR) and therefore we were able to limit loss of data by using a multiple imputation 
strategy. Multiple imputation has shown to be superior to complete case analysis since the 
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latter results in a large loss of power and might yield biased parameter estimates.41, 42 Also, 
for the development of the prediction model, we carried out a sensitivity analysis using 
complete cases only. This analysis showed similar results for both datasets. Hence, we 
believe that missing data did not lead to radically different results.  
Another drawback of both of the prediction studies is that usefulness of both prediction 
models has not yet been proven in terms of for example cost-benefit and patient 
satisfaction (i.e. impact analysis) . Performing an impact study is essential for determining 
actual model performance and clinical usefulness in terms of whether model application 
changes birth preferences and reduces feto-maternal morbidity. Model application may lead 
to a different selection of women who choose intended VBAC. This may alter model 
performance.43 Whether this effect actually occurs, should be evaluated in a prospective 
controlled trial in which the prediction model is applied. However, in line with the results of 
the pilot study of the PtDA, we think that clinical usefulness of a prediction model for 
successful intended VBAC is likely.  Also the results of the vignette study confirmed this 
assumption.   
 
With regard to the prediction of successful intended VBAC, we performed the first study 
that compared clinical judgement i.e. ‘skilled intuition’ to a prediction model. The main 
drawback of this type of study-design is whether the hypothetical context of a clinical 
vignette represents clinical practice.44 Hence, though the vignettes were developed through 
extensive literature research in accordance with a multidisciplinary project group, results 
should be confirmed in a prospective setting.  
 
After the development of the prediction model, the next step was to incorporate it in 
counselling on mode of birth. PtDA’s have proven to be effective tools for enhancing 
counselling and for increasing patients’ knowledge and involvement.45 Our PtDA was 
systematically developed in accordance with the criteria of the international patient decision 
aid standards (IPDAS) criteria.46 Thanks to the critical input of 25 women of the target 
audience, an expert panel and a multidisciplinary steering group, we presented a thoroughly 
reviewed and usable PtDA. A weakness in the design was the chosen setting of the pilot 
study, by involving only a tertiary hospital and a small sample of women with a low socio-
economic status, generalizability of the results may be too optimistic. The currently ongoing 
prospective controlled trial in which the PtDA is applied should further explore its usability, 
clarity and relevance. 
Implications for daily practice  
In this project we translated the results of the analysis of current Dutch care on CS into 
clinical practice by developing a tailored implementation strategy. Accordingly, we 
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developed a guideline based PtDA. This PtDA consisted of a booklet including unbiased 
balanced information on mode of birth after CS, a preference elicitation exercise and 
tailored risk information including a prediction model for successful VBAC.  The target 
audience of the PtDA is women who are pregnant following CS and their providers. For 
patients, the PtDA is likely to be an important tool to enhance their involvement in decision 
making on mode of birth after CS. For providers, usage of the PtDA will facilitate guideline 
adherence and therefore is likely to result in improvement of quality of care. Hence, the 
next step is carrying out a multicentre controlled trial in which care including the PtDA is 
compared to care without the PtDA in terms of guideline-adherence, effectiveness, 
feasibility and costs. When the PtDA indeed results in ‘better care’, it could be implemented 
on a larger scale. Subsequently, the PtDA could be handed out at the hospital, made 
available on the internet and for example be transformed into an application for 
smartphones. Also, it could be linked to the current Dutch guideline on birth after CS to 
increase its availability to providers .16 Accordingly, the PtDA could be discussed during 
consultation with the obstetrician or a specialised nurse. However, this requires a setting 
that is eligible for use of decision support aids and physicians who are know the concept of 
SDM. Hesitation of physicians to the use of decision support tools has been described in a 
systematic review by Gravel et al.47 The main barriers for using decision support tools were: 
time constraints, lack of applicability and the clinical situation.47 Also, a recent review by 
Elwyn et al.48, showed that widespread adoption of diverse decision support interventions 
had not occurred within routine care. The underlying issues preventing widespread adoption 
of the decision support tools could not be further specified. Hence, implementing the PtDA 
within routine care will be challenging. 
Implications for future research 
The results of our project are promising and raise important issues for future research. First, 
next to care regarding decision making on mode of birth after CS, we uncovered in total 
three other main indicators as targets for care improvement on CS in The Netherlands. 
Hence, an intervention strategy on ‘continuous support during labour’, ‘suspected fetal 
distress’ and ‘non-progressive labour’ will also beneficial for Dutch care. Second, the 
effectiveness of the developed tool for guideline implementation on birth after CS should 
be evaluated. Also its feasibility and costs have to be further assessed in order to maximize 
the success of the implementation process.  Third the validity of the developed prediction 
model should be further analysed through application. A prospective trial amongst 12 
Dutch hospitals has to be performed in order to answer these remaining items, this trial is 
currently carried out (SIMPLE TRIAL: NCT00800384). A challenge for future research 
would be to investigate the international applicability of both the prediction model and the 
PtDA.  
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General conclusion  
The results of this thesis lead to the following principal findings: 
‐ The following four subjects were uncovered as a possible target for an intervention 
strategy in order to improve current Care on both preventive measures as the decision 
making regarding the performance of a CS in The Netherlands: ‘previous CS’, 
‘continuous support during labour’, ‘suspected fetal distress’ and ‘non-progressive 
labour’.  
‐ In The Netherlands,  a large practice variation is observed on both the amount of 
ERCS and successful intended VBAC. This variation can only for the smaller part be 
explained by case-mix which indicates that local policy plays a more important role. 
‐ External validation of two predictive models developed in the United States revealed an 
adequate performance within the Dutch population. Yet these models were less 
applicable for clinical practice since they either include factors that are only known 
intrapartum or included factors that were less applicable in a West-European 
population.  
‐ We developed a new prediction model for successful intended VBAC for third-
trimester counselling in a West-European population, the following predictors are 
included: estimated fetal weight ≥ P90 in the third trimester, previous non-progressive 
labour, previous vaginal delivery, induction of labour, pre-pregnancy body-mass-index 
and ethnicity. This model has a good discriminative ability and is well calibrated. 
‐ In terms of both discriminative and predictive performance, clinicians perform poorly 
in respect to the developed prediction model for successful intended VBAC. Moreover 
clinicians tended to underestimate the actual probability of success. 
‐ In order to improve care on birth after prior CS, we developed a PtDA. This PtDA 
includes unbiased balanced information on mode of birth after CS, a preference 
elicitation exercise and tailored risk information including the prediction model on 
successful intended VBAC. It is likely that this PtDA supports the decision-making 
process. After effectiveness of this PtDA is established, it should be implemented in 
standard care. 
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Valorisatie 
Dit hoofdstuk beschrijft de valorisatie mogelijkheden van het in dit proefschrift beschreven onderzoek, ofwel 
hoe de resultaten vertaald kunnen worden naar de klinische praktijk en hoe deze ten gunste komen van het 
maatschappelijk belang in het algemeen en de zwangere vrouw met een keizersnedelitteken in het bijzonder.  
Relevantie 
Wereldwijd stijgt het aantal keizersneden. Deze toename wordt ook in Nederland gezien. In 
2013 werden er in Nederland bijvoorbeeld 170.059 kinderen geboren waarvan er 27.355 
kinderen met een keizersnede ter wereld kwamen.1 Dit is 16,4 procent van het totaal aantal 
geboortes. Ter vergelijking, in 1990 was dit percentage nog 7.4%.1 Een logisch gevolg 
hiervan is dat er tevens een stijging wordt gezien in het aantal vrouwen dat zwanger is na 
een eerdere keizersnede. Zoals beschreven in hoofdstuk 4 van dit proefschrift heeft anno 
2011 ongeveer 11% van alle zwangeren in Nederland een keizersnede in de 
voorgeschiedenis, dit betrof in dat jaar ongeveer 19.663 vrouwen. De stijging van het aantal 
keizersneden is relevant omdat een eerdere keizersnede een grotere kans geeft op 
morbiditeit en mortaliteit van moeder en kind bij een volgende zwangerschap. Dit komt 
vooral omdat tijdens de bevalling het litteken open kan  ‘scheuren’ (uterusruptuur). Ook 
impliceert een toename van het aantal keizersneden dat de  kosten van de gezondheidszorg 
stijgen. Derhalve is een zorgvuldige analyse van de huidige zorg en de mogelijke oorzaken 
en gevolgen van de stijging van het aantal keizersneden belangrijk. Opvallend is dat er 
internationaal gezien vooral een stijging wordt gezien bij nullipara (zwangeren die hun eerste 
kind verwachten) met een ‘ongecompliceerde’ zwangerschap.2 De vraag is dan ook of het 
onjuist stellen van een indicatie om een keizersnede te doen wellicht bijdraagt aan de stijging 
van het aantal uitgevoerde keizersneden. Over het stellen van een indicatie om een 
keizersnede te doen bestaan duidelijke richtlijnen. Zowel de Nederlandse Vereniging voor 
Obstetrie en Gynaecologie (NVOG), maar ook diverse leidende internationale beroeps-
organisaties hebben duidelijke richtlijnen gepubliceerd waarin staat wanneer een keizersnede 
geïndiceerd is. In hoofdstuk 3 van dit proefschrift analyseerden wij in hoeverre de geldende 
richtlijnen in Nederland daadwerkelijk werden nageleefd. Het doel hiervan was om de zorg 
voor zwangeren te verbeteren. De resultaten van hoofdstuk 3 lieten zien dat er in Nederland 
in de volgende vier ‘hoofdgroepen’ sprake was van onvoldoende adherentie aan geldende 
richtlijnen: 1) veronderstelde foetale nood; 2) niet vorderende baring; 3) continuïteit in 
begeleiding van de bevalling en 4) besluitvorming rondom de manier van bevallen na 
eerdere keizersnede. De analyse van de huidige zorg resulteerde in de ontwikkeling van een 
zorgverbeteringsstrategie met betrekking tot besluitvorming rondom de manier van bevallen 
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na een eerdere keizersnede. Tijdens een zwangerschap na een eerdere keizersnede dienen 
zwangere vrouwen gezamenlijk met de zorgverlener een keuze te maken over de manier van 
bevallen: een intentie tot vaginale bevalling ofwel een primaire keizersnede. Interventie op 
het gebied van counseling van deze groep vrouwen is nodig omdat uit ons dossier-
onderzoek bleek dat de zwangeren slechts in 15% van de gevallen adequaat volgens de 
richtlijn werden gecounseld. Zoals in hoofdstuk 8 van dit proefschrift beschreven is, bestaat 
de door ons ontwikkelde interventie uit een geïndividualiseerde keuzehulp die  tijdens de 
zwangerschap gebruikt kan worden om gezamenlijke besluitvorming c.q ‘shared decision 
making’ te faciliteren. Of implementatie van deze keuzehulp daadwerkelijk resulteert in een 
verbetering van de huidige zorg in termen van verbeterde richtlijn adherentie, patiënt-
tevredenheid en kosten, wordt momenteel onderzocht.  
Doelgroep 
De in dit proefschrift beschreven studies vallen onder het project SIMPLE (Sectio 
IMPLEmentatie studie). De doelstelling van dit project is om te analyseren of er juiste 
indicaties gesteld worden tot het uitvoeren van keizersneden en om dit proces zo mogelijk 
te verbeteren. De gegevens die zijn gebruikt voor de studies in dit proefschrift zijn 
verzameld vanuit de huidige reguliere zorg voor zwangere vrouwen in Nederland. De 
doelgroep van het project is dan ook zeer breed. Alle zwangere Nederlandse vrouwen vallen 
binnen de doelgroep. Maar de studie is ook van toepassing op zorgverleners zoals 
gynaecologen en artsen in opleiding tot gynaecoloog omdat zij degenen zijn die de indicatie 
tot het uitvoeren van een keizersnede stellen. Dit maakt dat deze artsen de mate van richtlijn 
adherentie deels bepalen. Ook zijn de artsen mede uitvoerders van een 
zorgverbeteringsstrategie.  
 
In hoofdstuk 8 van dit proefschrift staat de ontwikkeling van een keuzehulp beschreven met 
daarin een model voor het voorspellen van de kans op een succesvolle vaginale baring na 
een eerdere keizersnede. Deze twee onderdelen vormen, samen met de training van 
zorgprofessionals, de basis van de zorgverbeteringsstrategie op het gebied van 
besluitvorming rondom bevallen na een eerdere keizersnede. De in hoofdstuk 8 van dit 
proefschrift beschreven zorgverbeteringsstrategie is specifiek gericht op zwangere vrouwen 
in Nederland met een keizersnede in de voorgeschiedenis en de artsen die deze vrouwen 
voorlichten. Indien de keuzehulp succesvol geïmplementeerd zou worden en effectief blijkt, 
kunnen de resultaten mogelijk geëxtrapoleerd worden naar een klinische setting buiten 
Nederland. Of het ontwikkelde predictiemodel en de keuzehulp hier ook daadwerkelijk 
geschikt voor zijn, zou aanvullend onderzocht moeten worden. Zoals ook al bleek uit de 
 Valorisatie 
145 
V
al
or
is
at
ie
V
al
or
is
at
ie
studie die is beschreven in hoofdstuk 5 van dit proefschrift, is een predictiemodel namelijk 
niet zomaar zonder meer van toepassing en valide in een nieuwe setting. De belangrijkste 
reden hiervan is dat door verschillende populatie-kenmerken de validiteit van een model kan 
worden beïnvloed. Ook de ‘aanvaardbaarheid’ van de inhoud van de keuzehulp onder artsen 
en patiënten kan per land verschillend zijn. Of verdere uitbreiding van de doelgroep op 
internationaal niveau mogelijk is, dient dus aanvullend onderzocht te worden. 
Innovatie 
De SIMPLE studie is het eerste project dat een indicatoren set ontwikkelde om obstetrische 
zorg voor indicatiestelling van een keizersnede te meten voor, tijdens en na de partus. Door 
toepassing van deze set indicatoren werd op unieke wijze de huidige Nederlandse 
obstetrische zorg rondom keizersneden in kaart gebracht. De vervolgens ontwikkelde 
keuzehulp met predictiemodel is in het huidige stadium specifiek bedoeld voor Nederland. 
Innovatief aan deze keuzehulp is dat het de eerste keuzehulp over de manier van bevallen 
na een eerdere keizersnede is met een predictiemodel. Een voordeel van het toegevoegde 
predictiemodel is dat de keuzehulp aangepast kan worden aan de individuele patiënt en 
derhalve uitermate geschikt is om in te zetten voor ‘personalized medicine’. En in de 
hedendaagse geneeskunde wordt deze manier van geneeskunde bedrijven steeds meer de 
norm.3 
Implementatie, Planning en Realisatie 
In welke mate de ontwikkelde keuzehulp succesvol geïmplementeerd kan worden in de 
huidige obstetrische zorg wordt onderzocht in de SIMPLE II studie. De resultaten van dit 
onderzoek zijn nog niet bekend en zijn dan ook niet beschreven in dit proefschrift. Het doel 
van de SIMPLE II studie is om te evalueren of het inzetten van de in hoofdstuk 8 
beschreven keuzehulp ‘bevallen na een eerdere keizersnede’ leidt tot een hogere richtlijn 
adherentie zonder stijging van het aantal (spoed)keizersneden. De interventie werd 
ingevoerd in zes ziekenhuizen. In zes andere ziekenhuizen werd de reguliere obstetrische 
zorg gehandhaafd, deze ziekenhuizen dienden als controle. De zorg in combinatie met de 
keuzehulp zal worden geëvalueerd op het gebied van haalbaarheid en ervaringen. Daarbij zal 
worden gemeten of het percentage ‘vaginal birth after caesarean section’ (VBAC) in de 
studieperiode gelijk blijft en worden de kosten geanalyseerd. Indien deze studie zou 
uitwijzen dat de zorgverbeteringsstrategie haalbaar en effectief is, kan implementatie op 
grote schaal in Nederland overwogen worden. Hierbij kan men bijvoorbeeld denken aan het 
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koppelen van de keuzehulp aan de NVOG richtlijn ‘Zwangerschap en bevalling na een 
voorgaande keizersnede’. 
Referenties 
1. Stichting Perinatale Registratie Nederland. Perinatale Zorg in Nederland 2013. Utrecht: Stichting Perinatale 
Registratie Nederland. 
2.  Kwee A, Elferink-Stinkens PM, Reuwer PJ, Bruinse HW. Trends in obstetric interventions in the Dutch 
obstetrical care system in the period 1993-2002. Eur J Obstet Gynecol Reprod Biol. 2007; 132(1): 70-5. 
3.  Hayes DF, Markus HS, Leslie RD, Topol EJ. Personalized medicine: risk prediction, targeted therapies and 
mobile health technology. BMC Med 2014; 12: 37. 
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Nederlandstalige samenvatting 
Achtergrond en doel van het onderzoek 
De keizersnede was oorspronkelijk bedoeld als noodprocedure tijdens de bevalling. De 
huidige wereldwijde stijging in het aantal keizersneden dat wordt uitgevoerd impliceert 
onjuiste toepassing van de keizersnede. Meer keizersneden zou kunnen leiden tot meer 
complicaties voor moeder en kind en tot hogere kosten voor de gezondheidszorg. 
Het stijgende aantal keizersneden resulteert tevens in een groeiende groep vrouwen die 
zwanger zijn na een voorafgaande keizersnede, deze vrouwen hebben dus een litteken in de 
baarmoeder. De zorg in de zwangerschap en tijdens de bevalling voor deze groep vrouwen 
vereist een andere aanpak dan voor zwangere vrouwen zonder litteken in de baarmoeder. 
De reden is dat er een grotere kans op complicaties bestaat tijdens de zwangerschap en 
bevalling, zoals het scheuren van het litteken. Vrouwen die zwanger zijn na een eerdere 
keizersnede moeten dan ook worden gecounseld over de manier van bevallen. Hierbij 
dienen ze de keuze te krijgen tussen een primaire keizersnede en het nastreven van een 
vaginale bevalling (VBAC). Als een intentie tot VBAC niet slaagt, resulteert dit alsnog in een 
(spoed)keizersnede. Er bestaan duidelijke evidence-based richtlijnen over wanneer een 
keizersnede uit te voeren en hoe om te gaan met een zwangerschap na een eerdere 
keizersnede. Het is echter niet duidelijk of deze richtlijnen op de juiste manier worden 
gevolgd. Het doel van dit proefschrift is dan ook om in kaart te brengen in hoeverre 
richtlijnen rondom indicatiestelling en uitvoering van keizersneden in Nederland worden 
nageleefd door artsen. Vervolgens is het doel om op basis van de resultaten van deze 
analyse een strategie te ontwikkelen die gericht is op het verbeteren van de huidige zorg.  
 
Dit proefschrift bestaat uit twee delen. Het eerste gedeelte beslaat het meten van de huidige 
zorg rondom het uitvoeren van keizersneden in Nederland (hoofdstukken 2, 3 en 4). Op 
basis van de analyse in deel 1 van het proefschrift is een zorgverbeteringsstrategie 
ontwikkeld. Het proces van het ontwikkelen en uittesten van deze zorgverbeteringsstrategie 
staat beschreven in het tweede gedeelte van dit proefschrift (hoofdstukken 5, 6, 7 en 8). 
Belangrijkste bevindingen 
Zoals beschreven in hoofdstuk 2 is, op basis van het raamwerk van Grol et al., een strategie 
ontwikkeld om de huidige Nederlandse zorg op het gebied van keizersneden op een 
systematische wijze te analyseren en te verbeteren. Deze strategie bestaat uit vier ‘hoofd 
stappen’ 1: het ontwikkelen van op richtlijnen gebaseerde kwaliteitsindicatoren omtrent de 
beslissing wanneer een keizersnede uit te voeren; 2: het analyseren van de adherentie aan de 
kwaliteitsindicatoren in de huidige Nederlandse obstetrische zorg; 3: het onderzoeken van 
barrières en facilitatoren voor adherentie aan kwaliteitsindicatoren en 4: het ontwikkelen, 
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uitvoeren en evalueren van een zorgverbeteringsstrategie met als eindpunten effectiviteit, 
haalbaarheid en kosten. Dit proefschrift rapporteert de resultaten van stap 1 en 2, en de 
ontwikkeling en het pilot-testen van de zorgverbeteringsstrategie (stap 4 en tevens deel 2 
van dit proefschrift).  
Hoofdstuk 3 beschrijft de ontwikkeling en meting van de op richtlijnen gebaseerde 
kwaliteitsindicatoren. We hebben hiervoor een gestandaardiseerde methode gebruikt (de 
RAND-modified Delphi methode) om een set kern-aanbevelingen vast te stellen die 
geschikt waren voor transcriptie naar kwaliteitsindicatoren. Een uiteindelijke set van 27 
kwaliteitsindicatoren werd goedgekeurd door een nationaal expertpanel. Analyse van de 
adherentie aan deze indicatoren werd uitgevoerd in een multicenter setting en toonde vier 
belangrijke categorieën als doel voor een mogelijke interventie-strategie: 1) veronderstelde 
foetale nood (frequentie van voorkomen 17%, een keizersnede werd uitgevoerd na 
toepassing van de richtlijn in 46% van de gevallen); 2) niet-vorderende baring (frequentie 
van voorkomen 12%, een keizersnede werd in 75% van de gevallen te vroeg uitgevoerd); 3) 
continue begeleiding tijdens de bevalling (van toepassing op 88% van de bevallingen, een 
keizersnede werd uitgevoerd waarbij continue begeleiding tijdens de bevalling aanwezig was 
in slechts 37% van de gevallen) en 4) eerdere keizersnede (frequentie van voorkomen 12%, 
adequate counseling over de manier van bevallen in 15%). Onze hypothese is dat een 
richtlijn implementatie-strategie, gericht op deze onderwerpen, zal leiden tot een hogere 
richtlijn-adherentie, tot ‘betere zorg’ en zelfs tot een mogelijke reductie van het aantal 
keizersneden zonder negatieve impact op de uitkomst voor moeder en kind.   
In hoofdstuk 4 analyseerden we de kwaliteitsindicator op het gebied van ‘zwangerschap na 
eerdere keizersnede’ verder op het gebied van praktijkvariatie. In deze studie vergeleken we 
in 17 verschillende ziekenhuizen het aantal primaire herhalingskeizersneden dat werd 
uitgevoerd bij vrouwen die eerder één keizersnede hadden gehad. Tevens werd het aantal 
succesvolle pogingen tot VBAC onderzocht. De aantallen werden gecorrigeerd voor 
verschillen tussen patiëntpopulaties (casemix). We analyseerden hiervoor 763 patiënten-
dossiers, binnen deze groep bevielen 248 (33%) met een primaire herhalingskeizersnede en 
515 vrouwen (67%) streefden een VBAC na. De waarden per ziekenhuis, gecorrigeerd voor 
de patiëntenpopulatie, toonden een grote spreiding: het aantal primaire herhalings-
keizersneden was gemiddeld 29.8% maar met een spreiding tussen de 6 en 54%. Het aantal 
succesvolle intenties tot VBAC lag gemiddeld op 71.8% met een spreiding tussen de 
ziekenhuizen van 52.7% tot 90.0%. Deze data laat zien dat er een grote praktijkvariatie 
bestaat tussen Nederlandse ziekenhuizen op het gebied van bevallen na een eerdere 
keizersnede. Deze variatie kon niet voldoende verklaard worden door verschillen in 
patiëntpopulaties van de deelnemende ziekenhuizen. Hierdoor kunnen we stellen dat 
factoren op het gebied van zorgverleners en op ziekenhuisniveau een belangrijkere rol 
spelen in het ontstaan van deze praktijkvariatie.   
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In hoofdstuk 5 hadden we als doel om twee predictiemodellen te valideren voor de 
Nederlandse populatie. Dit betrof de Amerikaanse modellen van Grobman et al. waarmee 
voorspeld wordt wat de kans bij een intentie tot VBAC is dat deze succesvol is (dus 
daadwerkelijk resulteert in een vaginale baring en niet in een spoedkeizersnede). Het eerste 
predictiemodel, het ‘entry-to-care’ model (ETC), bevat de volgende variabelen: leeftijd van 
de moeder, body mass index (BMI) vóór de zwangerschap, etniciteit, eerdere vaginale 
bevalling, eerdere VBAC, eerder niet vorderende baring. Het tweede model,  het ‘close-to–
delivery’ model (CTD), bouwt hierop voort. In dit model is BMI voor de zwangerschap 
vervangen door BMI in het derde trimester van de zwangerschap en is toegevoegd: 
zwangerschapsduur ten tijde van de bevalling,  hoge bloeddruk tijdens de zwangerschap, 
parameters van lichamelijk onderzoek tijdens de bevalling (ontsluiting, het verstrijken van de 
cervix en indaling van het kind) en of er sprake was van het inleiden van de bevalling. De 
modellen zijn gemaakt voor zwangeren die maximaal één eerdere keizersnede hebben 
gehad, in de huidige zwangerschap een eenling verwachten in hoofdligging en die à terme 
bevallen. Om deze reden hebben wij alleen vrouwen geïncludeerd in onze studie die ook 
aan deze criteria voldeden. Voor iedere vrouw werd de kans op een succesvolle VBAC 
uitgerekend met beide modellen. Vervolgens werd berekend hoe goed de predictiemodellen 
presteren in ons cohort. Hiervoor werd gekeken naar onderscheidend vermogen (onder-
scheid hoge versus lage kans op slagen) en voorspellend vermogen (precisie). Beide 
modellen hadden een redelijk onderscheidend vermogen en er was sprake van een goede 
precisie. We concluderen dat beide modellen adequaat presteren in de Nederlandse 
populatie. De modellen zijn echter niet volledig geschikt voor toepassing in de Nederlandse 
zorg. Dit komt omdat we in Nederland counselen over de manier van bevallen in het derde 
trimester van de zwangerschap, maar sommige variabelen pas bekend worden tijdens de 
bevalling. Daarnaast zijn variabelen zoals ‘etniciteit’ minder van toepassing in de 
Nederlandse populatie.   
Derhalve presenteren wij in hoofdstuk 6 een nieuw predictiemodel, gemaakt op basis van 
bestaande modellen. Dit model is bedoeld voor counseling omtrent de manier van bevallen 
na een eerdere keizersnede in het derde trimester van de zwangerschap en is geschikt voor 
een West-Europese populatie. Om ervoor te zorgen dat het model extern valide is, dus niet 
alleen maar valide binnen de dataset, werd er een uitvoerig literatuur onderzoek verricht 
alvorens de variabelen te kiezen die werden opgenomen in het model. Het uiteindelijke 
model voor het voorspellen van een succesvolle VBAC bevat zes variabelen waaronder 
demografische variabelen (BMI voor de zwangerschap, Caucasische etniciteit), obstetrische 
voorgeschiedenis (eerdere vaginale bevalling en eerdere niet vorderende bevalling) en 
variabelen die bij de huidige zwangerschap horen (inleiding van de bevalling en geschat 
foetaal gewicht boven het 90ste percentiel). Het ontwikkelde predictiemodel heeft een 
redelijk onderscheidend vermogen en is accuraat, met name voor vrouwen met een 
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voorspelde slagingskans van 65% of hoger. Echter, of het model beter is dan de ‘klinische 
blik’ van de obstetricus is nog niet evident.  
Daarom hebben we vervolgens een studie uitgevoerd waarin het ontwikkelde 
predictiemodel werd vergeleken met de ‘klinische blik’ (hoofdstuk 7). Om de klinische blik 
te kunnen vergelijken met prestatie van het predictiemodel werden er vignetten ontwikkeld. 
In elk vignet werd een klinische casus gepresenteerd op basis waarvan clinici werden 
gevraagd om de kans op een succesvolle VBAC in te schatten. Vervolgens werd deze kans 
ook berekend met behulp van het predictiemodel en werden de kansen vergeleken met 
elkaar en de uiteindelijke uitkomst. Wij toonden aan dat wat betreft onderscheidend 
vermogen en precisie de clinici niet goed presteerden in vergelijking met het 
voorspellingsmodel. Clinici neigden naar onderschatting van de daadwerkelijke slagingskans.  
Tenslotte beschrijft hoofdstuk 8 de ontwikkeling en het pilot-testen van de keuzehulp. De 
keuzehulp is onderdeel van de zorgverbeteringsstrategie ten aanzien van zorg voor 
zwangeren met een keizersnede in de voorgeschiedenis. Het systematische ontwikkelings-
proces van deze keuzehulp bestond uit een constructie fase (bepalen van de doelgroep en 
het doel van de keuzehulp, selectie van de inhoud en selectie van de weergave van de 
keuzehulp) en een pilot-test fase. Het proces werd gesuperviseerd door een 
multidisciplinaire stuurgroep en een expert panel. De ontwikkelde keuzehulp bestaat uit een 
boekje met daarin een stapsgewijze aanpak van het keuzeproces. De keuzehulp bestaat uit 
neutrale en gebalanceerde informatie over bevallen na een eerdere keizersnede, een 
opdracht voor de patiënt om haar wensen en mening ten aanzien van de manier van 
bevallen te verhelderen en op maat gemaakte informatie inclusief het in hoofdstuk 6 
beschreven predictiemodel. De pilot-studie liet zien dat het waarschijnlijk is dat de 
ontwikkelde keuzehulp bijdraagt aan een beter keuzeproces.   
In het afsluitend hoofdstuk 9 worden de belangrijkste bevindingen van dit proefschrift 
samengevat en bediscussieerd. We stellen dat de ontwikkelde zorgverbeteringsstrategie 
veelbelovend is voor het verbeteren van de huidige zorg rondom het keuzeproces van de 
manier van bevallen na een eerdere keizersnede. 
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Dankwoord 
‘Birth after Caesarean, is it SIMPLE?’, de afgelopen vier jaar heb ik met veel plezier onderzoek 
gedaan en ontzettend veel geleerd. ‘Simpel’ was het zeker niet en dit proefschrift is dan ook 
tot stand gekomen dankzij de begeleiding en ondersteuning van velen.  
 
Als eerste een woord van dank aan mijn promotor en co-promotoren: Prof dr. J.G. Nijhuis, 
Dr. H.C.J. Scheepers en Dr. R.P.M.G. Hermens .  
Prof dr. J.G. Nijhuis, ik leerde u kennen nog tijdens de A-KO opleiding als projectlid van 
de SIMPLE studie. Toen ik vervolgens aangesteld werd als promovenda was het een 
logische stap dat u mijn promotor werd. Al snel werkten we op uitnodiging van het 
Nederlands Tijdschrift Obstetrie en Gynaecologie samen aan een klinisch stuk over VBAC. 
Voor mij de perfecte start van het proefschrift en een goede manier om verdieping te 
vinden in het onderwerp. Ik wil u vooral bedanken voor uw zeer snelle en scherpe 
commentaar, betrouwbaarheid en de zeer adequate bijsturing van mijn manier van 
wetenschappelijk schrijven. Ik vond het altijd erg fijn om zo snel, ondanks uw drukke 
agenda, zeer nuttig commentaar te krijgen op mijn manuscripten.  
Dr. H.C.J. Scheepers, beste Liesbeth, ik wil je bedanken voor de dagelijkse begeleiding van 
mijn promotietraject. Allereerst wil ik je bedanken voor de kans die je me hebt gegeven om 
al als student te starten met een PhD traject. Jouw positieve houding, tomeloze 
enthousiasme en betrokkenheid heb ik als zeer prettig ervaren en hebben enorm bijgedragen 
aan het proefschrift dat er nu ligt. Ik heb ontzettend veel van je geleerd, met name op het 
gebied van het translationele aspect van onderzoek doen. Ik ben trots één van je eerste 
promovendi te mogen zijn, ik weet zeker dat er nog veel succesvolle promovendi zullen 
volgen! 
Dr. R.P.M.G. Hermens, beste Rosella, ik heb ontzettend veel van je geleerd. Ik wil je 
bedanken voor je uitgebreide en constructieve feedback op mijn stukken. Je hebt de gave 
om precies helder te krijgen wat er nog ontbreekt aan een stuk of wat onduidelijk is. Jouw 
feedback heeft dan ook menig manuscript naar een hoger niveau getild. Ook al zat je op 
afstand, vanuit Nijmegen heb je via onze (twee)wekelijkse telefonische besprekingen een 
grote rol gespeeld in mijn ontwikkeling als wetenschapper. Bedankt daarvoor! 
 
De leden van de beoordelingscommissie: Prof. dr. M.H. Prins, Dr. M.J. Faber, Prof. dr. 
S.A. Scherjon, Prof. dr. M.E.A. Spaanderman en Prof. dr. R.G. de Vries, wil ik 
bedanken voor de beoordeling van dit proefschrift. 
 
Ik wil graag de leden van de SIMPLE projectgroep bedanken: dr. Luc Smits, prof. dr. 
Carmen Dirksen, prof. dr. Trudy van der Weijden, dr. Anneke Kwee en prof. dr. Ben 
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Willem Mol. Bedankt voor jullie inzet voor het SIMPLE onderzoek en voor jullie 
uitgebreide feedback op de diverse manuscripten! 
 
Sander van Kuijk, ik heb ontzettend veel van je geleerd. Je hebt een opvallend talent voor 
onderwijs geven en jouw begeleiding op het gebied van methodologie en statistiek zijn dan 
ook zeer belangrijk en in zekere zin bepalend geweest voor de totstandkoming van menig 
artikel in dit proefschrift. Daarnaast wil ik je bedanken voor de fijne en efficiënte 
samenwerking en alle tijd die je hebt uitgetrokken om met me te brainstormen en me dingen 
uit te leggen. Ik hoop dat we in de toekomst nog vaker gaan samenwerken! 
 
Emy Vankan en Sonja Melman, uiteindelijk wordt het een driedubbele promotie op de 
SIMPLE studie! Sonja, jij was tijdens de A-KO een fijne begeleider, dit ging daarna 
moeiteloos over in ‘collega’s’. Bedankt voor de fijne samenwerking! Emy, vanaf het begin 
dat jij erbij kwam klikte het al erg goed en ik ervaar onze samenwerking dan ook als zeer 
prettig. Jij maakt het laatste stuk van de SIMPLE II studie af en ik heb dan ook met veel 
plezier en vertrouwen dit stuk verder kunnen loslaten wetende dat het bij jou in goede 
handen is. Sonja en Emy, ik kijk ook erg uit naar jullie promoties! 
 
Chahinda, wij hebben elkaar leren kennen als collega’s bij de gynaecologie, inmiddels is 
‘collega’s’ uitgegroeid tot een fijne vriendschap. Bedankt voor alle uurtjes brainstormen op 
de vierde verdieping van het MUMC, dit heeft zeker zijn vruchten afgeworpen! Ik heb 
enorme bewondering voor je doorzettingsvermogen en je wetenschappelijk scherpe blik en 
ben dan ook heel benieuwd waar je over 10 jaar staat, ik weet zeker dat je een mooie carrière 
tegemoet gaat! 
 
Jannie, wij zijn samen als student begonnen aan de SIMPLE studie. Naast dat we het op 
persoonlijk vlak al goed konden vinden bleek dat we ook heel fijn en effectief konden 
samenwerken. Hierdoor heeft de start van mijn promotieonderzoek, waarbij jij me hebt 
geholpen met het verzamelen van mijn data, een enorme boost gekregen. Bedankt daarvoor! 
 
Ik wil ook ‘mijn studenten’ bedanken: Brigitte Augustijn, Marleen Alink, Mark de 
Koning, Dorien Hünen en Anouk van den Bosch. Ik vond het erg leuk om jullie allemaal 
te begeleiden in het doen van onderzoek en heb fijn met jullie allemaal samengewerkt! 
Bedankt voor jullie inzet! 
 
Mandy Bronsgeest, beste Mandy, ik wil je heel erg bedanken voor het maken van de 
omslag van mijn proefschrift, ik ben er erg blij mee! Ik wil ook graag Gerda en Leo 
bedanken voor jullie steun en interesse in mijn onderzoek en voor het feit dat jullie mij 
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Mandy hebben aanbevolen. Een heerlijke week in februari bij Gerda in Spanje heeft ertoe 
geleid dat ik de laatste puntjes op de i kon zetten voor de afronding van het manuscript 
waarna dit naar de beoordelingscommissie kon. 
 
Ik wil graag Tiny Wouters bedanken voor het opmaken van dit proefschrift! 
 
Uiteraard verdienen mijn paranimfen hier een uitgebreide vermelding: Hanke en Susan, als 
‘kwik, kwek en kwak’ danwel ‘K3’ zijn we gedrieën als huisgenoten, studiegenoten en 
vriendinnen de A-KO met veel plezier maar ook alle drie succesvol doorgekomen. Ook in 
onze promoties, al gaan deze over zeer verschillende onderwerpen aan verschillende 
universiteiten, hebben we elkaar gemotiveerd en gesteund: van advies op wetenschappelijk 
niveau tot aan ‘werkmuziekjes’,  de meer organisatorische aangelegenheden van het 
promoveren en natuurlijk de nodige ontspanning. Ik ben er trots op dat jullie de 23ste juni 
naast mij staan als mijn paranimfen. Enorm bedankt voor jullie vriendschap!  
 
Lieve vrienden en vriendinnen. Jullie vriendschap heeft me veel plezier en nieuwe energie 
gebracht tussen het harde werken door. Bedankt hiervoor en voor de interesse in mijn werk! 
 
Hamid, Susan, Michael en Tanja, ik had me geen fijnere schoonfamilie kunnen wensen. 
Bedankt voor jullie enthousiasme en brede ondersteuning. 
 
Lief zusje, lieve Esther, ook al zijn we wat betreft onze carrières twee totaal verschillende 
kanten opgegaan, aan belangstelling en betrokkenheid in mijn werk heeft het je nooit 
ontbroken. Zo heb je nog vanuit Egypte mijn artikel dat naar de Lancet ging nagekeken op 
taal, en ben je altijd goed op de hoogte van waar ik mee bezig ben. En uiteindelijk hebben 
we allebei veel plezier in schrijven en in het doen van wetenschappelijk onderzoek, of dat 
nou gaat over kwaliteit van zorg of over de revolutie in Egypte… Ik ben ontzettend trots op 
je en ben benieuwd, je hebt het er al vaak over gehad… wellicht over een paar jaar jouw 
promotie? En dan wordt natuurlijk de volgende vraag, waar gaat deze plaatsvinden: 
Zweden, Dubai, Egypte of toch heel misschien Nederland? Ik wens jou en Samy heel veel 
geluk toe.  
 
Lieve pap en mam, jullie belangstelling en steun zijn voor mij heel belangrijk geweest. Van 
het begin van het onderzoek tot het eind ‘zullen wij het voor je afmaken?’, zijn jullie altijd enorm 
geïnteresseerd geweest en betrokken gebleven. Meerdere gezamenlijke heerlijke weken in 
Zweden heeft onder jullie aanmoediging, omdat ik toch wel erg moe was van het harde 
werken in de kliniek, geleid tot het kunnen schrijven van de introductie en de discussie van 
dit proefschrift, bedankt voor alles! 
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Als laatste wil ik mijn allerliefste Mack bedanken. Lieve Siamack, bedankt voor je steun en 
aanmoediging bij eigenlijk alles wat ik onderneem of wil gaan ondernemen. Maar ook voor 
je begrip voor wanneer ik als echt avondmens midden in de nacht weer eens graag wilde 
praten over een moeilijke analyse, presentatie, nieuw idee, ofwel de feestlocatie voor mijn 
PhD receptie. Ik ben ervan overtuigd dat we elkaars positieve punten niet alleen op 
persoonlijk vlak maar ook op het gebied van werk versterken en dat is erg bijzonder. Nu 
jouw boekje nog en ondertussen, op naar onze bruiloft op 28 augustus! 
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VWO diploma met profiel ‘natuur en gezondheid’ en Latijn aan de Scholen Gemeenschap 
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geselecteerd voor de nieuwe research master ‘Arts-Klinisch Onderzoeker’ (A-KO). De 
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een brug te slaan tussen klinisch onderzoek en de medische praktijk. In het laatste jaar van 
deze masteropleiding is zij betrokken geraakt bij de SIMPLE studie. In de tijdens dit jaar 
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onderzoek. Na haar afstuderen als Arts-Klinisch Onderzoeker in augustus 2011 zette ze 
haar onderzoek dan ook voort in de vorm van een promotie traject onder supervisie van 
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2015 werkte ze als arts-assistent bij de interne geneeskunde in het MUMC+ om vervolgens 
in maart 2015 te starten met de huisartsopleiding in Maastricht. 
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